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Oh heavens, now,
is it the middle or right one to stop and the left one to go,
or middle to go, left to stop?
Maud Menten

Abstract
Tuberculosis remains one of the major global health threats responsible for over 1.5 million
deaths each year. This ’success story’ of the causative agent Mycobacterium tuberculosis is
thereby closely linked to a flexible metabolism, allowing growth despite the restrictive conditions
within the human host.
In this thesis, the flexibility of the mycobacterial central carbon metabolism is explored by
modeling approaches integrating high-quality experimental data. The analyses zoom in from a
network based view to the detailed functionalities of individual, virulence relevant pathways.
The interconnection of the central carbon metabolism to the remaining metabolic network is
charted as a prerequisite to characterize its thermodynamic landscape, debunking glycolysis
as bottleneck in different nutritional conditions. Based on steady state metabolomics and
proteomics data, regulatory sites for the metabolic transition between different carbon sources
are predicted by a novel method. Finally, the flexible interplay between two seemingly redundant
pathways for the catabolism of an in vivo-like carbon source is explained mechanistically by
means of thermodynamic-kinetic modeling.
By employing novel modeling methods in combination with high-resolution experimental
data, this work adds to the mechanistic understanding of the context dependent flexibility of
mycobacterial metabolism, an important target for the development of novel drugs in the battle
against tuberculosis.

Zusammenfassung
Tuberkulose ist auch heute noch eine der tödlichsten Infektionskrankheiten der Welt, der jährlich
Millionen Menschen, vor allem in Entwicklungsländern, zum Opfer fallen. Ihr Erreger, My-
cobacterium tuberculosis, unterwandert das menschliche Immunsystem durch eine Reihe von
hochentwickelten Strategien, zu denen auch ein extrem anpassungsfähiger Stoffwechsel gehört.
Die Dissertation untersucht diesen aus Sicht der Systembiologie und verbindet dabei Meth-
oden der mathematischen Modellierung mit neuen, qualitativ hochwertigen experimentellen
Daten. Ausgehend von einem Überblick über die metabolische Landschaft des zentralen Kohlen-
stoffmetabolismus und dessen systematischer Verknüpfung zu umgebenden Stoffwechsel- und
Biosynthesewegen, erhöht sich Schritt für Schritt die Detailtiefe bis hin zur genauen, thermo-
dynamisch konsistenten Analyse der kinetischen Eigenschaften spezieller infektionsrelevanter
metabolischer Wege.
Basierend auf der Analyse der erhobenen experimentellen Daten werden zunächst allgemeine
Größenordnungen für die Komponenten (Konzentrationen, Flüsse etc.) der nachfolgenden
Modellierungsansätze etabliert. M. tuberculosis wird ausführlich "vermessen" und seine phys-
iologischen Eigenschaften in Relation zu anderen Zellen gesetzt. Diese rein datenbasierte
Auswertung gibt bereits wichtige Hinweise auf die Anpassung des zentralen Kohlenstoff-
metabolismus unter verschiedenen Nahrungsquellen und Wachstumsphasen.
Diese solide Datenbasis wird verwendet um das zentrale metabolische Netzwerk M. tuberculo-
sis’ im Fließgleichgewicht zu charakterisieren. Zum einen wird eine neu entwickelte Methode
vorgestellt, die solch isolierte metabolische Teilnetzwerke basierend auf einem bereits existieren-
den genomskaligen Modell sinnvoll in den Gesamtstoffwechsel einer Zelle einbettet (’Biomass
Backtracking’). Neben einigen allgemeineren Anwendungsbeispielen wird die Methode verwen-
det um wachstumsbedingungsspezifische, biologisch korrekte Randflüsse zu errechnen, die für
alle weiteren Modelle unabdingbar sind. Das kontextualisierte Netzwerk wird dann mit Hilfe
eines Ansatzes der linearen Programmierung thermodynamisch charakterisiert. Dabei werden
existierende Methoden, wie die thermodynamische Fluss-Bilanzanalyse oder die Optimierung
der Maximum-Minimum driving force, kombiniert um thermodynamischer Optimalität auf
Netzwerkebene Rechnung zu tragen. In diesem Licht stellt sich die Glykolyse als limitierender
Stoffwechselweg in allen getesteten experimentellen Bedingungen dar.
Im nächsten Verfeinerungsschritt, wird das obige rein stöchiometrische System durch kinetische
Gleichungen für alle beteiligten Reaktionen erweitert, um die Abhängigkeit der Flüsse von den
experimentell quantifizierten Metabolitdaten zu ergründen. Das so entstandene Modell wird in
einem neuen Optimierungsansatz verwendet um ein minimales Set regulatorischer Punkte zu
identifizieren, das alle Unterschiede in den Metabolitdaten im Fließgleichgewicht wiedergeben
kann. Dazu werden ebenfalls Proteindaten in das Modell integriert. Die Optimierung charakteri-
siert die obere Glykolyse sowie die zweite Hälfte des Zitronensäurezyklus als regulatorische
Punkte für den Übergang zwischen glykolytischen und gluconeogenetischen Kohlenstoffquellen.
Im letzten Teil, wird das Fließgleichgewicht verlassen, um die Funktionalität zweier spezieller
Abbauwege für Propionat, einer Kohlenstoffquelle die die Bedingungen im menschlichen
Wirt nachahmt, zu verstehen. Zusätzlich wird ein thermodynamischer Term in die kinetis-
che Beschreibung der Reaktionen eingefügt. Basierend auf experimentellen Zeitverläufen der
Konzentrationen der beteiligten Metabolite nach schnellen Wechseln der Kohlenstoffquelle,
können den beiden scheinbar redundanten Abbauwegen spezifische Funktionen zugeordnet
werden: Der thermodynamisch limitierte Methylmalonyl-Weg kann schnell auf Änderungen
der intrazellulären Propionatkonzentration reagieren, auch um potentielle Intoxikation durch
metabolische Zwischenprodukte zu verhindern. Der transkriptionell regulierte Methylzitrat-Weg,
erreicht eine höhere Flusskapazität und metabolische Kontrolle, weshalb er als spezialisierter
Abbauweg verwendet wird. Diese funktionelle Diversifizierung und mögliche Kompensation
kann als ein Konzept der krankheitsrelevanten metabolischen Flexibilität M. tuberculosis’ gese-
hen werden.
Durch die Weiterentwicklung von Methoden zur metabolischen Modellierung sowie die gezielte
Integration hochauflösender, quantitativer Metabolit- und Proteomdaten trägt die Arbeit so
ihren Teil für ein besseres Verständnis der Grundlagen des zentralen Kohlenstoffwechsels in
Mykobakterien bei.
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1. Introduction
Are you interested in tuberculosis? The following Chapter will introduce basic facts on tubercu-
losis and explain why studying the pathogen Mycobacterium tuberculosis, and especially its
metabolism, is at the core of efforts to tackle the global tuberculosis pandemic. It will also
describe why integrative systems biological approaches – such as mathematical modeling and
large scale experimental measurements – are required to advance understanding in this field.
1.1 Tuberculosis
1.1.1 Epidemiology and pathogenesis
A forgotten enemy
While tuberculosis incidences in Europe are almost negligible and have hence vanished from
public attention, the disease remains a major global health threat: Around one third of the
world’s population is infected with M. tuberculosis. Even though infected patients have an only
10 % lifetime risk of developing open tuberculosis, the active form of the disease, the death toll
accounts to over 1.5 million persons per year, or one each 21 seconds. Only second to HIV,
tuberculosis is a leading cause of premature death due to infection worldwide. Incidences are
high in developing countries, with 22 high-burden countries registering over 80 % of the global
tuberculosis cases (Figure 1.1).
0–9.9
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≥500
No data
Not applicable
Estimated new TB 
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per year
Figure 1.1: Tuberculosis incidence per year and country, darker blue indicates a higher number of tuberculosis
patients. The figure was taken and modified from the WHO global tuberculosis report [209].
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Figure 1.2: Alveolar macrophage with phagocytized
M. tuberculosis, isolated from a patient (electron micro-
graph). The figure is taken from Russell et al. [167].
Access to medication and diagnostics is often limited in those countries, explaining the fatalities
despite the availability of effective antibiotic medication. Nonetheless, there are also success
stories to be told: Global efforts focused on improved diagnosis and treatment have decreased
tuberculosis mortality by 47 % and incidences by more than 18 % in the last 25 years. Newly
developed drugs with shorter treatment regimens can further advance this progress. [209]
Pathogenesis
After having co-evolved with its human host, probably since the beginnings of modern man-
kind [61], M. tuberculosis was identified as the causative agent of tuberculosis by Robert Koch in
1882 [95]. Due to this co-evolution, M. tuberculosis is a highly specialized pathogen, perfectly
adapted to its living environment. A solid body of knowledge on many aspects of tuberculosis’
pathogenesis, M. tuberculosis itself and its interplay with the host has accumulated. Here, a
concise summary of the aspects relevant to this work will be given.
M. tuberculosis enters (and leaves) the human host via the respiratory tract in small aerosol
droplets. The infectious dose is thereby as low as 10-100 bacteria, rendering tuberculosis an
extremely contagious disease. The locus of the primary infection is usually in the lower regions
of the lung, whereas in later stages of the disease, M. tuberculosis can invade virtually all other
tissues in the body.
The bacteria hijack an integral compound of the human immune system, the macrophage. These
professional phagocytes engulf the bacteria within phagosomes (Figure 1.2). By acidification
of the phagosomal lumen and the secretion of reactive oxygen and nitrogen intermediates, the
macrophages in the most cases clear engulfed bacteria. However, during the co-evolution with
its human host, M. tuberculosis has learned to hinder this phagosomal digestion process at
several levels to conquer the phagosome as its habitat. Secreted proteins inhibit the acidification
of the phagosome as well as its fusion to the lysosome – both steps that are required for
bacterial killing. The arrest in phagosome maturation also reduces the contact to the antigen
processing machinery required for an efficient adaptive immune response. At the same time,
the M. tuberculosis-bearing phagosomes retain fusion with recycling endosomes containing
a limited pool of nutrients, which can be exploited for bacterial growth. Within this harsh
environment, the bacteria grow slowly, with division times around 24 h. The scarcity of nutrients
entails the need for an extremely flexible metabolism, which can utilize small amounts of
distinct nutrients. Also the physiology of the bacteria contributes to coping with the hostile
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conditions in the phagosome: M. tuberculosis is shielded by a thick cell envelope, consisting
of specialized lipids, the eponymous mycolic acids and others, which act as major virulence
factors and nutrient storage at the same time. [87, 88, 167, 174]
M. tuberculosis-infected macrophages, in their struggle to kill the internalized bacteria, are
imprisoned by the host immune system in so called granulomas – localized aggregates of
infected macrophages tightly surrounded by lymphocytes. The granuloma mainly acts as a local
constriction of the bacteria, as a restriction to nutrient and oxygen availability and as a focal
point of the immune response. Nevertheless, the host immune system often fails to clear the
granuloma from M. tuberculosis, such that the bacteria survive within it for long time periods,
even for the entire lifetime of the infected host. M. tuberculosis, on the other hand, has learned
to exploit its prison, infecting new immune cells that are delivered directly to the contained
bacteria. Additionally, the bacteria modulate the granuloma interior to reduce adaptive immune
cell proliferation. Complex bacterial lipids are at the core of this process, triggering the release
of inappropriate cytokines from host cells. [167]
In this see-saw battle between host and pathogen, M. tuberculosis exits its cell cycle if living
conditions become too harsh. The bacteria enter a state of dormancy, characterized by drastically
reduced metabolic activity, absence of growth and tolerance to antibiotics. Dormant bacteria
are associated with phases of latency of the disease, sustaining the danger of re-activation over
decades, especially in situations of reduced immunocompetence. [49, 63, 89, 187]
1.1.2 Frontiers in tuberculosis treatment
Tuberculosis can be treated with antibiotics, but due to the slow growth rates, the inaccessible
micro-environments in the granuloma and the presence of dormant bacteria with low uptake of
drugs, treatment regimens are long (6 months) and require four antibiotics at the same time.
If the treatment is interrupted or not completed, subpopulations of resistant M. tuberculosis can
evolve. In countries with poor health-care systems and infrastructure, resistant strains are
frequent, especially in previously treated patients. Treatment against resistant strains requires
taking more expensive drugs with larger side effects for longer periods (up to 20 months) and
has a lower success rate. This clearly highlights the need for the development of new drugs with
the capability of bypassing the evolved resistance mechanisms. [187, 209]
Especially in African countries, co-infection with the human immunodeficiency virus (HIV)
impedes tuberculosis control. Immunocompromised patients infected with HIV and M. tuber-
culosis have a drastically higher risk to develop open tuberculosis and treatment outcomes are
worse. Co-infection speeds up the progress of either disease and impedes tuberculosis diagnosis.
Additionally, patients are more susceptible to resistant strains, as mutated strains are usually less
fit and can often be cleared by immunocompetent hosts. Again, more effective antibiotics, but
also a better understanding of the mechanistic processes in M. tuberculosis’ biology can help to
address these problems. [2, 209]
Although not directly linked to this work, vaccination as a major frontier in global tuberculosis
control is mentioned here in brief. External activation of macrophages by the adaptive immune
response overwrites the phagosome maturation block in infected macrophages and is an efficient
way to clear bacteria – vaccination can hence be a powerful tool in the battle against tuberculo-
sis. However, the only available vaccine, an attenuated form of M. bovis BCG which causes
bovine tuberculosis, shows poor efficiency, especially in adults. A number of new vaccines
is under development, representing a major route on the way to the eradication of the disease.
[87, 187, 209]
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1.2 Metabolism
When focusing on the pathogen side of tuberculosis, the mycobacterial metabolism is a promis-
ing research target, as it is central to a multitude of virulence mechanisms: The synthesis of
complex lipids plays an important role in immunomodulation and physical protection of the
bacteria, but inflicts a high burden on the metabolism. The nutrient limitation in the phagosome
requires an extremely flexible metabolism that can utilize non-canonical carbon sources in small
quantities. Transition to the dormant state requires an almost complete shutdown of metabolism,
but at the same time residual metabolic activity has to be guaranteed for resuscitation, poten-
tially after decades of dormancy. As all those metabolic processes are very distinct from the
metabolism in the human host, they are promising targets for novel antibiotics.
In the following Section, fundamentals on cellular metabolism will be introduced and subse-
quently linked specifically to the metabolism in mycobacteria.
1.2.1 Complexity, modularity and regulation
Fundamentals
Metabolism is the set of chemical reactions within a cell that facilitates the production of energy
and biomass required for cell growth from external nutrients. The nutrients are thereby broken
down by catabolic reactions into a conserved set of precursor metabolites. These precursors are
then used in anabolic reactions to build the integral parts of the cell’s biomass: Proteins, nucleic
acids, lipids and complex sugars. This so-called bow-tie structure allows for the same set of
chemicals to be used to build diverse complex macromolecules, sharing many steps on the way
to their production. Such production ways are referred to as metabolic pathways and represent
a set of subsequent chemical transformations. The entirety of pathways in a cell constitutes its
metabolic network, where reactions are inter-wired and inter-dependent on many others.
Besides the production of precursors, the breakdown of extracellular nutrients in catabolic
pathways additionally releases energy, which can be stored by the cell in form of high energy
compounds such as adenosine-triphosphate (ATP) or as redox equivalents. This energy is then
used in anabolic pathways to build complex molecules from the precursors.
Metabolic reactions are usually facilitated by enzymes – cellular proteins that act as catalysts.
Enzymes speed up the chemical reaction by orders of magnitude and are also effective levers to
control the metabolic activity in the cell. Enzymes are subject to evolutionary pressure: The
better catalysts they are and the less material needs to be invested in them, the faster the cells
can grow, resulting in an evolutionary advantage over other organisms in the same habitat.
Metabolism is tightly linked to other cellular processes via regulatory paths. Often metabolites
are sensors for the overall state of the cell and accordingly adapt other processes like the cell
division cycle, the replication of the genetic information, mating or the transition to dormancy.
What shapes metabolic flux?
As environmental conditions are usually changing over time, but metabolism always has to
guarantee for the production of functional biomass, metabolic adaptation is required. Changing
availability of nutrients but also environmental stresses result in differential utilization of
metabolic pathways, the flux v of metabolites through specific reactions is altered. To achieve
this re-routing of mass flux, several factors can be tuned by the cells.
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Conceptually, v can be described as a function of five major contributions:
v = f
(
enzyme
amount
(i)
,
catalytic
activity
(ii)
,
enzyme
saturation
(iii)
,
thermodynamic
gradient
(iv)
, regulation
(v)
, · · ·
)
. (1.1)
First and foremost, the flux depends on the availability of catalyzing enzyme (i), but also the
catalytic properties of the enzyme influence the flux. Two parameters are thereby relevant: The
binding affinities of the metabolites to the enzyme and the catalytic activity of the enzyme once
a substrate is bound. In simpler terms, it is important how readily enzyme and substrate bind
to each other and how much the catalysis speeds up the underlying chemical reaction. The
latter term directly translates to increasing fluxes (ii), whereas the former changes with the
concentration of available substrate metabolites, defining the saturation state of the enzyme (iii).
More specifically, if a high concentration of a high-affinity substrate is present, all available
enzyme molecules will constantly be occupied by substrate molecules, resulting in a saturated
enzyme population without idle enzymes.
Chemical reactions also have an energetic aspect: According to the rules of thermodynamics,
they can only occur spontaneously if they dissipate energy. The more energy a reaction dissipates,
the more likely it will take place. This aspect affects metabolic fluxes via the thermodynamic
gradient (iv) which depends on the chemical nature of the reaction as well as on substrate and
product concentrations.
Finally, cells have developed regulatory mechanisms (v) to further alter the flux through a
reaction. They can either affect the enzyme or interfere with the binding of substrates. In
the former case, specific substances can additionally bind to the enzyme or compete with the
substrate for binding sites, to activate or inhibit the reaction. In the latter case, the enzyme
itself is modified, for example post-translationally by phosphorylations, which enhances or
decreases the catalytic activity. Often, these regulations are the outcome of signaling pathways
that transmit environmental information into the cell.
The above factors can be seen as constraints but also as levers for the cell to adapt metabolic
fluxes according to its environment. All five are addressed in this thesis to characterize metabolism
in mycobacteria (see Section 1.4). Although covering the major flux shaping factors in bacteria,
this is not an exhaustive analysis, as further conceivable aspects can contribute to flux control,
for example enzyme localization in the cell or co-localization with other enzymes. [46, 93, 136]
Central carbon metabolism
The central carbon metabolism is the backbone of cellular catabolism which converts sugars into
biomass precursors. It includes the well studied pathway of glycolysis, the pentose phosphate
pathway and the Krebs cycle, along with a set of connecting reactions. It is surprisingly well
conserved between species [139], potentially because it represents an evolutionarily beneficial
minimal set of chemical reactions for its task [135]. Central carbon metabolic enzymes often
take up a large fraction of the cellular protein content, especially in bacterial cells [105], and
have higher catalytic capacities compared to remote pathways [11], corresponding to the large
fraction of the total metabolic flux that is processed by them. Alterations in the environmental
conditions directly affect this part of metabolism, as catabolic routes of almost all nutrients
converge here. Especially beneficial for quantitative as well as theoretical studies, the central
carbon metabolism is well accessible to experimental measurements, allowing for time resolved
determination of metabolite concentrations and reliable quantification of involved enzymes. For
these reasons, the central carbon metabolism was chosen as a target for this work.
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1.2.2 Mycobacterial metabolism
As described above, mycobacterial metabolism is a promising frontier in the battle against
tuberculosis. However, many open questions remain, including the precise wiring of the central
metabolic network, preferentially used enzymes and even the major carbon source in vivo [158].
Finding the major carbon source(s) in the pathogenic context, and alongside the active and
essential pathways, is central to identifying promising drug targets. A body of evidence has ac-
cumulated for the primary utilization of host derived lipids, especially cholesterol [99, 127, 142].
This is consistent with the genes of β -oxidation, the major catabolic route for fatty acids, being
heavily duplicated in the M. tuberculosis genome [37] and up-regulated during infection [171].
In addition, other studies measured carbon dioxide fixation [21] and predicted the metabo-
lization of amino acids and other compounds containing two to three carbon atoms [22] by
intracellular M. tuberculosis. The utilization of the latter carbon sources, as for example acetate
or pyruvate, has been shown to contribute to the ability to grow in low pH media [8], mimicking
the intraphagosomal environment.
How these potential nutrients could be taken up by the bacteria is poorly understood [132], but
certainly challenged by the thick cell envelope. Downstream of nutrient import, most genes of
the canonical central carbon metabolism are present in M. tuberculosis, but their exact wiring
is debated [127, 194, 203]. Nevertheless, mutagenesis studies identified many of the genes as
essential for mycobacterial growth [170] and infection [171].
Dormant bacteria are almost impossible to kill by antibiotics and therefore form a natural reser-
voir for tuberculosis. However, even in the dormant state, the bacteria show residual metabolic
activity [24, 64]. Characterizing active metabolic functions in this context can reveal drug
targets, whose disruption specifically eliminates the non-replicating bacterial population.
1.3 Systems, models and data
The previous Sections outlined the importance of studying M. tuberculosis and its metabolism,
but also the complexity of the system became evident. Especially the central metabolic pathways
are highly interconnected. They depend on environmental conditions and are subject to cellular
regulation. In addition, the mere size of the system renders it beyond intuitive understanding. It
is, for example, difficult to understand how the lack of canonical carbon sources in the phago-
some influences cellular growth and energetics. Are fatty acids enough to compensate for them?
What happens to the redox state of the cell, will there be enough energy for gluconeogenesis?
In the following Section, the integration of mathematical modeling with experimental measure-
ments is described as means for studying such systems on different levels of granularity, while
combining a multitude of available information.
1.3.1 More than the sum of it’s parts
Complex systems, one of which is cellular metabolism, have the striking property that their
behavior cannot be understood by examining their constituents individually. The interactions
between the constituents give rise to systemic features, such as robustness, memory, compensa-
tion, amplification and others. Such effects cannot be achieved on the level of individual agents,
but are integral features of live. To add even more complexity, cellular metabolism is tightly
connected to other cellular processes, such as gene expression, protein production or cellular
signaling, which add additional complexity.
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Computer aided mathematical modeling is a way to analyze systemic behaviors, allowing for
the processing of large numbers of system constituents, linked by complex mathematical rules.
Those rules are abstractions of the underlying biological mechanisms. In systems biological
studies, such as the one presented here, mathematical models are equipped with and tailored to
available biological data in order to learn about mechanistic processes within cells. [93, 165]
1.3.2 Big data! Big models?
Brave new omics
Advances in experimental biology and measurement techniques in the last decades have made it
possible to measure a vast amount of intracellular compounds. The entire genetic information
of a cell, the genome, can be accessed and modified using genomics, proteomics identify and
quantify all expressed proteins, the pool of transcribed genes is captured by transcriptomics and
intracellular metabolites can be measured by metabolomics. Besides their grandiosity, these
so-called omics approaches share their striving for completeness: The entirety of the cell is
to be examined. Omics efforts generated a plethora of large datasets over the past years, that
have revealed many facts about the functional composition of cells in different environmental
conditions. However, these datasets are often too complex to intuitively draw mechanistic
conclusions from them, such that many omics studies remain at a mostly descriptive level.
Models as useful abstractions
Mathematical models come into play to understand the mechanisms behind the measured
data. Models are formalizations of knowledge obtained from different sources, including mea-
sured data as well as abstract concepts. Metabolic models, for example, rely on data about
the concentrations of metabolites and enzymes, but also include concepts of mass balance,
thermodynamics and the mechanisms of enzyme action. The formalization is based on (often
nonlinear) mathematical equations, which approximate the dependencies of the participating
agents. For example, each of the terms in Equation 1.1, can be described as a mathematical
function expressing the dependency of the flux on metabolite and enzyme concentrations, kinetic
parameters and others.
Figure 1.3: Coverage and resolution of sys-
tems biological approaches, with focus on
the terms relevant for this work.
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As models will always include reductions, simplifications and approximations, their level of
granularity has to be chosen with care, consistent with the corresponding data (Figure 1.3).
Accordingly, models are as good as their data in terms of resolution and accuracy. However,
non-intuitive, mechanistic conclusions can be drawn from them and, moreover, consistency of
the data and its compliance to theoretical concepts can be tested rigorously. From consistent
models, the system’s behavior in other contexts can be predicted, including scenarios that are
inaccessible to experimental investigation.
The more accurate models are and the more dependencies they include, the more difficult it
is to analyze and simulate them. Omics-size models are therefore often simplified, such as
purely stoichiometric models of the entire metabolic network of a cell, or face problems of
combinatorial expansion or limiting computational capacity. [93, 141]
Need for specific questions
In the light of these restrictions, modeling efforts require specific questions. Based on the nature
of the desired knowledge, the model resolution needs to be adapted and matching data has to be
included or requested. The model can then either give a direct answer to the posed question or
propose a set of testable hypotheses, complying with the current state of knowledge and data.
In the best of all worlds, experimental and modeling efforts can complement each other and
iteratively advance understanding of the biological system.
1.4 A set of questions
How is the central carbon metabolism embedded in the cellular metabolic network?
Which of its reactions are thermodynamically limiting and are they limiting in all conditions?
Where are regulatory points in the mycobacterial central carbon metabolism?
Which concepts facilitate metabolic flexibility in mycobacteria?
In this thesis, the above questions are addressed by integrating mathematical modeling and
experimental data to study the central carbon metabolism in mycobacteria. The following
Section outlines the contents of this work, a graphical overview is given in Figure 1.4.
The analysis starts from an examination of the available data for modeling the central carbon
metabolism in mycobacteria. For the purpose of this work, a set of experiments was carried
out by experimental partners in which proteomics and metabolomics data were acquired, as is
described in detail in Chapter 3. Chapter 4 consists of a careful analysis of these data sets to
highlight the insight that can be attained from the data already without any modeling involved.
The processed data are the basis for all further results in the thesis.
The subsequent Chapters will employ different modeling approaches to arrive at a deeper
understanding of the mechanistic processes underlying the data. The work thereby zooms in
from a network based view of the entire central carbon metabolism to a detailed, dynamic
description of individual, pathogenicity related pathways.
By formalizing a method to systematically analyze and quantify boundary fluxes (biomass
backtracking) of the central metabolic system, the demand that remote biosynthetic processes
exert in order to supply functional biomass for bacterial growth is charted (Chapter 5.1). Based
on these boundary fluxes, the thermodynamic landscape of the system will be characterized.
A linear programming approach is used to combine and extend existing methods such as the
Maximum-Minimum driving force and thermodynamic flux balance analysis to the network
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Figure 1.4: Overview of the results of this work, for a detailed description please refer to the text.
context, while integrating absolute measurements of metabolite concentrations (Chapter 5.2).
In Chapter 6, the stoichiometric and thermodynamic analysis will be complemented by enzyme
kinetic equations. A consistent, literature derived model is presented, covering a large part
of the current knowledge on the central carbon metabolism of M. tuberculosis (Chapter 6.1).
The model is then used to exemplify a novel method to predict regulatory sites in metabolic
networks as a minimum set of interventions which guarantee data consistency in steady state
(Chapter 6.2), focusing on the transition between experimental carbon sources. The quantitative
metabolomics and proteomics data are at the core of this analysis.
Leaving the realms of steady state, Chapter 7 further zooms in onto a specific metabolic function
of M. tuberculosis, the catabolism of the potential in vivo carbon source propionyl-CoA. The
role of two seemingly redundant pathways for the robust execution of this task is resolved by
means of thermodynamic-kinetic modeling. Accordingly, specific functions can be assigned
to each of the two pathways: While one acts as a transcriptionally regulated, high-capacity
catabolizer, the other can dynamically detoxify sudden catabolic challenges. In the pathological
context, the results explain one feature of flexibility of the mycobacterial metabolism.
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2. Computational methods
This Chapter summarizes all computational methods employed within this work. Methods and
techniques for processing and analysis of the experimental data are introduced in short. The
main focus lies on the description of the methods required for the computational modeling
central to this work. General approaches of metabolic modeling are explained, introducing
concepts of flux balancing, kinetic modeling as well as biological thermodynamics. The required
numerical methods to simulate and optimize such models are be described subsequently.
2.1 Statistics, data analysis and integration
2.1.1 Integration of various data types
The modeling approaches presented in the following integrate data from various data sources,
types of experiments and measurements as summarized in Figure 2.1. The integration requires
standardized and careful unit conversions as well as consideration of the cell state and envi-
ronmental conditions that the data were derived from, as will be described later. In all cases,
quantitative data are preferred, whereby also relative data in form of fold changes to a reference
condition can be included via appropriate observables (cf. Chapter 2.3.4).
enzyme concentrations
- proteomics measurements
- protein complex structure
- moonlighting acitivity
reaction flux
- uptake and secretion rates
- flux balance analysis
- 13C flux measurements
kinetic parameters
- enzyme kinetic measurements
- parameter estimation
- existing models
- structural calculations
Gibbs energies
- measurements 
- group contribution 
  estimates
v = E · kcat+ ·
(
∏i(Si/kMs,i)
∏i(Si/kMs,i)+∏ j(Pj/kMp, j)+1
)
· (1− e∆rG′/RT )
Figure 2.1: Possible ways to integrate data into kinetic network models on the example of a thermodynamic form of
the Michaelis-Menten kinetic [136]. All factors in black were applied within the scope of this work, gray denotes
possible other factors.
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Table 2.1: List of all used databases and their purposes.
Database Used for Reference
KEGG Referencing compounds and reactions, reaction definition [84]
ChEBI Referencing compounds [69]
Tuberculist M. tuberculosis gene database, gene names, functions [101]
BRENDA Enzyme kinetic parameters, regulators [175]
Pfam Detection of regulated protein domains [55]
UniProt Identifier mapping between databases, protein referencing [12]
Bionumbers General biological numbers [123]
eQuilibrator Gibbs energies, consistency of reactions [58]
2.1.2 Database mining
Information on the central carbon metabolism in mycobacteria was collected from several
databases. Where available, application programming interfaces (API) were used to extract data.
The used databases are summarized in Table 2.1.
2.1.3 Classification and enrichment
Principal component analysis
Principle component analysis (PCA, [143]) was used to classify the experimental data and to
identify general trends and groups of behaviors. The analysis decomposes a dataset, commonly
in the form of a matrix, into the major components able to explain the observed total variance.
In multivariate statistics, PCA is used to identify groups of variables with a common behavior.
The analysis is based on the eigenvalue decomposition of the covariance matrix of the data.
Here, the Matlab implementation in the function pca was used.
Differential expression and enrichment tests
Experimental proteomics data were assumed to be log-normally distributed. Proteins were clas-
sified as differentially expressed, when the null-hypothesis that the logarithmic measurements
of the current condition have the same mean expression like all other conditions, was rejected
with a p-value smaller than 0.01 in a two sided t-test. Enrichment tests were conducted using
the statistical over-representation test in the PANTHER online interface [121], with the whole
M. tuberculosis genome as background.
2.2 Modeling methods
Metabolic modeling intends to describe the behavior of cellular metabolites. Their intracellular
concentrations x are altered with a given stoichiometry by the action of enzymatic reactions
carrying out chemical transformations or by source and sink reactions across the boundaries of
the modeled system. The fluxes through all reactions, i.e. the amount of metabolites processed
per unit of time, can be summarized in the flux vector v. The matrix of the linking stoichiometric
coefficients ϑi, j is called stoichiometric matrix N. The system of metabolites and reactions can
then be expressed mathematically as
∂x
∂ t
= N ·v. (2.1)
In the following, used methods to simulate and optimize such systems are described.
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2.2.1 Flux balance analysis on the genome scale
Genome-scale metabolic reconstructions
Genome-scale metabolic reconstructions collect all information on the metabolic network of
a species: Known reactions, linked to their catalyzing enzymes; all involved metabolites,
potentially associated with their localization in a specific compartment; uptake and secretion
reactions, potentially via their specific transporters. The reconstruction is usually based on
genomic information as well as literature and database mining. Numerous methods exist to
curate the reconstructions, such as mass and charge balancing or gap filling. The reconstructions
usually include an artificial reaction that consumes metabolites towards the formation of biomass,
with stoichiometries based on experimental assessment of the cellular composition. Also the
cost of maintenance, payed usually in form of ATP, is included in the reconstruction. In that way,
the genome-scale metabolic reconstruction provides the stoichiometric matrix N of the whole
known metabolism of a cell in a well annotated manner, which can now be used for modeling.
[52, 192]
Flux balance analysis
By assuming the metabolic system to be in steady state (N · v¯ = 0), flux balance analysis
(FBA, [53]) can calculate a distribution of fluxes in the network. This distribution is shaped by the
constraints imposed by the network topology, encoded in N, as well as by the chosen boundary
fluxes (i.e. allowed uptakes and secretion routes), which can be bounded by experimental
measurements. The constraints thereby define a whole space of feasible flux distributions.
To transition from feasibility to biologically relevant optimality, objective functions c that
mimic possible cellular objectives can be formulated. These objectives are usually linear
combinations of fluxes describing for example the maximization of biomass, an overall low total
flux associated with a low enzyme burden, maximization of ATP production or the maximization
of the production of a desired chemical compound in metabolic engineering [178].
Mathematically, FBA can be described as a linear, constrained optimization problem
max
v
cT ·v (2.2)
subject to N ·v= 0
vlb ≤ v≤ vub,
with vlb and vub as lower and upper bounds on the fluxes.
FBA has proven to be useful in a wide range of biological and biotechnological applications
and a whole genealogy of extending methods is available to integrate additional constraints
and types of data [23]. On the downside, FBA alone does not process metabolite concentration
values and their impact on the fluxes. Also the lacking time resolution renders it insufficient for
many common applications.
2.2.2 Kinetic modeling
Ordinary differential equations
While genome-scale, constraint-based methods focus on the cellular metabolism in steady state,
much information on biological functionality is encoded on the transient time-scale. Describing
functional kinetic mechanisms of enzyme action is therefore bound to add a more detailed level
of understanding to the static descriptions.
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Ordinary differential equations (ODEs) are commonly used to model cellular processes on
a mechanistic level and have proven to be useful tools in many studies [18, 31, 94, 190]. In
contrast to the FBA formulation, the metabolic system’s time evolution is here described by a
set of ODEs for the metabolite concentrations x rater than a set of linear equations employing
only the numeric value of the flux v¯ in steady state. Thereby, each ODE formulates as the sum
of all fluxes producing or consuming metabolite xi with the stoichiometric coefficients in N:
∂xi
∂ t
=
nr
∑
j=1
ϑi, j · v j(E j,x,θ ), (2.3)
with nr as the total number of reactions in the system. The fluxes v are thereby functions of the
enzyme concentrations E, the metabolite levels x as well as of a set of parameters θ , which can
include enzyme kinetic constants, thermodynamic parameters, activation or inhibition constants
and others.
The ODE formulation relies on a number of assumptions that have to be examined critically
for their validity for each new model. A well stirred system is assumed, where no spatial
concentration gradients exist. Intracellular concentrations are also assumed to be normally
distributed, for example across a cell population, such that they can be described reliably by
their mean. While capturing time evolutions and mechanistic dependencies of the fluxes on
metabolite concentrations, ODE systems are often large and complex with a vast number of
potentially unknown parameters.
Reaction kinetics
A review of available kinetic laws and their parameterization in
the -omics era was published within the scope of this work as:
Tummler, K., Lubitz, T., Schelker, M. & Klipp, E. (2013)
New types of experimental data shape the use of enzyme kinetics
for dynamic network modeling. FEBS journal 281(2):549-71
The enzymatic mechanism is modeled by a specific rate law for each flux v j, describing the
dependencies of the reaction rate on the concentrations of substrates, products and the catalyzing
enzyme (cf. Equation 1.1 in the Introduction). The rate laws can also include influences of
activating or inhibiting compounds, thermodynamic relations, effects of post-translational
modifications and other factors. In their most general form, the rate laws constitute of an enzyme
concentration dependent term f and an independent term g which are connected multiplicatively:
v j = f (E j) ·g(x,θ ) (2.4)
Hence, the flux will linearly depend on the (active) enzyme concentration, given all other
variables are held constant. The enzyme concentration is thereby equal to the concentration
of active catalytic sites for the specific reaction, considering enzyme complex structure and
possible moonlighting activities [46, 81]. The function g is used to describe the molecular
mechanism of the catalyzing enzyme. While the rate of uncatalyzed chemical reactions only
depends linearly on the concentration of the substrates according to the law of mass action,
enzyme catalyzed reactions usually show saturating behavior for high substrate concentrations,
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coinciding with all available enzyme molecules being occupied. The first and very famous
model of this observation was formulated in 1913 as the Michaelis-Menten kinetic [122]:
v j = vmax · SS+ kM (2.5)
with S as substrate concentration, vmax as maximum possible reaction rate, given by the product
of enzyme concentration E and the catalytic activity kcat , and kM as the Michaelis-Menten
constant, signifying the substrate concentration at which the rate reaches half its maximum.
According to the above notation, the parameter vector θ for a Michaelis-Menten flux would
contain entries for vmax and kM. The kinetic law is derived from the full set of mass action
equations describing binding, catalysis and dissociation of enzyme, substrate and product, and
assuming a fast equilibration of the substrate binding reaction. Similarly, more detailed rate
laws have been derived over the years to describe the action of several substrates, binding
order, interactions with activating or inhibiting compounds, competition, cooperativity and other
effects [196]. These rate laws provide a higher level of mechanistic accuracy in the description
of enzyme action at the price of extremely complex mathematical terms with a large number of
kinetic parameters.
Metabolic control analysis
Metabolic control analysis (MCA) provides a well established framework to quantify the
control of single reactions or species on the flux of a metabolic network [70, 83]. Despite
being limited to characterizing systems in steady state, MCA gives insight into the systemic
properties of metabolic pathways and the interdependencies of the participating agents. In
practice, MCA requires a fully parameterized dynamic network model for the calculation of the
control distribution, which is not always available, especially for larger systems.
MCA distinguishes between control coefficients, which measure the effect of small changes in
the participating enzymes’ concentrations E on redistributing (i.e. controlling) the steady state
flux v¯ or the steady state concentrations x¯ of the entire system, and response coefficients, which
quantify the response of steady state fluxes v¯ and concentrations x¯ to small perturbations in the
kinetic parameters θ . Flux control coefficients Cv¯ jvi are defined as
Cv¯ jvi =
vi
v¯ j
∂ v¯ j
∂vi
(2.6)
and signify the effect of small perturbations in a specific flux vi on flux v¯ j in the new steady
state. Please note, that v¯ is used as the vector containing all network fluxes in steady state for
consistency with the above definitions. In the original MCA works this entity is usually referred
to as J. The control coefficients in the above equations are the normalized ones. Biologically,
the perturbations can be due to a change in the total enzyme concentration or caused by enzyme
activations and inhibitions. The control coefficients differ from classical sensitivities, as they
describe the final effect after the equilibration to a new steady state following the perturbation
rather than immediate responses. Concentration control coefficients are defined accordingly as
Cx¯ jvi =
vi
x¯ j
∂ x¯ j
∂vi
, (2.7)
with x¯ as the vector of metabolite concentrations in steady state. Flux and concentration response
coefficients are analogously composed of partial derivatives of v¯ and x¯ with respect to all kinetic
parameters in θ .
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In the scope of this work, a version of metabolic control analysis was implemented in Matlab, to
be used in the D2D framework [156]. The calculation is based on the matrix notation of the
control and response coefficients (described in detail e.g. in [72]).
2.2.3 Thermodynamic methods
Besides the dependency of the flux on the concentrations of the reaction’s educts, also the chem-
ical nature of the transformation restricts the reaction rate. The following Section summarizes
how these effects can be included into metabolic network modeling with the help of biological
thermodynamics.
Thermodynamic entities and their relation
The direction, in which a reaction runs, is defined by the energetics of the chemical transforma-
tion occurring. If energy is released, the reaction can happen spontaneously according to the
second law of thermodynamics. The amount of energy released is measured as change in the
system’s Gibbs free energy G in kJ/mol. If the change in free energy due to the reaction, ∆rG′,
is negative, energy is released. The reaction is feasible in this direction and called exergonic. If
∆rG′ is positive for a reaction, it will be infeasible and is called endergonic. At the same time,
the same reaction in reverse direction will be feasible, with a free energy change of -∆rG′.
Feasible thereby means that the flux in one reaction direction is larger than in the reverse one,
not that the flux in the reverse direction vanishes. Accordingly, ∆rG′ defines the ratio between
forward J+ and backward J− flux through the reaction in the flux force relationship [16] as
J− = e∆rG
′/RT · J+, (2.8)
with R as the universal gas constant in kJ/K and T as the absolute temperature in K. The net-flux
v j, which is observed macroscopically, is thereby the difference between J+j and J
−
j .
At ∆rG′ = 0, J+ equals J− and the reaction is in equilibrium. Again, this does not refer to a
stalling reaction, but rather that the fluxes in forward and backward direction are exactly the
same, such that no net-flux occurs (i.e. no substrate or product is effectively produced). The
concentrations of substrates and products at equilibrium define the equilibrium constant keq as
keq =
nx
∏
i=1
x¯ ϑii , (2.9)
with x¯ as the (active) concentration of the educts of the reaction at steady state, ϑ as their
corresponding stoichiometric coefficients and nx as the number of metabolites participating in
the reaction. The product in the above equation is often referred to as the reaction quotient Q or
as mass action ratio Γ.
The equilibrium constant is an intrinsic property of a chemical reaction. It is linked to the
standard Gibbs free energy ∆rG0 of a reaction by
∆rG0 =−RT · ln keq. (2.10)
Equilibrium constants and hence ∆rG0 can be assessed experimentally by measuring substrate
and product concentration in an equilibrated solution [66]. As equilibration times for many
reactions are extremely long, it is also useful to calculate ∆rG0 from the standard Gibbs
formation energies ∆ f G0 of the participating educts, signifying the amount of energy required
to form them from their elements in standard state, as
∆rG0 =
nx
∑
i=1
ϑi ·∆ f G0. (2.11)
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∆ f G0can be measured experimentally or estimated by group contribution [117, 136]. Both keq
and ∆rG0 can be used to calculate the current thermodynamic potential ∆rG′ of a reaction, which
additionally depends on the concentrations of its substrates and products. The reaction quotient
Q, as already defined in equilibrium for keq, thereby quantifies how much the potential is shifted
relative to ∆rG0 due to concentrations differing from their equilibrium value. If, for example,
substrate concentrations are drastically decreased, the thermodynamic gradient will become
shallower in the reaction direction that consumes the substrate. The concentration adjusted
∆rG′ calculates as
∆rG′ = ∆rG0+RT · ln Q. (2.12)
Using measured intracellular metabolite concentrations, ∆rG′ can then give insight into the
thermodynamic landscape that constrains cellular metabolism. [3]
Assessing reaction reversibilities
To quantify how far a reaction is from its equilibrium given a set of educt concentrations, the
disequilibrium ratio ρ can be used. It is defined as
ρ = Q/keq. (2.13)
If ρ is smaller than 1, the reaction is feasible in the forward direction, for ρ larger than 1 in the
backward direction. ρ can only be calculated if all educt concentrations are known. Additionally,
especially when cellular metabolic regulation is investigated, it is interesting how much effort,
in terms of changes in metabolite concentrations, it would require to change the direction
of the reaction. For FBA approaches, a sound definition of the reactions’ potential to invert
their direction is considered essential. However, this potential for reversal also depends on the
stoichiometry of a reaction: It is more effort for the cell to reverse a 1:1 reaction than, e.g. one
with 3:3 stoichiometry, as the required change in Q has to be achieved by adjusting only one
concentration on either side of the reaction as opposed to the product of three concentrations.
To assess these issues of uncertain or unknown concentrations and variable stoichiometry, the
reversibility index γˆ can be used as a stoichiometry adjusted measure for how reversible a
reaction is [133]. γˆ assumes all educt concentrations to lie within a logarithmically symmetric
range around a sensitive physiological concentration C (usually 100 µM). With ns as the number
of substrates and np as the number of products, the reaction quotient then reads as QRI =Cnp−ns .
With this, the reversibility index is defined as
γˆ =
(
keq
QRI
)2/(np+ns)
(2.14)
For quantitative assessment, the distance of γˆ to 1 can be used. The larger it is, the more
irreversible is the reaction. Noor et al. [133] used a threshold of γˆ > 103 to classify a reaction
as irreversible in the forward direction (accordingly γˆ < 10−3 in backward direction). If the
concentration of a metabolite is known, it can be substituted for the default concentration C in
QRI , thereby reducing the number of unknown substrates nS or products np by one.
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Integration of thermodynamic constraints in kinetic reaction equations
For biological systems, the energetic restriction of metabolic reactions gives rise to several
constraints on the feasible space for kinetic parameters. The Haldane relationship [25] formal-
izes the dependency of Michaelis-Menten constants and catalytic activities on the equilibrium
constant:
keq =
kcat+ /k
M
s
kcat− /kMp
. (2.15)
For all parameter sets θ fulfilling this relationship, the net-flux through the corresponding
reaction will vanish when the species reach their equilibrium concentrations as defined by keq.
For systems of reactions that form a loop, all associated equilibrium constants have to fulfill the
Wegscheider condition
nl
∏
i=1
keq,i = 1, (2.16)
with nl being the number of reactions involved in the loop.
In works of thermodynamic FBA this is also referred to as a generalization of Kirchoff’s loop
law for electrical circuits [14, 147]. More generally, both approaches state that the conservation
of energy forbids circular fluxes (currents) to occur.
Several works have proposed kinetic rate laws that integrate these thermodynamic constraints.
The rate of an reaction is not completely defined by its thermodynamic gradient, i.e. thermody-
namically feasible reactions can still take very long to equilibrate. However, the flux force ratio
which is defined by the gradient (Equation 2.8) will fix the extent of the net flux and should
hence be considered for kinetic modeling of metabolic pathways.
The thermodynamic version of the convenience kinetic, introduced by Liebermeister and Klipp
[104], is one example of such rate laws. It is convenient, because reactions of arbitrary stoi-
chiometry can be described in an automated manner. Similarly, the modular rate laws [106]
allow the integration of regulatory terms alongside the thermodynamically consistent kinetic
formulation. Thermodynamic kinetic modeling (TKM, [50]) was developed in analogy to
electrical engineering and can be applied to transform kinetic laws to their thermodynamically
consistent form. Noor et al. [136] proposed a decomposed rate law derived from the Michaelis-
Menten kinetic that has the benefit of a clear separation of the kinetic and thermodynamic
contributions to the reaction speed, which can then be analyzed individually.
2.3 Numeric methods
2.3.1 Numeric integration of ODE systems
If each reaction in the entire or a considered subpart of a cellular metabolic network is described
by a more or less complex enzymatic rate law, the resulting system of differential equations is
far beyond analytic solvability. Such systems are commonly solved by numeric integration, for
which a number of computational algorithms are available. Mathematically, the problem can be
formulated as an initial value problem of approximating a function y(t) that is the solution of
∂y(t)
∂ t
= f (t,y(t),θ) (2.17)
with y(t0) = y0.
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Please note that in the following the notation y(t) for a single variable is used, but the methods
are directly applicable to sets of ODEs of several variables y(t). Numeric methods try to
subsequently extrapolate values of y for the next time step tn+1 using the value at the current
time y(tn) (explicit methods), from previous time steps y(tn−1···i) (multi step methods) or the next
time step y(tn+1) (implicit methods) and their derivatives (cf. Table 2.2). In implicit methods the
value of y(tn+1) is required to solve for y(tn+1), resulting in an usually nonlinear equation, which
can for example be solved using Newton’s method (see Chapter 2.3.3). This extra computational
cost is redeemed by a higher accuracy of the solution.
Originating from the explicit Euler method, which walks along the tangent at the current value
y(tn) for a small time step h, sets of more complex methods have been developed to reduce
the prediction error. Runge-Kutta methods calculate and average additional increments ki at
different positions within the h-step, to correct for over- or underestimation of the change by the
derivative at the current point. The number of increments used defines the order of the method,
with more increments improving accuracy but complicating the calculation. Adams-Bashforth
type methods take into account the calculated function and derivative values of the previous
time steps to increase accuracy. Also for them, the number of previous time steps used defines
the order of the method and a higher number results in higher accuracy. Adams-Moulton and
Backwards differentiation formulas (BDF) are extensions of the implicit backward Euler method
in the same manner, each with their specific way of defining the coefficients for averaging.
The smaller the step size h is, the more accurate the solution for all mentioned methods will be,
at the cost of increasing calculation times. Around time points, where fast changes in the value
of y can be observed, this step size reduction is most beneficial. Accordingly, most modern
algorithms employ an adaptive regulation of the step size, relative to the steepness of f , to
increase accuracy while limiting computational costs. If the order of the methods is also changed
accordingly, the algorithms are referred to as variable step-size, variable order (VSVO).
Especially when simulating biological systems, such changes in the steepness of the derivative
do not only occur at different times but also for different species - a problem referred to as
stiffness. Stiff equation systems lead to issues of stability in the numerical algorithms and force
extremely small step sizes and long computation times, with results being error prone. Stiffness
issues are commonly addressed with BDM and Adams-Moulton type algorithms. [27, 146]
Table 2.2: Selection of common methods for numeric integration, along with their calculation rules. *s will denote
the order of the Runge-Kutta method, ** shown is the 2-step Adams-Bashforth method
Method Approximation Type
Euler method y(tn+1) = y(tn)+h · f (tn,y(tn),θ) explicit
Runge-Kutta* y(tn+1) = y(tn)+h∑si=1 bi · ki explicit
Backward Euler y(tn+1) = y(tn)+h · f (tn+1,y(tn+1),θ) implicit
Trapezoidal rule y(tn+1) = y(tn)+ 12 h( f (tn+1,y(tn+1),θ)+ f (tn,y(tn),θ)) implicit
Adams-Bashforth** y(tn+2) = y(tn+1)+ 32 h f (tn+1,y(tn+1),θ)− 12 h f (tn,y(tn),θ) implicit,
multi-step
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Simulation standards
Metabolite trajectories x(t) were simulated in logarithmic space in µM concentrations. A fixed
conversion factor was calculated based on cell size and the number of cells per optical den-
sity (OD) unit to convert from the experimentally measured concentrations in pmol/mLOD600=1
to intracellular concentrations as described in Section 3.1.
2.3.2 Optimization problems
The information collected from literature and biology during the construction of a model does
in the vast majority of cases not define its behavior uniquely. The open question remains, which
behavior is the best or most realistic one in the biological context. Optimization methods tackle
this problem by systematically tuning the model’s degrees of freedom, such as unknown param-
eters or boundary fluxes, to achieve a behavior best matching experimental data. In metabolic
modeling, many optimization approaches have been employed to learn about biological function-
ality. They mainly fall into two groups: (i) FBA based approaches employ linear optimization to
calculate system wide flux distributions and (ii) kinetic models rely on nonlinear optimization
for the estimation of model parameters to reproduce the time evolution of metabolic entities. In
the following Section, both aspects will be explained as far as they were applied in this work.
Linear optimization problems
In its standard form, a linear optimization problem describes a set of linear constraints that
bounds the feasible solution space for the variables d. Please note that the vector of variables d
can contain any type of entity such as concentrations x, fluxes v, Gibbs energies ∆rG′ and others.
The constraints can define equality or inequality relations. Often an objective function c as a
linear combination of values in d is defined, which is intended to be optimized. The standard
form of the problem then reads as:
max
d
cTd (2.18)
subject to A ·d≤ b.
Depending on the rank of the matrix [A b], which collects all coefficients of the equality and
inequality relations, the system can have no, one or infinitely many solutions. Please note that
the equation shows an inequality constraint, but equalities can be included in the same manner.
Duality
Each linear optimization problem has a corresponding dual problem of the form
min
l
bTl (2.19)
subject to lT ·A= c, l≥ 0.
Similarly, equality constraints can be reformulated as inequalities (≤) in the dual problem. If
the original (primal) problem has a unique solution d∗, it will define the solution l∗ to the dual
problem as cTd∗ = bTl∗.
For each constraint in the primal problem, one variable exists in the dual problem. The dual
variables l are also referred to as shadow prices. Conceptually, a shadow price describes
how much the optimum value of objective function cTd∗ would improve if the corresponding
constraint would be relaxed by one unit. Shadow prices can therefore be used to investigate
where constraints are exhausted and hint to effectively restricting variables and constraints.
[119, 134, 146]
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Nonlinear Optimization Problems
If a system of equations contains any kind of nonlinear terms with respect to the variables d, its
optimization becomes more challenging. A general nonlinear optimization can be formalized as
max
d
g(d,Θ) (2.20)
Where g(d,Θ) is a nonlinear function of the systems variables and possibly of external parame-
ters Θ. The system can also be subjected to constraints on d, which can be linear or nonlinear
equality or inequality constraints.
2.3.3 Numeric optimization algorithms
Linear Optimization Algorithms
Linear optimization problems are comparably easy to solve, a number of efficient algorithms are
available. The most commonly used algorithm is the Simplex algorithm [45]. The algorithm
exploits the fact that the feasible solution space is a convex, possibly unbounded polytope in the
variable space. If an optimum of the objective function cTd exists, it will lie on an edge or vertex
of that polytope. The algorithm first finds an initial extreme point on the hull of the polytope
(i.e. a corner) and then follows the edges in the direction of improving objective function to
the next extreme point. It thereby visits points with better objective values until the next step
does not yield any further improvement or an unbounded edge is reached (termination criteria).
The initial point can be found by a number of different methods, however, if no initial feasible
point can be found, the feasible solution space is empty and the problem has no solution. The
algorithm has been improved steadily since its development, resulting in a faster convergence.
Even though its worst case complexity is exponential, meaning that the time to compute a
solution depends on the number of variables in an exponential manner, for the vast majority of
applications the algorithm converges faster (average case complexity, polynomial).
Interior point algorithms advance through the interior of the polytope using e.g. Newton’s
method. The system’s constraints are thereby encoded in logarithmic barrier functions, directly
added to the objective. Interior point algorithms can also make use of the dual problem to
improve convergence. They have polynomial worst case convergence, but are in practice often
slower than simplex methods. [146]
For many practical linear optimization problems, the variables d can only take discrete or
boolean values. Such mixed integer linear programming problems (MILP) can be solved with
branch-and-cut/bound algorithms (BC/BB) that approximate the integer solution by solving
the corresponding continuous problem (e.g. with the simplex algorithm) and adding new con-
straints if the solution is not integer-valued. The solution of MILP problems is computationally
difficult and can have very long convergence times in practice.
Nonlinear optimization algorithms
The feasible solution space of nonlinear problems does not necessarily have the shape of a
convex polytope and hence its beneficial characteristics cannot be exploited by algorithms. Most
nonlinear optimization algorithms apply iterative approaches to move in the allowed variable
space towards regions of lower objective values. Some commonly used algorithms, part of
which were also applied in this work, are described briefly here.
The Nelder-Mead version of the simplex algorithm [131] tries to search the variable space based
only on evaluation of the objective function g. It spans a polytope in the variable space with one
additional dimension (e.g. a triangle in a search space of two variables) and moves towards the
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vertex associated with the best objective value by a series of transformation events (flipping,
contraction, expansion). In practice, such so called derivative free methods can usually be
improved by considering the derivative of the objective function with regard to the variables.
Derivative based algorithms generally try to find the direction in the search space in which the
decrease in the objective function is steepest. Based on this steepness, the algorithms estimate
how far they can likely step in that direction to maximally improve the objective value. Many
different methods are available to calculate or approximate the descent and the step size of an
iteration step h. Newton’s method, as a method to find roots of functions, is used in optimiza-
tion to find the root of the first derivative of g, i.e. the extremum of g. For example in an one
dimensional search space, the step h taken from the current point dn in the variable space is
calculated as
h=−γ ∂g(dn)
∂d
/
∂ 2g(dn)
∂ 2d
, (2.21)
based on a Taylor expansion of g. The scaling parameter γ can be used to adjust the step length.
The objective value g(dn +h) is then hopefully, and most likely, better than the current one
g(dn). In higher dimensions, the first and second derivatives, also referred to as the Jacobian
matrix J and the Hessian matrix H, respectively, are used to calculate the direction of the steepest
descent in the variable space. The usage of the Hessian improves convergence compared to
calculating h based only on the Jacobian, as is done for example in the gradient descent method.
However, often the calculation of Hessians is computationally expensive and sometimes numeri-
cally error-prone. Both methods from above also show poor convergence in shallow regions of
the variable space. To resolve these problems, more sophisticated methods combine the Newto-
nian root finding with other numeric steps to improve convergence. Trust region algorithms
approximate g within a neighborhood – the trust region – of dn by a simple, often quadratic
function that can be easily solved. h is then calculated based on the approximation. If g(dn+h)
is a better point the trust region shrinks, until it is small enough for the desired accuracy of the
solution. In contrast, line search methods take the Newtonian direction of the step, but adapt
its length (γ in Equation 2.21) at every iteration step to approach the optimum faster, but also
to avoid overshooting. For constraint problems, interior point and active set algorithms can
be used. They implement penalty terms for violating constraints, which have to be minimized
alongside the objective function.
Often objective functions of optimization problems take the form of sums of squared differences,
so-called residuals r, as for example when distances of a model to several measured data points
are to be minimized. Algorithms specifically and efficiently dealing with such problems are the
Gauss-Newton method that requires only the Jacobian to calculate the step h as
h =−J
T
r r(dn)
JTr Jr
, (2.22)
with Jr as the Jacobian of the residuals with respect to the variables d. The Levenberg-
Marquardt [100, 113] algorithm interpolates between Gauss-Newton and gradient descent
steps to improve convergence. [146]
The selection of the appropriate algorithm depends on the specific problem as well as the avail-
able computational capacity. Often it is helpful to test the performance of several algorithms in
the specific context.
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Global optimization heuristics
For linear optimization problems, if they are feasible, the found optimum will contain the best
function value in the entire variable space – the global optimum. Non-linear problems, on the
other hand, can contain multiple, local optima of which only one will be the best. The algorithms
described above will be trapped in a local optimum, due to their dependence on the gradients
which are positive in any direction from the local optimum. Several heuristics allow such local
optimizations to scan a wider range of the variable space.
Simulated annealing [91] perturbs the found set of locally optimal variables in the hope of
moving it to the attracting basin of another, potentially better optimum. Sampling strategies, such
as the systematic Latin hypercube sampling (LHS, [120]), start the optimization from many
different initial points, to allow scanning of possible optima in the entire variable space. For a
large number of variables, such approaches require usually infeasibly many optimization runs to
reasonably cover the variable space. Other global optimization heuristics borrow principles from
genetics, evolution or particle swarms to escape local optima, all based on stochastic elements.
In practice, such algorithms usually show poor convergence [155].
Multiple objectives
Biological systems often have to fulfill more than one objective. Microbial metabolism, for
example, can be described as trade-off between optimizing energy-yield, growth rate and enzyme
investment [179]. In such cases, optimization problems are called multi-objective and their
solutions will lie on Pareto fronts. Each point on the Pareto front describes one optimum
solution, for which no single objective can be improved further without another objective
becoming worse. In practice, multi-objective functions are often weighted sums of objectives.
The weights assigned to each objective denote the importance of their contribution to the overall
optimality and hence changing weights can move the Pareto front.
2.3.4 Optimization of biological models
The model calibration problem
For biological ODE models (Equation 2.3), many of the parameters in θ are usually unknown
and have to be optimized such that the model will show a biologically meaningful behavior.
In such cases, the objective function g (Equation 2.20) will describe the distance of the model
trajectories to some experimentally measured data points yˆ.
While the model usually describes the behavior of the internal biological species x, experimental
measurements cannot always access each species individually. Often, only sums of species,
such as isomeric metabolites or different phosphorylation states of proteins, can be measured.
To formally address this problem, the concept of observables has proven useful. Observables y
are functions of internal variables and specific parameters θ e
y(t,θ ) = f (t,x(t,θ ),θ e). (2.23)
θ e are thereby the parameters of the error model σ associated with the observable, f is an
arbitrary function such as a sum. The error model can be used to encode information about
measurement noise in the observable. For biological data, usually a log-normally distributed
error is assumed. Other common forms of error models are fractions of the observables
(e.g. the error is 25 % of the observed value) or additive offsets (e.g. corresponding to a blank
measurement). In this work, the error model was estimated alongside the ODE model. This
approach is opposed to directly calculating an estimator such as the standard deviation from the
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data, which has been shown to improve the parameter estimates’ accuracy [155].
The distance between model observables y and measured data yˆ can be formalized as the sum of
squared differences between them. To also include measurement noise, the likelihood function
L can be used as objective g:
L(yˆ|θ ) =
nt
∏
i=1
ny
∏
j=1
1√
2πσ2i, j
exp
(
− 1
2σ2i, j
(yˆi, j− y j(ti,θ ))2
)
, (2.24)
with ny as the number of observables and nt as the number of measured time-points.
The likelihood describes the conditional probability of the model with the parameter set θ , given
the measurements in yˆ. The likelihood takes this form only for normally distributed errors. To
use this notation y and yˆ can be transferred to the log space, transforming the log-normally
distributed error to a normally distributed one. Accordingly, y and yˆ will denote the logarithmic
entities in the following.
The optimization problem can then be written as
min
θ
−2ln(L(yˆ|θ )) = nt ·ny · ln(2π)+∑
i, j
[
2ln(σ2i, j)+
(
yˆi, j− y j(ti,θ )
σi, j
)2]
, (2.25)
with −2ln(L(yˆ|θ )) denoting the log-likelihood LL.
What was referred to as the variable space before will now be the parameter space, as all
variables to be optimized are parameters of the ODE model. The first term in the sum in
Equation 2.25 denotes the individual contribution of the error model σ to the likelihood.
Profile likelihoods and confidence intervals
The likelihood function can also be used to calculate confidence intervals CI for the parameter
estimates. Given a confidence level α , these are regions that contain the true parameter value
with a probability of α . The confidence region is bounded by the parameter value for which
LL exceeds a threshold ∆α compared to the lowest likelihood value found. ∆α can be computed
as the α-quantile of a χ2 distribution, with one degree of freedom (point wise confidence
intervals) or as many degrees of freedom as the number of parameters (simultaneous confidence
intervals).
For which values CIui and CI
l
i of a parameter θi this threshold is reached, can be calculated by
profile likelihood estimation (PLE). The profile likelihood is obtained for each parameter by
increasing and decreasing it and refitting all other parameters until LL exceeds the threshold. In
other words, as soon as a perturbation in the optimal parameter value cannot be compensated by
adjusting all other parameters, one confidently left the optimum range for that parameter.
The shape of the resulting likelihood profiles can also help to further assess the quality of
the estimation for each parameter (Figure 2.2). From the profiles, three general types of
identifiabilities can be characterized: Structural non-identifiabilities (Figure 2.2 A) do not allow
for a sensitive estimation of the parameter. They usually hint to explicitly dependent parameters
(i.e. one parameter can be expressed as a function of another) and can only be resolved by
changing the model structure. Practical non-identifiabilities (Figure 2.2 B) mark parameters
that have a defined optimum value, which cannot be detected with high enough confidence.
They can be resolved by additional measurements. For identifiable parameters the PLE exceeds
the threshold in both directions. PLE derived confidence intervals can also be asymmetric, as
opposed to classical confidence estimators, representing the nonlinear properties of the system.
[56, 97, 154, 155]
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Figure 2.2: Possible scenarios of parameter identifiabilities. A Structural non-identifiability with a flat likelihood
profile, B practical non-identifiability with a defined optimum that is not different enough from the surrounding region.
C, D Identifiable parameters with asymmetric and symmetric confidence intervals, respectively. The parameter
values for which the likelihood profile hits the 95 % confidence threshold mark the upper and lower limit of the
confidence region of the parameter (blue interval). Each black dot represents an individual fit. The example is taken
from Chapter 7.
2.3.5 Used software
Within this work, the solvers of the Matlab ODE-suite [182], which are based on Runge-Kutta or
trapezoidal rules, where used to solve differential equations. For the simulation of the dynamic
metabolic models, the Matlab based D2D framework [156] was used, which invokes the CVodes
solver [181] in C to speed up the calculations. The solver uses BDF and Adams-Moulton-type
algorithms and can additionally supply sensitivity equations. Those can be used to calculate
gradients for the optimization algorithms.
For all linear optimizations, the open source solver glpk [112] was used with the default simplex
algorithm. glpk also includes branching sub-algorithms for MILP problems as well as a pre-
solving routine to simplify redundant problems.
For constrained nonlinear problems the Matlab internal fmincon optimizer was used with an
interior point algorithm. Linear as well as nonlinear constraints were implemented. For dynamic
model fitting the Matlab optimizer lsqnonlin with a trust region algorithm embedded in the
D2D tool was used. D2D supplies symbolic sensitivity equations for faster and more accurate
calculation of the Jacobian. To address local optima issues, LHS strategies were applied and
convergence was monitored with convergence plots as described by Raue et al. [155]. Well
converging algorithms are thereby characterized by a step-like profile of final objective values,
where each plateau can be assigned to a local optimum (for examples see Appendix A.28).

3. Data basis
The experiments described in the following Section were planned and executed
within the scope of this work in collaboration with Michael Zimmermann.
Metabolomics and proteomics measurements as well as the corresponding sample
preparation were carried out by Michael Zimmermann and Olga Schubert,
respectively. Experiments and measurements were conducted at the Molecular
Systems Biology Department of the ETH in Zürich.
All subsequent data analyses are part of this work.
This Chapter summarizes the experimental efforts specifically linked to this work. As the exper-
iments themselves are not part of this work, the description remains at a low level of practical
detail, referencing to the corresponding literature for in-depth descriptions and reproducibility.
The Chapter focuses on a general understanding required for the classification of the strengths
and weaknesses of the experimental methods for the modeling approaches central to this work.
Additionally, the Chapter includes the non-experimental methods used for processing of the
acquired data and preparations for their integration into mathematical models. Thereby, further
data from literature and open source databases is used as is described in the following pages.
3.1 Experimental design for modeling
A set of experiments was designed within the scope of this work to decipher the dynamic behav-
ior of the central carbon metabolism in mycobacteria (schematic overview in Figure 3.1). The
experiments were intended (i) to cover different carbon sources which require a vastly different
flux distribution in the central carbon catabolic network, (ii) to test common experimental carbon
sources, such as glucose and glutamate but also to (iii) relate to possible carbon sources that
might be available to intracellular bacteria, such as propionate, and (iv) to dynamically challenge
the central metabolism to be able to learn about transient flux rerouting and the kinetic properties
of the involved enzymes, in a resolution suitable for mathematical modeling approaches.
M. bovis BCG as experimental system
Mycobacterium bovis bacillus Calmette-Guérin (BCG) is the mycobacterial strain used for
vaccination against tuberculosis. M. tuberculosis and M. bovis BCG share 99.5 % of their
genome [19], which is why the non-pathogenic M. bovis BCG is frequently used as an ex-
perimental model system for M. tuberculosis. Handling of M. bovis BCGdoes not require
special security laboratories, whereas experiments with M. tuberculosis require biosafety level 3.
M. bovis BCG, after decades of laboratory life, has lost three genetic regions, mostly including
genes for virulence relevant processes. In 13C labeling experiments, minor differences in the
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Figure 3.1: Schematic representation of the experimental workflow. Please refer to the text for a detailed description.
metabolic flux distribution between M. tuberculosis and M. bovis BCG have been found [21],
but the overall pattern is conserved, such that insights from M. bovis BCG are most likely
transferable to M. tuberculosis.
Experimental workflow
M. bovis BCG cells were cultured in media containing solely one of the carbon sources glucose,
glutamate or propionate, which enter the central carbon metabolism via glycolysis, the Krebs
cycle and the methylcitrate and -malonyl pathways, respectively. Samples were taken at optical
densities listed in Table 3.1 and transferred to a Büchner funnel with nitrocellulose filter, which
is constantly perfused with medium. The cells, which are trapped on the filter, were allowed to
acclimate to the new aeration conditions for one minute under constant perfusion with media
containing the culture carbon source, before they were perfused with new media containing a
different carbon source. The resulting abrupt switch in carbon source availability forces the
bacteria to quickly adapt their metabolic fluxes. The intracellular metabolites were extracted
at different time-points within three minutes after the shift to obtain time series data. The
experiments were carried out as described in Murima et al. [129].
Conversions and comparability
The cell number was assumed to scale approximately linear with the optical density and the cell
size was taken to be constant over the range of growth conditions tested. Hence, a constant factor
of 8 ·108 cellsmLOD600=1 was used to convert between available optical density values and cell numbers.
To calculate intracellular concentrations, a cell volume of 0.5 fL was used, approximated from
the shape, length [4, 191] and an assumed diameter of ∼ 0.2 µm (see also Table 4.1). One
unit of metabolite or protein in the raw data units fmolmLOD600=1 then translates to 1.25
molecules
cell or a
2.5 nM concentration.
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3.2 Proteomics
As described in the Introduction (see Equation 1.1), intracellular fluxes depend linearly on
the active enzyme concentration. It was therefore intended to gain insight into the cellular
protein distribution in the experimental conditions used. Many methods are available for relative
measurements of protein concentrations, including the well known Western Blot. In contrast to
this qualitative method, mass spectrometry driven quantitative proteomics allow for the absolute
quantification of proteins within a cell while yielding a high coverage of the proteome. The
absolute concentrations can then be used directly in the rate laws of kinetic models. The genome
wide data can be used to gain insight into the general cellular constitution and its enzymatic
inventory.
3.2.1 Data acquisition
Samples
For each cultivation condition samples for proteomics measurements were taken (Figure 3.1). It
was assumed that the proteome will change with the cultivation carbon source but be approxi-
mately constant during the relatively short timespan of the dynamic shift. The analyzed samples
are summarized in Table 3.1. The cells were disrupted and subjected to tryptic digestion to
obtain peptides that can be screened using mass spectrometry in two different measurement
set-ups as described below.
Absolute label free quantification (ALF)
For a proteome wide quantification of the samples, sequential window acquisition of all theoreti-
cal spectra (SWATH) mass spectrometry, which is based on absolute label free quantification
as described in [177], was employed on whole-cell lysates. The technique applies targeted
proteomics (selected reaction monitoring, SRM) using a comprehensive fragment library of all
M. tuberculosis proteins. The acquired intensity values for each protein, i.e. the sum over all
associated peptide fragment intensities, were shown to correlate linearly with the actual cellular
protein concentration [109]. 27 anchor proteins, spanning the entire protein expression range
and being absolutely quantified with peptide standards (see below), were then used to interpolate
absolute abundances for all expressed proteins (1527 proteins). This method has the benefit of
a genome wide coverage, but relies on the assumption that peptides behave similarly to their
neighboring anchor peptides in the mass spectrometer. This assumption might not hold for all
peptides, depending for example on the ionization technique used.
Experiment Replicate Name OD600
µg protein
mLOD600=1
glucose, early A Glc1 0.36 105.2
B Glc2 0.33 116.0
C Glc3 0.36 124.3
propionate, early E Prop1 0.35 122.9
F Prop2 0.34 141.6
G Prop3 0.36 126.8
glutamate, late A2 #6 Glut1 late 0.93 56.2
B1 Glut2 late 0.94 49.7
B2 Glut3 late 0.96 53.1
glucose, late C1 #2 Glc1 late 0.87 41.0
C1 #4 Glc2 late 0.90 49.2
Table 3.1: Overview of the used samples
for the proteomics measurements
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Absolute quantification with standard peptides
For a subset of the central metabolic proteins, stable heavy isotope-labeled reference peptides
(AQUA peptides) were available which allow for direct, absolute quantification by SRM mass
spectrometry as described by Schubert et al. [176]. The AQUA peptides are added to the sample
in a known concentration and undergo all processing steps in the same way as the cellular
peptides. Biases, for example due to a different efficiency of the ionization, can therefore be
corrected after the measurement, resulting in a more accurate estimate of the cellular protein
concentration.
Overall, a good correlation between ALF and AQUA data could be observed, except on
the boundaries of the expression spectrum for very high or very low abundant proteins (Ap-
pendix A.1 A). Hence, AQUA data was preferred in the following and only for proteins not
contained in the AQUA datasets, ALF values were used. Both methods can reliably detect a
1.6-fold difference in a protein’s concentration between two samples, an accuracy high enough
to feed the modeling approaches in the following Chapters.
3.2.2 Data processing
Normalization to total protein amount
The protein quantification is dependent on the efficiency of the protein purification from the
bacterial samples. The total amount of protein extracted varied significantly between the samples
(see Table 3.1, last column), with samples from later growth phases yielding less protein per
mL at a given optical density. This could for example be due to structural rearrangements
within the cells restricting the protein extraction. The protein concentrations were subsequently
normalized to the median of the distribution of the ALF data. In Appendix A.1 B, a summary
of the normalization is shown, alongside a comparison between normalizing to the median of
AFM or AQUA data, highlighting the influence of the much smaller sample size of the latter.
The normalization neglects the fact that the total protein content (as a fraction of the dry cell
mass) could change with the growth phase and rate of the bacteria. However, for M. bovis
BCG in chemostat culture the protein content does not vary significantly with the growth rate
(22.9 % and 21.4 % at doubling times of 69.3 and 23.1 h, respectively [20]). In modeling terms,
a change in overall protein content would uniformly scale the measured protein concentrations
and accordingly all reaction fluxes, conserving their relation to each other as well as the overall
metabolic behavior.
Calculation of active site concentration
For modeling purposes, the best practice is to define the catalytic activity kcat per active site
of an enzyme complex (e.g. [46]). The complex structure was collected for all enzymes of
the reactions considered in the modeling approaches. Information on the different enzyme
complexes was collected from primary literature and related databases such as BRENDA [30],
KEGG [84] and Tuberculist [101]. The results are summarized in Appendix A.20.
To attain the concentrations of active sites, the lowest concentration of a subunit divided by its
stoichiometry in the complex was used. This assumes that all the enzyme measured is active in
one reaction, neglecting potential moonlighting activity in other pathways [81]. Therefore, if a
protein exhibits significant moonlighting activity, its kcat will be underestimated in the reaction
in question, whereas all other parameters should remain valid. For reactions that are catalyzed
by two or more isoenzymes, their active concentration was added and they were assumed to
have identical kinetics. To resolve differences between isoenzymes, additional data, e.g. from
knock-out experiments, would be required.
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3.3 Metabolomics
Intracellular metabolite concentrations are required to gear metabolic models to biological
reality. Their absolute quantification can be achieved with high accuracy by targeted mass
spectrometry. The obtained values can be directly included in and compared to the model simu-
lations. Metabolic fluxes can be reconstructed from such data, when direct flux measurements,
for example via 13C-labeling experiments, are not available as is the case for this work. To
identify the correct order of magnitude of intracellular fluxes, uptake and secretion rates of a
batch cultivation experiment were integrated as described below.
3.3.1 Data acquisition
Samples
All shift experiments for which metabolomics data were acquired are summarized in Table 3.2.
Metabolites were measured at 0, 10, 20 40, 80 and 160 seconds after the switch to the new
medium (see Figure 3.1). Control experiments were carried out analogously, but with media
containing the same carbon source before and after the switch.
Absolute quantification by mass spectrometry
Metabolites were measured by mass spectrometry and absolutely quantified by relating them to
13C-labeled standard metabolites with known concentration as described by Büscher et al. [26].
Similarly to the proteomics method, a 13C-labeled standard with a known concentration for
each desired metabolite is added to the probe after sampling and undergoes all processing
steps together with the internal metabolites. All influences of the subsequent extraction and
measurement steps will will distort standard and bacterial metabolite pools in the same way,
such that the original bacterial concentrations can be recalculated with the help of the measured
Cultivation on Growth phase Shift medium # Replicates
glucose early acetate 1
glucose 3
glucose, acetate 3
glucose, glutamate 3
glucose, glycerol 3
glucose, propionate 3
glucose, pyruvate 1
glucose, succinate 1
glutamate 1
glycerol 1
no carbon 1
propionate 1
pyruvate 1
succinate 1
propionate early glucose 1
glutamate 1
propionate 1
propionate, glucose 1
glucose late glucose 1
glucose, acetate 1
glucose, glutamate 1
glucose, glycerol 1
glutamate late glutamate 3
glutamate, acetate 3
glutamate, glucose 3
glutamate, glycerol 3
Table 3.2: Summary of the
metabolomics data.
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standard concentration. In total, concentrations of 35 different metabolites participating in the
central carbon metabolism could be measured, some of which were pooled concentrations of
two or more metabolic species (Appendix A.19). Some metabolites are only available for a
subset of the measured samples. On average, a standard deviation of 25 % can be assumed for
measurements of that type. [26, 129]
3.3.2 Estimating the range of boundary fluxes
Unfortunately, no direct measurements of the uptake and secretion rates of the above cultures
were available. Hence, physiological ranges for uptake and secretion fluxes were estimated from
a reference experiment of M. bovis BCG grown on glutamate and glycerol (experiment by cour-
tesy of Michael Zimmermann at the ETH Zürich). An exponential growth model was fitted to
the bacterial growth curve and corresponding uptake rates for all measured compounds (glycerol,
glutamate, citrate, isocitrate, aconitate, succinate) were estimated based on it (Appendix A.2).
Based on the estimated rates, the general boundaries for growth, uptake and secretion rates were
defined as summarized in Table 4.2.
3.4 Notes on enzyme kinetics
Enzyme kinetics and their parameters have been measured in a vast number of experimental
biochemistry studies [196]. In such assays, enzymes are purified from cell extracts, exposed to
different concentrations of their substrates and their rate of substrate consumption is measured.
From these data, kinetic parameters can be calculated, as in the pioneering work of Michaelis
and Menten [122]. Ideally these parameters could be incorporated directly as parameters in
ODE models, but in practice they often prove incompatible with the modeled in vivo conditions
or lack mechanistic resolution.
On the one hand, in vitro conditions such as pH, availability of cofactors, salt concentrations or
the lack of chaperones in the essay medium, can have a large impact on the enzymatic turnover
rate. The assay mixture also cannot mimic possible intracellular regulation. On the other hand,
different notations are used to describe enzyme action, some of which are not directly integrable,
as they do not normalize for mass or amount of the enzyme tested, such as for example the
specific activity in µmol/(min · (mg total protein)). In addition, conversions between different
measures are non-trivial and accordingly converted values as well as database entries can be
error prone [46].
kM values are somewhat less affected by these error sources, as the tested concentrations are set
externally, such that they can be used as a direct prior for model parameters. A list of kM values
available for M. tuberculosis and other related mycobacteria can be found in Appendix A.15.
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4. Explore the data
Besides many other hopes placed on systems biological approaches, the integration of virtually
all available types of data on a biological system is one of the major promises of this scientific
field. While carefully considering the experimental contexts and accordingly their potential
limitations, bringing together all available data can give an unbiased view on the current state of
knowledge on the specific system. Usually, contradictions will occur that can either point to
experimental inconsistencies or, more excitingly, reveal knowledge gaps that require closing in
order to fully understand the underlying biological process. Mathematical models can be used
to bridge these gaps with several hypotheses, often identifying a most likely one which is then
open for targeted experimental validation.
The following Chapter will deal with the careful assessment of the data situation, integrating the
acquired experimental measurements with other data available from literature. The contextual-
ized data will be the basis for the studies presented in the subsequent Chapters and outline the
insight that can be gained from the data alone, without any modeling involved.
4.1 Measuring M. tuberculosis
M. tuberculosis by the numbers
As introduced before, quantitative biology is constantly improving itself, yielding data covering
ever-larger parts of the biological system in question with ever-higher accuracy. While, for
example, individual protein concentrations used to be assessed relatively by the density of
Western Blot bands, they can now be measured with quantitative mass spectrometry for the
Table 4.1: Summary of important numbers and characteristics of M. tuberculosis as used throughout the work.
BNIDs are identifiers of the Bionumbers database [123].
Entity Value Unit Reference
cell length 1.5 - 6 µm [40, 168]
cell diameter 0.2 - 0.5 µm [40, 44]
thickness of cell envelope 15 - 20 nm [44]
intracellular volume 0.5 fL calculated from shape
(lower bound)
elemental composition (dry mass) C1H2N0.1O0.7P0.005S0.002 - [20]
mass per mol carbon 26 g/Cmol calculated from formula
mass of one cell 216.5 fgDW calculated based on [20]
mass of all cells in 1 mL culture at OD600 = 1 343.4 µgDW measurement
M. Zimmermann, ETH Zürich
number of cells in 1 mL culture at OD600 = 1 1.58·109 - calculated
division time on glycerol and glutamate 38 h BCG reference dataset
total carbon uptake 135 µM C/s BCG reference dataset
total carbon required to build one cell 8.3 fmol C/cell calculated
total carbon flux required to build one cell 121.2 µM C/s calculated
intracellular pH 7.5 - assumed, BNID
106187,108096,111346
total intracellular ionic strength 0.2 M assumed, BNID 107522
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Figure 4.1: E. coli and M. tuberculosis compared. Upper part shows a schematic drawing of the cell shapes, with the
corresponding dimensions. The pie charts below denote the macromolecular composition of the cells. The stacked
bars dissect the protein fraction further into functional categories. Percentages refer to mass percent (%(w/w)). The
categories are further decomposed in Figure 4.2 A. E. coli data is taken from Bionumbers (BNID 101788, 111490).
entire proteome. The calculation of absolute abundances from such data, however, has to be
embedded in the overall mass and energy balance of the cell, which is why general features such
as cell size and mass have to be considered during the calculations. Based on those numbers, it
is also possible to estimate sensible ranges for biological entities. For example, the range of the
carbon uptake flux can be estimated from the molecular composition of the cell and its growth
rate. For M. tuberculosis, the relevant published and derived numbers are collected in Table 4.1.
M. tuberculosis compared to other cells
For context, the physiology of M. tuberculosis as described by the collected numbers above, will
be related to other cells in this Section. Compared to its natural habitat, the human macrophage
with a volume of roughly 5000 fL (BNID 103566), M. tuberculosis is four orders of magnitude
smaller (Figure 1.2). Nevertheless, the bacteria are often densely packed in the phagosomes of
infected macrophages, resulting in nutrient and spatial limitations.
While comparable in size, the surface to volume ratio of M. tuberculosis is larger than that
of the model bacterium E. coli (Figure 4.1). Along with the thick cell envelope, this poses a
substantially higher biosynthetic burden for cell wall biosynthesis on M. tuberculosis. This is
also reflected in the cellular composition of the bacterium, whose dry weight consists to almost
45 % of lipids, required in large number to form the cell envelope [20]. Additionally, complex
carbohydrates are incorporated in the envelope. They constitute 20-30 % of the cell dry weight,
depending on the growth rate.
Figure 4.2: A Proteomap [105] of the M. bovis BCG protein composition in propionate media. The area representing
1 % of the total protein number is shown in the upper right corner. Functional classes are grouped and colored
together, single tiles represent the amount of a protein. Some selected proteins of each class are labeled with their
common name. B Ranges of protein concentrations and their variability between the four conditions compared to
the mean expression in all conditions. Each dot represents one protein, differentially expressed proteins are shown
in non-transparent color (dark red - glucose, early growth phase, blue - propionate, early growth phase, light red -
glucose, late growth phase, gray - glutamate, late growth phase). Inset: Venn diagram of differentially expressed
genes (p<0.01, [1]). Please see Methods Section 2.1.3 for criteria of differential expression.
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For bacterial cell division, especially the number of ribosomes plays an important role. From the
proteomics data (see Section 3.2), the fraction of ribosomal proteins in the total protein amount
can be calculated as roughly 3 % (Figure 4.2 A). The fast growing E. coli’s ribosomal fraction is
higher, reaching up to 20 % at high growth rates (BIND 102345). The ribosomal fraction, along
with the cellular translation rate defines the translational capacity, which correlates well with the
division time of bacterial cells ([180], Appendix A.3). Accordingly, due to the low percentage
of resources allocated to the replicative machinery of the cell, M. tuberculosis is limited to the
slow growth rate observed experimentally. The majority of resources seems to be rerouted to
build up defensive biomass in the cell envelope.
4.2 Analysis of the experimental data
In the following Sections, the protein and metabolite data obtained from the shift experiment are
analyzed. Metabolic setup and protein inventory are compared between the experimental condi-
tions. A first scan of the thermodynamic landscape based on the reversibility index is conducted.
While not employing any mathematical modeling, conclusions about proteome and metabolome
homeostasis as well as on potential thermodynamic bottleneck reactions can be drawn.
4.2.1 Proteomics
Functional proteome fractions
First, the overall distribution of the mycobacterial proteome is analyzed. For that, the distribution
of proteins, clustered according to their molecular function is summarized in Figure 4.2 A,
exemplarily for the propionate culture condition. The most abundant proteins are the chaperones
groEL and groES. Together with other proteins of that class, they form a large group of non-
growth associated proteins. In contrast, ribosomal proteins make up only about 3 %(w/w) of the
total proteome, resulting in the low growth rate as described before. In a similar way, catabolic
enzymes, generating energy and biomass precursors (brown tiles in the Figure, 12.3 %(w/w))
are outnumbered by large amounts of biosynthetic proteins, especially for lipid and amino acid
synthesis (beige/yellow tiles, 25.1 %(w/w)), which require precursor supply from the former
group. Only a small fraction of the proteome is dedicated to regulatory functions (cell cycle,
red; transcription factors, dark blue; signaling, turquoise). A rather large fraction of the overall
protein has unknown function (gray tiles, 23.1 %(w/w)).
From this functional proteome distribution, mycobacterial protein resource allocation can be
characterized as being governed by protective efforts such as protein maintenance via chaperones
or the biosynthesis of protective lipids. Catabolic enzymes, energy generating reactions and
ribosomal proteins, which fuel and facilitate cellular growth, receive little resources, correlating
with the bacterias’ slow growth rate.
Differential expression
The overall proteome composition is well conserved between the four analyzed conditions, with
less than 200 proteins expressed differentially in each condition (Figure 4.2 B). The sets of
differentially expressed proteins show very little overlap between the conditions (Figure 4.2 B,
inset). However, it has to be stated here that the statistical power of the differential expression
test is low, with only 11 samples per protein from the proteomics measurements (see Table 3.1).
Unsurprisingly, GO-enrichment tests identified that for all conditions metabolic proteins are
over-represented in the differentially expressed set (Appendix A.4), including processes of
nucleotide, fatty acid and amino acid biosynthesis. When the amino acid glutamate is supplied
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in the medium, the processes surrounding that metabolite, such as arginine and glutamine
biosynthesis, appear to be regulated by differential expression. In summary, the bacteria seem
to maintain their general proteome composition in changing nutrient conditions, at least for
the carbon sources tested here, while only a small subset of metabolic genes change their
abundance.
The central metabolic proteins
The central metabolic enzymes are of special importance for the following Chapters, which is
why their concentration pattern in the different nutrient conditions is examined here in detail
(Figure 4.3 A). As described in the Methods Section, proteomics samples were normalized to
the median of the ALF quantification. However, even after this normalization, overall protein
expression in the central carbon metabolism differs between the conditions, potentially masking
relative changes of the proteins to each other. More specifically, on propionate media, enzymes
of the central carbon metabolism seem to be generally higher expressed than in other conditions
(red color in Figure 4.3 A). It is unclear if this is a real biological effect, a side effect of the
normalization or due to measurement error. Nevertheless, some protein concentration changes
are evident even given this limitation. Specifically, Pep-carboxykinase (pckA) is up-regulated in
the two gluconeogenetic conditions, consistent with its preferentially gluconeogenetic function
described in vitro [110]. The proteins of the pentose phosphate pathway appear to be higher
expressed in early growth phases. This is especially evident from the comparison between the
two glucose conditions, arguing for a carbon source independent regulation of the pathway.
Under propionate conditions, the initial enzymes of the Krebs cycle (citrate synthase, aconitase)
do not follow the overall up-regulation trend, which could hint to a specific regulation of the
amount of flux entering the cycle in this condition. The enzymes of the methylcitrate pathway
are highly up-regulated under propionate conditions, consistent with their catabolic function.
The parallel methylmalonyl pathway does not show an equally strong increase between glucose
and propionate conditions (and was not detectable in late growth phase samples).
In summary, some of the observed proteome changes in the central carbon metabolism can
be directly related to the change in nutritional condition, such as the up-regulation of the
methylcitrate pathway enzymes on propionate or the increased concentration of pckA during
gluconeogenesis. Reasons for other changes remain elusive, such as the lack of up-regulation
of the methylmalonyl pathway on propionate, but can be tackled by modeling efforts in the
following.
4.2.2 Metabolomics
Condition dependent metabolite concentration changes
In comparison to the protein measurements, the metabolomics data show clearer condition
dependent concentration changes (Figure 4.3 B). When classified by their steady state, mea-
surements of the late growth phase samples from the cultures on glutamate and glucose show
similar metabolite landscapes. Concentrations in those two conditions are very distinct from
the early growth phase samples from propionate and glucose cultures, which in turn are clearly
distinguishable from each other (based on principle component analysis, Appendix A.5). Be-
sides the nutrient availability, the growth phase therefore seems to have major influence on the
intracellular metabolic landscape. Several metabolites show distinct concentration levels for a
specific condition or growth phase (Figure 4.3 B and in detail in Appendix A.6). The pentose
phosphate pathway intermediates ribose- and ribulose-5-phosphate (R5P, RL5P) are present
in concentrations vastly different between early and late growth phases, consistent with the
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Figure 4.3: A Changes in protein concentrations relative to the median of all conditions. Please, note that most of
the fold changes have an absolute value smaller than one. Empty circles denote not detected proteins B Changes in
metabolite concentrations relative to the median of all conditions. Empty squares denote missing values. C Reaction
reversibilities based the metabolite concentrations defined by the reversibility index γˆ (dark blue) or the inverse
disequilibrium ratio ρ ′ (light blue and red). For the calculation of the disequilibrium ratio, the mean steady state
concentrations were used. For an annotated map of the depicted reaction network, please refer to Figure 6.1.
4.2 Analysis of the experimental data 61
observed differential expression of the pathway’s enzymes as described in the proteomics Sec-
tion above. The Krebs cycle shows increased concentrations under growth on glutamate, along
with increased levels of the first metabolite of lower glycolysis (bisphosphoglycerate, BPG).
Under early phase growth on glucose, ATP and GTP levels are increased (Appendix A.6), along
with the concentrations of many glycolytic intermediates, potentially indicating a better overall
energetic situation of the cells. In media containing propionate, levels of the intermediates of
both available catabolic pathways for propionate (methylcitrate and methylmalonyl pathways)
are increased, while the concentrations of other measured metabolites are generally decreased.
As changes in metabolite concentrations do not necessarily translate one-to-one into changes in
the cellular flux distribution, modeling approaches are used to describe their influence in the
following Chapters, explaining the observations described here.
Aside from the steady state behavior, it is also worthwhile to identify metabolites that specifically
change their concentration in response to the fast nutrient switches (Appendices A.7 and A.8).
Those can hint to transient rerouting strategies of the cells to transit from one steady state to
another. Overall, only few metabolites show a strong dynamic change and, not surprisingly,
such metabolites will mostly occur in proximity of the perturbation in the metabolic network. In
such a way, the intermediates of the methylmalonyl and methylcitrate pathways quickly increase
after the addition of propionate to the media. Upon acetate addition, a slow increase of the
first metabolites of the Krebs cycle can be observed (aconitate, isocitrate). Dihydroxyacetone
phosphate (DHAP) accumulates upon the addition of glycerol.
However, also longer range effects can in distant network parts became evident, such as the
decrease of acetyl-CoA upon the addition of propionate and, vice versa, the decrease of pro-
pionyl and methylmalonyl-CoA when acetate is added to the medium. When the cells are
shifted from glucose to acetate only, many intermediates of the pentose phosphate pathway and
upper glycolysis are depleted, indicating another network effect. The dynamic data also allow
for better assessment of measurement quality. RL5P, as an example, is clearly up-regulated
in the late growth phase control conditions as described above, but shows a noisy behavior
in the dynamic dataset. This becomes evident when comparing the initial time-point of the
dynamic experiment to the control conditions (Appendix A.8, upper left, t = 0s): RL5P shows
strong variation over almost all experiments at this time already, potentially arguing for a large
influence of secondary effects of the experiment, such as the changed aeration condition on the
filter. All changes observed at this time point cannot be due to specific flux-rerouting, as the
cells were never exposed to medium with a new carbon source.
General bounds for entities in modeling approaches
According to the range of measured metabolite concentrations and based on the uptake rates
from the BCG reference experiment as described in the Methods, general bounds for the entities
used in the later modeling process were defined as summarized in Table 4.2.
Entity Description Lower bound Upper bound
x metabolite concentrations 1 µM 50 mM
kM Michaelis Menten constant 1 µM 50 mM
kcat catalytic activity 10−6 1/s 106 1/s
rup,rsec uptake / secretion rate 10 µM/s 50 µM/s
rg growth rate* 0.017 1/h 0.02 1/h
Table 4.2: Default bounds of enti-
ties in the optimization problems
based on available data. *Note that
the unit is changed to 1/s in later
analyses for numerical convenience
(explained in detail in Chapter 5.1).
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Reversibility index: Constraining reaction directionalities
As a first glimpse on the possible flux distribution within the central metabolic reactions, their
reversibility was classified individually based on the measured metabolite concentrations with
the reversibility index γˆ ([133], for detailed description see Methods around Equation 2.14)
Whenever measured metabolite concentrations were available for the educts of a reaction, they
were included in the calculation of γˆ . To include uncertainties in the measured metabolite
concentrations, the mean measured concentration plus the measurements standard deviation
was used if the metabolite occurs as a substrate (accordingly, minus the standard deviation for
products). Due to the adjusted default concentration bounds (Table 4.2), a reaction was defined
as irreversible here if | ln(γˆ)| > ln(xub− xlb) ≈ 10.8. For absolute values of ln(γˆ) larger than
that, the metabolite concentrations would have to exceed the default concentration bounds to
revert the reaction. The default concentration C was defined as the geometric mean of the default
metabolite range (C ≈ 220µM). For reactions with all reactant concentrations measured, the
inverse of the disequilibrium ratio as ρ ′ = 1/ρ = keq/Q (see Equation 2.13) was calculated as a
measure for the distance to the equilibrium based on the mean of the metabolite concentrations.
As for the reversibility index, ρ ′ is larger than one if the reaction runs in forward direction. The
further it is from one, the more irreversible it will be. The calculated values for γˆ and ρ ′ are
mapped to the network in Figure 4.3 C.
Based on this calculations, some reactions can already be associated with a direction. The
pyruvate kinase reaction (pyk) is irreversibly glycolytic in all conditions. Hence, the only
feasible way to feed gluconeogenesis is via PEP-carboxykinase (pck), which is in accordance
with the found preferential working direction of this enzyme [110] and its increased expression
in the proteomics data in gluconeogenetic conditions (see Section 4.2.1). The initial reactions
of the pentose phosphate pathway are irreversibly glycolytic. For the early growth conditions,
upper glycolysis seems to be thermodynamically restricted.
From the overall distribution of γˆ values it becomes evident that the method is heavily dependent
on the number of metabolite concentrations known for the specific reaction (Figure 4.4). A
reaction is more likely to be irreversible if all its educts concentrations are known. Reversibilities
could hence often be due to the lack of constraints from missing metabolite measurements,
rather than a real close-to-equilibrium reaction. A bold conclusion of this would be that the
majority of reactions can only operate in one direction given a specific metabolic condition.
Accordingly, the late growth phase landscapes are less restricted as they are based on a lower
coverage metabolite data set.
Figure 4.4: Dependency of the reversibility index γˆ on the
number of known educt concentrations. Reactions, for which
all educt concentrations were measured, were left out. Red
lines indicate the median, the blue boxes extend between the 25
and 75 % quantiles, whiskers extend between the highest and
lowest values, and black dots are all γˆ values. The reversible
range for γˆ values as described in the text is shown in gray.
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4.2.3 Discussion
Proteomics
From the data, the proteome of M. bovis BCG can be characterized as relatively constant.
The cells react specifically by adjusting a small set of protein concentrations in response to
perturbations in the carbon source. Metabolic flexibility seems to be limited to a small subset of
the metabolic network, at least in the specific experimental setup tested here.
In the face of the functional protein distribution, the slow growth of the bacteria can be explained
by the low fraction energy generating and ribosomal proteins. The majority of the resources
available for proteins is invested in defensive precautions, such as the production of complex
lipids or stabilization of proteins, which do not contribute directly to the replication of the cell
but rather to the protection of the cell against the host’s defensive actions.
Metabolomics
Steady state metabolite concentrations change dramatically between the tested conditions.
Some changes are specific to the growth phase rather than the nutrient condition, such as the
concentration increase in RL5P and R5P. The nucleotide triphosphates ATP and GTP are strongly
increased in the early glucose condition, potentially arguing for a favorable energetic situation.
BPG acts as a marker for gluconeogenetic flux on glutamate, but not on propionate where the
same flux reversal is required. In the dynamic data, only few directed metabolite concentration
changes could be identified, especially given the measurement noise. The concentrations of
most of the metabolites seem to be homeostatic on short time scales. The interconnection of
the CoA compounds could argue for a limitation in the cofactor, as soon as larger amounts of
acetate or propionate have to be catabolized.
What the data tells
From this purely data based analysis, a lot can be learned about the mycobacterial metabolism,
highlighting the strengths of omics approaches. The slow growth rate can be explained by
the defensive resource allocation in the proteome. The metabolomics data reveal energetic
properties of the different nutritional conditions and allow for the preliminary assessment of
thermodynamic features. Metabolic perturbations reveal homeostatic and nutrient- or growth
phase-sensitive metabolites.
Modeling efforts can complement these findings by contributing a more detailed analysis of
the underlying mechanisms. In the following Chapters questions that remained open in the
data analyses will be specifically addressed. The reaction thermodynamics are further assessed
and embedded in the network context, resolving inconsistencies on the way (Chapter 5.2).
The metabolome and proteome changes are linked mechanistically via a minimum-regulation
approach (Chapter 6.2) and on the pathway level, the distinct expression patterns of the two
propionate catabolic pathways will be explained (Chapter 7).

5. Linking genome and small scale
How is the central carbon metabolism embedded in the cellular metabolic network?
Which of its reactions are thermodynamically limiting and are they limiting in all conditions?
Systems biology employs two major strategies to understand mechanistic processes (see Fig-
ure 1.3). Top-down approaches measure cellular entities on the whole-cell level: A whole
family of omics techniques captures the overall cellular behavior and responses to perturbations.
High-level data analysis is then employed to draw conclusions on the underlying regulatory
processes. Especially in metabolic research, also modeling efforts have reached the genome
size, with models covering the entirety of all known metabolic pathways. On the other side
of the complexity spectrum, bottom-up approaches aim to understand single processes on a
detailed level: Classical biochemistry and molecular biology join forces with mathematical
modeling to mechanistically describe a single metabolic pathway or a genetic regulation circuit.
The mechanistic detail requires a sound data base and comes at a high computational and
experimental cost.
This Chapter will address the interface of these two approaches and how knowledge can be
transferred from one to the other. Specifically, it will tackle the open issue of how small dynamic
metabolic models can benefit from the knowledge collected in genome-scale approaches. A
technique is presented that allows embedding of small mechanistic models in the flux context
given by a genome-scale model in a specific environmental condition, thereby meaningfully
defining their boundary fluxes (Section 5.1). With these calculated leak fluxes, condition depen-
dent, optimum thermodynamic landscapes are then calculated for the central metabolic network
in M. bovis BCG (Section 5.2), improving the reversibility index approach described in the
previous Chapter.
5.1 Biomass backtracking
This Section is based on the publication:
Tummler, K., Kühn, C., & Klipp, E. (2015).
Dynamic metabolic models in context: biomass backtracking.
Integrative Biology, 7(8), 940-951.
5.1.1 Context for small metabolic models
Metabolism has been an early target of mathematical modeling efforts, due to its chemical
traceability. Existing models mirror the two modeling types described above: Small, bottom-
up models in the form of ordinary differential equations have proven to be powerful tools to
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Figure 5.1: Schematic overview of the backtracking approach (Figure from [195]).
understand the intrinsic dynamics and complex functionalities of cellular metabolism [94, 201].
Yet, due to limitations in computational power as well as in the availability of high quality
data and calibration algorithms, these algorithms are usually restricted to a small region of
the entire metabolic network or to a simplified description. Additionally, single pathways can
show drastically different behavior in changing cellular contexts, which might not be included
in the focused models. On the other hand, top-down, genome-scale metabolic models can
predict genome wide flux distributions under various external conditions integrating a variety of
different experimental data [23], but lack mechanistic detail as well as temporal resolution.
A number of methods exist that intend to improve the predictive power of large scale models
by linking the two modeling types. Examples reach from the integration of a framing dynamic
model describing growth and nutrient uptake rates (dFBA [111]), inclusion of kinetics of single
reactions (k-OptForce [34]) to the full "ODE-fication" of the flux carrying sub-network [186] in
a specific condition.
The inverse approach of improving dynamic models with genome-scale information is presented
here: Biomass backtracking, a method to exploit the extensive knowledge collected in genome-
scale reconstructions to contextualize dynamic pathway models. A calculated genome-wide flux
distribution is thereby used to establish a stoichiometrically exact, condition dependent biomass
reaction for the dynamically modeled network part.
Defining reactions connecting dynamic metabolic models to cellular context, often in the form
of biomass reactions, is a complex task that is usually carried out by hand based on one’s own
experimental data or crude estimates. In this process it is easy to overlook systemic effects such
as side products of distinct synthesis pathways that re-enter the dynamically modeled network
part (e.g. pentose phosphate pathway) or the effect of additional nutrients entering at distinct
areas of the metabolic network. However, drains into biomass or cellular products and their
exact stoichiometry can have a dramatic influence on the kinetics of the modeled reactions.
If, for example, a dynamically modeled metabolite x is consumed in large quantities for the
production of biomass, the reactions consuming it in the dynamic model will have to carry much
less flux to maintain the steady state concentration of x than the ones producing it. This strongly
influences the kinetic parameters of the associated enzymes as well as all downstream fluxes.
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Backtracking in a nutshell
The start of backtracking is (i) a detailed dynamic model (DDM) covering part of metabolism
but lacking a detailed biomass reaction and (ii) a genome-scale metabolic model (GSM) of
the same organism (Figure 5.1). The backtracking workflow embeds the DDM in the broader
context of the GSM and provides a stoichiometrically consistent reaction consuming species of
the dynamic model to generate biomass (or any other target metabolite) as defined in the GSM.
For this, the overlap between the DDM and the GSM has to be defined (mapping). The mapping
of metabolites is based on unique database identifiers as well as on metabolite sum formulas.
The reactions can be assigned based on identifiers and the reaction stoichiometry linking the
mapped metabolites. The mapping will result in a set of reactions and metabolites that is part of
both models. Subsequently, a target metabolite from the GSM is selected, for which the required
production fluxes from the dynamic model will be quantified. In most cases this will be the
biomass, but any other metabolite in the GSM can be used as well, for example if the entity of
interest is a specific secreted metabolite. The flux through the GSM reaction consuming the
target metabolite is then set to a fixed value, to allow for normalization of the computed leak
fluxes. In the next step, a parsimonious flux balance analysis (pFBA, [73]) is run to calculate
flux distributions in the GSM. At this point, also further information, such as thermodynamic
constraints, experimentally measured uptake rates, fluxes or enzyme expression data, can be
included to constrain the solution space of the GSM. From the obtained flux distribution, the leak
fluxes of each mapped metabolite of the dynamic model are calculated as the sum of all fluxes
affecting that metabolite (i.e. have non-zero entries in the respective row of the stoichiometric
matrix), excluding those that have been mapped to be contained in the DDM.
5.1.2 Mathematical formulation
Implementation
The backtracking workflow was implemented in Matlab, employing the SBML toolbox [90]
for model import from and export to the commonly used Systems Biology Markup Language
(SBML, [78]). The Cobra Toolbox [17] was used to handle models and calculate optimum FBA
solutions by means of the open source linear programming solver glpk [112].
Preparations: Mapping and target definition
The DDM is mapped to the GSM primarily via annotations of database identifiers (ChEBI [69],
KEGG [84]) provided in both SBML files. If annotations are not provided, metabolites can
be mapped via their sum formulas, which are automatically looked up in the above databases.
The DDM reactions are mapped via KEGG identifiers or similar stoichiometries of mapped
metabolites in both models. The mapping is semi-automatized, with a list of likely matching
entities provided for each metabolite and reaction, from which the user can select.
One reaction or metabolite has to be defined as the target of the backtracking. The calculated
leak fluxes will be normalized to the flux through this reaction, resulting in relative leak fluxes
in the unit mol/(mol target). The target will usually be the biomass, but can also be specific
(secreted) products of interest or submodules producing individual biomass constituents, as
required for modular modeling.
Leak calculation
For the calculation of the leak fluxes a feasible flux distribution for the GSM is calculated. Here,
the minimum sum of all fluxes, coinciding with a low overall enzyme load (pFBA, [73]) was
used as an objective. pFBA has been shown to correlate well with experimental data [102, 178],
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but other more sophisticated or data driven objectives and constraints can be used.
The resulting flux vector v¯, fulfilling the steady state assumption N · v¯= 0, contains entries vm
for the fluxes of all reactions that have been mapped between the GSM and the DDM, and vGSM
for all fluxes only present in the GSM. The leak fluxes vleak,i are calculated as the sum of fluxes
vGSM of all reactions that consume or produce a metabolite xi of the DDM and are themselves
not part of it, multiplied by their respective stoichiometric coefficient ϑi, j:
vleak,i =
nr
∑
j=1
ϑi, j · vGSM, j, (5.1)
with nr as the number of reactions in the GSM.
Handling of lumped reactions and metabolites
For reactions and metabolites with one-to-one mapping the leak fluxes can be easily calculated
as a simple weighted sum. However, simplifications in the model topology - often by lumping
several reactions or metabolites into a common entity - have to be treated with care.
Leak fluxes for lumped metabolites are calculated as the sum over all leak fluxes of all mapped
species of the metabolite pool. Reactions inter-converting between the pool species will cancel
out in the summation, but their contribution to the turnover of cofactors will still be represented
in the optimal flux distribution. Lumped reactions, for example one single reaction representing
a linear pathway, have to be treated more carefully. As they also bridge several intermediate
metabolites, the leaks of those will not be represented in the DDM. However, those leaks
could be essential sources for biomass precursors and neglecting them could introduce large
errors in the flux distribution of the DDM. Therefore, a summed stoichiometry of the lumped
reaction from the optimal flux distribution with amended stoichiometric coefficients of substrates
and products is calculated. For each lumped reaction, a waste term is generated including all
intermediate leaks from the bridged metabolites.
5.1.3 Results: What backtracking can do for you
Condition and species specific leak fluxes
In the publication [195], several test cases were used to point out the complexity and variability
of biomass leak stoichiometry. The impact of altered environmental conditions on the leak
fluxes from yeast glycolysis was characterized, based on an experimental data set of yeast
grown under different aeration conditions [82]. It was also shown that biomass leaks heavily
depend on the organism in question, caused by alternative metabolic wiring or a different
biomass composition. Exemplarily, glycolytic leaks for 4 different species with available high
quality GSMs (S. cerevisiae, E. coli, M. tuberculosis and B. subtilis) showed vastly different
distributions.
Backtracking also supplies values for cellular uptake or secretion rates for all required media
compounds. This might be helpful if, for example, the sensitivity of a distinct metabolic pathway
to the availability of external compounds such as oxygen is to be modeled. Additionally, it
allows for a consistency check of the calculated leaks and the GSM flux distribution, e.g. by
balancing carbon atoms in biomass and uptake fluxes. Additionally, backtracking allows to
dissect cofactor turnover, as was shown for the case of ATP in yeast, split in glycolytic and
respiratory ATP production in the mitochondrial compartment. These findings are useful if
dummy ATP consuming or respiratory chain reactions shall be included in a model, as they
allow for an accurate calculation of either stoichiometry.
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Figure 5.2: Comparison of leak fluxes of existing dynamic models with the results of backtracking. A Leak fluxes
were calculated for two dynamic models of E. coli from Chassagnole et al. [31] (BIOMD0000000051) and Singh et
al. [184] (BIOMD0000000221) based on the iJO1366 GSM [137], and the dynamic models of S. cerevisiae from
Hynne et al. [79] (BIOMD0000000061) and van Eunen et al. [200] (MODEL1403250001) based on the Yeast 7
GSM [7] and compared to the steady state fluxes that leave the respective models as simulated in COPASI [75].
Fluxes in the red area were predicted by backtracking but absent in the dynamic models. B Summary of all dynamic
metabolic models in the Biomodels database with regard to their definition of boundary fluxes. Figure taken from
[195], for detailed information on the shown models please refer to the publication.
Most published metabolic models neglect leak fluxes
Despite the importance of contextualization, many published models pay little attention to their
boundary fluxes. Of the 169 dynamic ODE models for metabolic pathways in the Biomodels
database [32] none has used information on system wide flux distributions, and only 9 take con-
sumption fluxes for biomass production from intermediate species into account (Figure 5.2 B).
However, GSMs of over 100 species are available to obtain such information [23].
To exemplify the extent of the leaking fluxes that were neglected in dynamic models, backtrack-
ing was applied to several high-quality dynamic metabolic models. Two models of E. coli and
two of S. cerevisiae were embedded in their respective GSMs and leak fluxes were calculated
under conditions as defined for the dynamic models. The results were compared to the boundary
fluxes present in the original models in steady state (Figure 5.2 A).
For all models, backtracking predicts leak fluxes that were neglected in the DDMs. The closest
match to the backtracking leaks was found for the model of Chassagnole et al. [31], whose
boundary fluxes are based on detailed experimental data. However, the vast majority of currently
available metabolic DDMs have less detailed boundary fluxes and could potentially be improved
by more accurate leak fluxes from backtracking (Figure 5.2 B).
Model simplification, extension or splitting
Backtracking can also be used to define consistent boundary fluxes for changing model structures
in the iterative process of model development or for integrative modeling, where sub-models
need to be connected via meaningful interfaces. In the backtracking publication, all potentially
occurring scenarios – model splitting, extension or simplification – were exemplified using yeast
glycolysis (Figure 5.3 A).
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Splitting models into smaller submodules eases computational simulation effort as well as the
complexity of parameter estimation, which is why it can be used in large modular modeling
projects up to whole-cell modeling. The consistent and automatic recalculation of boundary
fluxes between the modules, as exemplarily shown in Figure 5.3 B, is thereby crucial for the
interplay of the modules and can be achieved by backtracking with manageable effort.
Simplifying models becomes necessary, wherever the data coverage is not high enough to allow
the estimation of kinetic parameters with sufficiently high confidence. The reduction of DDMs
can be based on time scale separation (lumping of fast reactions [6, 151]) and topological fea-
tures of the model [153]. Simplified models hold the same benefits as smaller models in terms
of computational effort and clarity. The reduction is usually achieved by lumping metabolites
and/or reactions. Both cases are exemplified in Figure 5.3 C, where three lumped reactions
and one lumped metabolite were introduced to the hypothetical glycolytic model. Merging
reactions is more complex if the resulting lumped reaction skips intermediates that contribute to
the biomass production. In the example, it would be wrong to assume that all acquired glucose
molecules are converted to fructose-1-6-bisphosphate (fdp[c]) by the first lumped reaction LR1,
as part of them are also used elsewhere (e.g. the pentose phosphate pathway and the direct
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Figure 5.3: Calculating biomass leaks for split (B), simplified (C) and extended (D) models of yeast glycolysis (A).
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production of biomass). The subsequent FBA reaction would hence have to carry much less flux,
which directly impacts on the estimation of its kinetic parameters. The backtracking workflow
resolves this inaccuracy by introducing waste terms for each lumped reaction in the DDM as
well as an amended stoichiometry. Importantly, the stoichiometry of the lumped reactions can
be different between two distinct biological scenarios. In the example, LR1 is consuming one
glucose molecule but produces only 0.66 molecules of fdp[c] and a waste term as shown in the
table in Figure 5.3 C. The occurrence of large waste terms for lumped DDM reactions may also
help in the model design process as it hints at potentially important, but not yet included system
features. For pooled species, the leak fluxes of all mapped metabolites belonging to the pool
will be added up. The reactions inter-converting between pooled species are taken into account,
if they have been mapped. This is especially important if they also turnover cofactors and ATP.
Extending models is a joyful task when new data becomes available to improve the model.
Backtracking allows to retain leak fluxes from the unchanged part of the model and consistently
distributes the leak fluxes of the changed part to the new species and reactions. In the example,
the pentose phosphate pathway was added to the model (Figure 5.3 D).
5.1.4 Results: Leak fluxes of the mycobacterial central carbon metabolism
Within the scope of this work, biomass backtracking was applied to calculate condition
dependent leak fluxes from the central carbon metabolism in mycobacteria (formalized in the
CCMtb model, cf. Chapter and Figure 6.1). The network includes the major carbon catabolic
pathways glycolysis, pentose phosphate pathway, Krebs cycle, glyoxylate shunt, anaplerosis, as
well as the methylcitrate and methylmalonyl pathways. A dummy respiratory chain is included
to also account for ATP that is de novo synthesized via respiration.
As context, the most up-to-date GSM for M. tuberculosis, sMtb [159], was used with
several small modifications, necessary to guarantee physiological function (summarized in
Appendix A.9). The GSM contains an experimentally determined biomass composition, which
will be the base for the calculated leak fluxes.
Leaks in three growth conditions
The leaks in the 3 experimental growth conditions (glucose, propionate, glutamate) were
analyzed and exhibited a generally comparable distribution (Appendix A.10). In Figure 5.4 C,
the distribution of leak fluxes required for the synthesis of the different biomass constituents for
growth on glucose media is shown. For propionate and glutamate conditions, the distributions
can be found in Appendix A.11.
The biomass of M. tuberculosis largely consists of complex lipids and carbohydrates constituting
the thick cellular envelope that protects the bacteria against host induced killing (see Figure 4.1).
Accordingly, almost 40 % of the taken up carbon is incorporated into the lipid fraction of
the biomass, 30 % is channeled into the biosynthesis of complex carbohydrates. Lipids are
predominantly build up from pyruvate, as well as acetyl- and propionyl-CoA. Flux towards the
production of carbohydrates drains mainly from glycolysis. However, it becomes evident that
both synthesis pathways, as well as the ones for RNA, DNA and protein, are highly complex,
utilizing a variety of central carbon metabolism intermediates in vastly different stoichiometries.
Backtracking allows to identify all contributions reliably based on the current knowledge on the
entire metabolism of M. tuberculosis.
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Figure 5.4: Biomass leaks in the three different growth conditions. A Summary of the fate of ingested carbon in the different growth conditions as derived from the backtracking.
Negative values signify a resorption of carbon via CO2 fixating reactions. B The same results as in A dissected into the requirements for subgroups of biomass components.
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model. They are indicated here as colored, stacked bars on the biomass component’s side (the green bar, for example, indicates released CO2), and shown in detail in Appendix
A.12. Abbreviations: Cmmol - mmol of carbon atoms, gDW - gram dry weight, species abbreviations are as in sMtb [159] and Appendix A.18.
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Carbon conservation
As a quality and consistency check, the number of carbon atoms required for the production of
each biomass component was analyzed. The results for the production of the entire biomass and
single subgroups of biomass constituents are shown in Figure 5.4 A and B, respectively.
Theoretically, the sum of all carbon atoms of the dynamically modeled metabolites consumed
in the leak should equal the number of carbon atoms per mole of biomass component, minus
the amount that is released as carbon dioxide (CO2) or other metabolites along the synthesis
way. For CO2, two different scenarios can occur: Either the CO2 is released by reactions in the
dynamically modeled network part (dark blue bars) or from distant biosynthetic reactions (light
blue bars). The latter term would occur as a leak of positive sign for the CO2 species of CCMtb
(i.e. it is produced on the way to the biomass component and reinserted in the model), the former
term would not, as it is already accounted for in the dynamic model. For the production of
some biomass components additional secretion of other intermediates is required in sMtb (light
red bars). This can be attributed to the minimalistic nature of the pFBA approach used in the
backtracking, which sometimes favors unphysiological solutions with a smaller active network
over more physiological ones which would include long range effects. This especially happens
when only a single biomass constituent is backtracked (cf. Appendix A.13), as a number of
network constraints are released in this optimization. If the used GSM is not fully consistent,
unexplained carbon occurs as indication that the number of carbons in the atomic formula of the
biomass component does not match the number of carbons incorporated (’Unexplained carbon’
in Figure 5.4 A and B). This is the case for only a number of biomass components with difficult
and variable composition (arabinogalactan/peptidoglycan and phosphatidylinositol mannosides),
arguing for a high overall quality of the used GSM.
The propionate condition has the lowest overall loss to CO2, the glutamate condition the highest.
This is due to the fact that gluconeogenetic flux under glutamate conditions will have to pass
through the reductive branch of the Krebs cycle. Hence, 1 of 5 acquired carbon atoms will
be lost as CO2 in the kdh or kgd reactions, which shows as a leak from the CCMtb model in
Figure 5.4 B and Appendix A.14 (dark blue bars).
5.1.5 Discussion
Backtracking provides a solution to the problem of contextualizing detailed dynamic models of
metabolic pathways. The condition dependent embedding allows a more realistic simulation of
such pathways and their contribution to overall cellular functionality.
The overall mass balance, which – in contrast to isolated signaling models – has to be fulfilled
by metabolic pathway models, usually complicates model calibration rather than easing it.
Consistent and biologically meaningful leak fluxes ease this process. In this work, the calculated
leak fluxes are essential for all other modeling approaches presented in the following Chapters.
As shown above, the backtracking can also support an easy quality control of the used GSM, on
whose accuracy and experimental backing the calculated leak fluxes will rely.
Biomass backtracking can also be seen as a means of large scale data integration. Data from
omics measurements are frequently used to restrict the feasible flux space in sophisticated FBA
methods [38, 42, 76, 98, 103, 210]. Leak fluxes calculated from such experimentally constraint
flux distributions will transmit the information to the pathway of interest – as some kind of
simple transfer function that can be refined as needed and as the data situation allows. This
might also have applications in the integration of patient data for personalized medicine.
Another focus of application is the iterative development and improvement of models as is
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required for modular or whole-cell modeling [28, 86, 94]. Modified models will still need to
match the overall context and, moreover, interfaces between modules have to be consistent.
Backtracking provides a reliable and reproducible way to ensure these criteria.
Limitations
Backtracking in different nutritional conditions cannot account for changes in the actual compo-
sition of the biomass, which is very likely to change between different growth conditions: It
has been shown for the lipid content during different growth phases [169] or different growth
rates in the chemostat [20]. The single component backtracking, provides a way to generate
distinct reactions for the synthesis of each component. If individual, and potentially regulated
reaction kinetics are defined for each of those reactions, the composition can be easily adapted
in accordance with the biological context.
Unfortunately, the plasticity of biomass production pathways if one precursor is missing cannot
be represented by the model with fixed biomass drains. The production of the biomass will cease
as soon as one of the precursors is no longer available. A next step would be to develop new
methods to more precisely couple dynamic simulations with constraint models of metabolism
and simulate them together.
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5.2 Extending driving force optimality to the network context
While backtracking defines sensitive boundary fluxes for metabolic models, it is solely based on
the steady state assumption of the underlying network and on minimizing the overall enzyme
production cost by applying pFBA. However, these are only some of the conceivable constraints
that cellular metabolic networks could be subjected to. An inevitable constraint will be the
fulfillment of energy balance (i.e. thermodynamic consistency), while others could include
building up defensive mechanisms, like a thick cell wall as in mycobacteria [44], nutrient
storages for potential harsher times [183] or maintaining transmembrane ion gradients [208].
Within the central carbon metabolism, a good coverage of measured metabolite concentrations
and thermodynamic reaction enthalpies can be achieved, such that they can be incorporated in
order to get a deeper understanding of the flux distributions within this part of the metabolic
system. This can refine the findings based on the thermodynamic characterization of the network
by the reversibility index (Section 4.2.2) by additionally incorporating the network topology.
For this task, a number of FBA based methods are available, as outlined below. In addition, this
work focuses on applying a measure of optimality to the thermodynamic landscape, which is
new to the world of network thermodynamics. Thereby, existing methods are combined to a
novel setup assuring mass and energy balance while striving for thermodynamic optimality.
5.2.1 A network approach to maximum-minimum-driving forces
Previous methods to link mass and energy balances
A number of methods are already available to combine stoichiometric network models with ther-
modynamic constraints, examining consistency and partly also optimality of flux distributions
and metabolomic datasets.
Network embedded thermodynamics [98, 212] strive to calculate boundaries for physiologically
possible ∆rG′ values or metabolite concentrations given a set flux distribution in a network,
based on the consistency of reaction direction and the sign of -∆rG′. Flux directions are thereby
inferred from experimental flux measurements, flux balance analysis or can be left undefined
where unknown. This last feature, however, while reducing the number of assumptions, does
not guarantee a feasible steady state of the network.
The inverse approach of defining feasible flux directions from thermodynamic constraints was
formalized by Beard et al. (Energy Balance Analysis [14, 15]) and systematically applied to
the then available genome-scale network of E. coli by Henry and coworkers (Thermodynamic
FBA/TMFA [71]). They thereby applied default bounds on metabolite concentrations as well as,
after an unfeasible system resulting from the initial approach, included uncertainties in ∆rG0.
As a combination of the above methods, Hoppe et al. directly included information on metabolite
concentrations in the thermodynamically consistent flux calculation (Thermodynamic Realiz-
ability [76]). Also here, measurement errors of the ∆rG0 were accounted for. Additional bounds
corresponding to measured metabolite concentrations were elegantly implemented by partly
nonlinear penalty functions. As a computational drawback, the resulting optimization problem
has a nonlinear scoring function, which is difficult to solve numerically.
On the pathway level, where the direction of the flux for all reactions is known, pathway ther-
modynamics [134] can be applied. Thermodynamic principles are here applied to transition
from a feasible, pathway-wide thermodynamic gradient to an optimal one. Optimality is thereby
formulated as the least feasible reaction in the pathway reaching its maximum possible driving
force (i.e. the inverse of ∆rG′) in the pathway context. Additionally to this new optimality
thought, also the optimization problem formulates as a linear, easily solvable one.
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This approach
The approach presented here combines the pathway based calculation of the maximum-minimum
driving force (MDF) via pathway thermodynamics [134] with the network oriented TMFA [71]
framework. This allows to calculate a set of thermodynamically optimal metabolite concentra-
tions and flux directions for the central carbon metabolism in mycobacteria.
5.2.2 Mathematical formulation
The desired approach can be formalized as a linear optimization problem with thermodynamic
and mass balance constraints on the flux distribution. To optimize for a favorable thermodynamic
landscape, the MDF is introduced to the optimization as a common upper bound on the Gibbs
energies of active fluxes. Its minimization will force all ∆rG′ to decrease in order to achieve a
maximally steep thermodynamic gradient for all reactions. The required constraint equations
and possible objective function for the implementation are described in the following.
Set of Constraints
N′ ∈ Rm×r is defined as the stoichiometric matrix of the irreversible version of the metabolic
network in question, with r as the number of reactions and m as the number of metabolites. To
obtain this version, all reversible reactions are split in one reaction for each direction. For a
subset of rt reactions (excluding transport and biomass reactions) thermodynamic constraints
were included. N′t ∈ Rm×rt is the corresponding part of N′.
The vector of variables to be optimized d includes the metabolic fluxes v ∈ Rr, the logarithmic
metabolite concentrations x ∈ Rm, binary variables u ∈ Rr and q,z ∈ Rrt corresponding to
pointers for positive flux, positive ∆rG′ and a flux direction violating the thermodynamic
gradient, respectively, the violating flux values w∈R1×rt , the reaction Gibbs energies ∆rG′ ∈Rrt
(normalized by RT ), the standard Gibbs energies ∆rG0 ∈ Rrt and the maximum-minimum-
driving force MDF, which is the target of the optimization. ∆rG′max and Vmax are large numbers
outside the range of possible ∆rG′ and flux values, respectively.
A linear optimization problem as described in Section 2.19 with the following set of constraints
is solved:
N′ ·v= 0 mass balance (steady state) constraints (5.1)
N′t
T ·x−∆rG′−∆rG0 = 0 ∆rG′ according to concentrations in x (5.2)
0≤ v≤Vmax lower and upper bounds on the flux (5.3)
xlb ≤ x≤ xlb data based lower and upper bounds
on the metabolite concentrations (5.4)
∆rG0lb ≤ ∆rG0 ≤ ∆rG0ub data based lower and upper bounds
on ∆rG0 (5.5)
v−u ·Vmax ≤ 0 pointer u for positive flux (5.6)
∆rG′−q ·∆rG′max < 0 (≤−ε) pointer q for positive ∆rG′ (5.7)
u+q− z≤ 1 violating flux pointer z (5.8)
v+ z ·Vmax−w≤Vmax flux value of violating reactions (5.9)
w≥ 0 lower bound for violating flux (5.10)
∆rG′+u ·∆rG′max−MDF ≤ ∆rG′max MDF constraint on all active fluxes (5.11)
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The system of constraints can be interpreted as follows: To ensure mass conservation the sum of
all changing fluxes v for each metabolite in x has to be 0 (constraint 5.1). As the biomass leaks
are included as one combined biomass reaction with the respective stoichiometric coefficients,
this will also guarantee biomass production in the right proportions. The flux through this
reaction was fixed to arrive at a division time of 38 h (cf. Table 4.2).
The dependency of ∆rG′ on ∆rG0 and the logarithmic metabolite concentrations x is imple-
mented in constraint 5.2. Note that here also the ∆rG0 are variables rather than fixed values.
The constraints 5.3-5.5 implement bounds on the fluxes, metabolite concentrations and on ∆rG0
(based on the measured data: 2 standard deviations (sd) for the metabolite data, 3sd for the
standard Gibbs energies). Lumped observables, i.e. measurements of the sum of two or more
metabolites, are resolved to allowing all summand metabolites to vary within the full range of
the summed concentration, resulting a maximum 2-fold error. If the summation would be imple-
mented directly the problem would become nonlinear as the space of logarithmic concentrations
is searched.
Constraint 5.6 introduces the boolean pointer u for positive flux, which is forced to be 1 for all
positive fluxes in order to fulfill the constraint equation. The same holds for pointer q and the
∆rG′ in constraint 5.7. This constraint has to be a strict inequality, as also for the equilibrium at
∆rG′ = 0, no net flux can occur. As the common linear programming solvers do not account for
strict inequalities, it was resolved to a non-strict inequality by the introduction of ε > 0.
In the original TMFA, constraint 5.8 would read as u+q≤ 1, assuring that whenever a positive
flux forces its respective pointer u to be 1, the corresponding Gibbs energy pointer q needs
to be 0, encoding a negative ∆rG′. However, if the problem with the given constraints and
data is infeasible, as was the case here, this constraint has to be modified to identify exhausted
constraints. On the way to a feasible solution, the pointer z was introduced to soften this
constraint. All fluxes violating the relation between flux direction and the sign of ∆rG′ will
force a 1 in the respective position of z. Along with constraint 5.9 that introduces the vector w
containing the actual values of all infeasible fluxes, this allows for a systematic reduction of
infeasibilities as described below. Constraint 5.10 corresponds to the lower flux bound for the
violating fluxes, in order to guarantee again a irreversible network.
Finally, the MDF, as an upper bound on ∆rG′ for flux carrying reactions marked in u, is imple-
mented in constraint 5.11. In contrast to the original publication by Noor et al. [134], where the
MDF is the lower bound for the driving force -∆rG′, the inverse notation is used to allow for a
common optimization sense ("minimization") if the MDF is combined with other objectives.
As in the original TMFA, the resulting problem formulates as a mixed zero-one linear program-
ming, as some of the variables are booleans whereas some are continuous. The solution of this
type of problems is computationally expensive and requires long computation times.
Objective function
The objective function was intended to represent both optimum physiological flux distribution
as well as a high driving force. The first aspect is commonly implemented by parsimonious
FBA, while for the latter aspect, the optimization of the MDF as described by Noor et al. is
employed. The overall objective then reads as:
min
x,v,∆rG0,MDF,u,y,z,w
(MDF +wpFBA
r
∑
i=1
vi), (5.12)
with wpFBA as weight with which the parsimonious FBA contributes to the optimum solution.
However, this objective function gives biologically meaningful results only if the search space
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Table 5.1: Summary of the feasible solutions of the described optimization problem for the 4 experimental conditions.
Glucose, early Glucose, late Glutamate, late Propionate, late
runtime [s] 0.99 2.47 108.62 37.74
pFBA weight wpFBA 0.01 0.001 0.001 0.001
Max-min driving force
(MDF, kJ/mol) 1.59 3.23 1.24 0.046
contains a feasible solution. When this is not the case, the bounds have to be systematically
relaxed to arrive at a feasible solution, for which the following other objectives were used:
(i) Minimizing the number of all infeasible reactions (min∑z) and (ii) minimizing the sum of
fluxes for all infeasible reactions (min∑w). Both approaches help to identify critical, infeasible
reactions, as long as the system is not thermodynamically feasible, but can include flux loops and
non-physiological solutions (e.g. futile cycles). For this reason, those objectives were abandoned
as soon as the system was feasible.
Iterative MDF
As the MDF only acts as an upper bound for ∆rG′, it is usually possible to lower the remaining
reactions’ ∆rG′ further than in the found solution to the MDF problem, to arrive at a more
beneficial thermodynamic landscape. For this, shadow prices of the optimization result can be
exploited to identify limiting constraints. Here, the reactions employing only metabolites with
the highest shadow prices, i.e. with a ∆rG′ equal to the found MDF value, were fixed to this
found value. With the given optimum flux distribution, the MDF for the remaining reactions
was optimized again. This process was repeated until all reactions were fixed, arriving at the
best network-wide driving force distribution.
5.2.3 Results: Resolving infeasibilities
To arrive at a mass balanced system with an optimal thermodynamic landscape, the central
metabolic network along with the corresponding metabolite measurements from four different
cultivation conditions were iteratively analyzed.
No feasible solution with the initial bounds on ∆rG′ and metabolite concentrations could be
found, except for the late exponential growth on glucose. A combination of different objective
functions that were used to identify infeasible reactions is summarized in Appendix A.16,
employing the described markers z and flux values w for infeasible reactions. For the identified
reactions the corresponding bounds on the metabolite concentrations were expanded by 4 sd
(based on the experimental data). This was the case for the tpi reaction on early glucose and the
pgk reaction on glutamate and propionate.
Figure 5.5: Thermodynamically optimal, mass balanced flux distributions in the central metabolic network. For each
measured experimental condition (A Glucose, early growth phase, B Glucose, late growth phase, C Glutamate, late
growth phase, D Propionate, early growth phase) flux distributions are shown, where the width of the arrows represents
the strength of the flux. Please not that for clarity biomass leaks are not shown, but drain and feed into the network
in the calculations (e.g. fumarate feed explains sdh flux direction). In A the involved pathways are labeled in gray
as: PPP - pentose phosphate pathway, GLY - glycolysis (upper, u and lower, l), ANA - anaplerotic/gluconeogenetic
reactions, TCA - Krebs cycle, MCIT - methylcitrate pathway, MMCO - methylmalonyl pathway. Each reaction is
labeled with its ∆rG′ in kJ/mol after the iterative optimization, the bottleneck reactions are shown in red. For detailed
information on the shown reactions see Appendices A.20 and A.21 . Metabolites with the highest shadow prices are
highlighted as boxes (red - negative shadow price, blue - positive shadow price, the price itself is printed behind the
metabolites’ names). Dashed lines indicate reactions that do not carry flux.
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Also after this release, which allowed for a fully feasible flux distribution, these reactions
remained part of the thermodynamic bottleneck in the respective conditions. The MDF reaches
the lowest value on propionate, comparable higher values for glutamate and early exponential
glucose conditions, and the best value for the late exponential glucose condition (summarized in
Table 5.1, the found optimum metabolite concentrations along with their bounds are depicted in
Appendix A.17).
5.2.4 Results: Glycolysis as thermodynamic bottleneck
The found optimum flux and thermodynamic gradient distribution is mapped to the central
metabolic network considered in Figure 5.5 and summarized in Figure 5.6. In all examined con-
ditions, glycolysis reveals itself as thermodynamic bottleneck (reactions are indicated in red in
Figure 5.5, with corresponding optimal ∆rG′equaling the MDF). From early to late exponential
growth phase on glucose, the thermodynamic bottleneck slides from upper to lower glycolysis,
thereby always marking non ATP coupled reactions. For the gluconeogenetic carbon sources
glutamate and propionate, lower glycolysis including the pgk reaction is the most inefficient
part, being barely feasible on propionate (∆rG′ = -0.05 kJ/mol, J−/J+ = 0.98).
For all conditions, the Krebs cycle runs in the generic (oxidative) direction, most likely due to
the extremely low ∆rG0 of the kdh reaction. This argues for favorable redox conditions, where
a reductive reversal of the left half of the cycle is not required [204]. If glutamate as carbon
source is supplied, the right half of the Krebs cycle is not required, as no biomass components
drain from there (cf. Figure 5.4 C and Appendix A.11).
For the production of virulence relevant lipids, intermediates of the methylmalonyl and methyl-
citrate pathways are required. In all conditions, their production via the methylmalonyl pathway
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Figure 5.6: Network wide summary of the found optimum solution. The upper panel shows a histogram for all
reactions’ driving forces (-∆rG′ in kJ/mol) for the 4 experimental conditions, with the median marked as red line and
corresponding value. The lower panel shows the occurring driving force values dissected in the single pathways
considered in the network (dots), lines depict the range for each pathway. The gray areas illustrate the found lowest
driving force.
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is preferred. The methylcitrate cycle only becomes active in the late growth phase on glucose, a
condition for which its intermediate metabolites were not quantified. As explained before (see
Figure 4.4), the number of measured metabolites influences the definition of the thermodynamic
gradient and the reaction reversibility, such that this result could be an artifact.
The PEP-pyruvate-oxaloacetate node, which distributes carbon between gluconeogenesis/
anaplerosis and the Krebs cycle [172], shows non-intuitive behavior, especially for the glucose
conditions, where the pyk reaction, the second last step in glycolysis, is bypassed. In the late
growth conditions, several reactions share the title of the least feasible reaction. This has been
described earlier as the concept of distributed bottlenecks, in which a set of reactions, rather
than only one, becomes thermodynamically limiting [118].
While the MDF is lowest on propionate, the overall distribution of ∆rG′ in this condition is more
favorable compared to growth on glutamate (Figure 5.6). In this comparison, also early and late
glucose conditions show a more comparable gradient distribution that also has a higher median
compared to the gluconeogenetic carbon sources.
5.2.5 Discussion
Towards thermodynamic network optimality
In the described approach, the central carbon metabolic network of M. bovis BCG was evaluated
for both thermodynamic consistency and optimality. While there is room for improvement, a first
endeavor to apply thermodynamic optimality principles on purely stoichiometric networks is
presented. Glycolysis is identified as critical bottleneck in all tested conditions. It can be argued
that due to their reversible nature, glycolytic reactions cannot be proficient in one direction,
especially in an organism relying on fast rerouting of its metabolism in changing environments.
Not surprisingly, the thermodynamic landscape is more beneficial on the high energy compound
glucose than on the gluconeogenetic carbon sources propionate and glutamate (Figure 5.6).
Bias of measured metabolites
As already shown for the calculation of the reversibility index, a strong bias by the number of
measured educts for a reaction becomes evident. For example could the striking differences
between the two glycolytic conditions potentially be an artifact of missing metabolite measure-
ments, that allow the MCIT pathway to be used in reverse direction (Figure 5.5 B), thereby
rerouting many fluxes in the right half of the Krebs cycle. Also, the additional measurement of
F6P in the early growth condition tightly constrains the pgi reaction, even defining a new overall
bottleneck compared to the late growth condition, where this measurement is lacking.
It can hence be concluded that for understanding the optimal thermodynamic landscape as
opposed to a merely feasible one, quantitative metabolomics measurements are indispensable.
Further use
For the work presented in the following Chapters, the found infeasibilities in the metabolite data
set will be considered. The results will be used to relax the bounds on metabolite concentrations
where specifically necessary to guarantee thermodynamic feasibility in later applications of the
model and data. The allowable changes are summarized in Table 5.2.
Condition Metabolites on which bounds were relaxed
Glucose, early -
Glucose, late G3P, DHAP
Glutamate, late 13PDG, 3PG
Propionate, early 13PDG, 3PG, PEP
Table 5.2: Metabolites for which bounds
based on the measured metabolite con-
centrations were released to allow for
thermodynamic network feasibility.
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Limitations and possible improvements
While combining network derived flux feasibility with thermodynamic optimality has the poten-
tial to improve understanding of cellular metabolism, the method has some practical limitations
discussed in this Section along with possible ways to resolve them in future works.
A major limitation is the computationally hard formulation as a mixed zero-one linear program-
ming problem, which is not efficiently solvable with the currently available linear programming
solvers. The nature of the problem arises from the binary ’choosing’ of different fluxes to be
active or not in the given flux distribution in addition to the maximization of the driving force,
which is in itself an easily solvable linear problem.
A complementary approach could be the calculation of thermodynamically feasible elementary
flux modes as described by Gerstl et al. (tEFMA [65]). These paths trough a network include all
possible ways to fulfill the flux balance (and hence also the appropriate biomass formation) in
a minimal, non-splittable fashion. If all elementary flux modes of the network are known, the
original linear MDF optimization could be easily used to thermodynamically optimize each of
them and select the best one, representing a global solution that is minimal in flux expenditure
and maximal in the driving force distribution. However, the problem of finding all elementary
flux modes in the first place, is again computationally expensive [213].
Even with this potential global solution, a relation between the actual extent of the flux and the
thermodynamic feasibility is lacking in all of the above methods. From an overall optimality
point of view, it might not be important to improve the thermodynamic gradient for all reactions,
but only for those required to carry a large flux to attain a large effect on the total enzyme costs.
However, this cost does not only depend on the thermodynamic landscape, but also on the mass
and the saturation state of the enzymes as well as on active regulatory effects. To describe
these dependencies, detailed information on the kinetic properties of the involved enzymes are
required as will be described in the following Chapters.
6. CCMtb: Modeling central carbon
metabolism in mycobacteria
Where are regulatory points in the mycobacterial central carbon metabolism?
The flux through a metabolic network is limited, but not fully defined, by the thermodynamic
landscape characterized in the previous Chapter. As stated before, the flux also directly depends
on the amount of enzyme available. However, even if the enzyme concentrations are known
from measurements, kinetic and regulatory effects have large impact on the flux distribution.
While the previous Chapter focused on thermodynamics, the following Chapter will employ
enzyme concentrations and kinetic descriptions of each reaction in the central carbon metabolism.
The compilation of a detailed dynamic model will be described, which includes these two
factors of intracellular flux regulation. Subsequently, the model will be used to identify potential
regulatory points for the transition between the experimental carbon sources in a new model and
data driven optimization approach.
6.1 Compiling a detailed model of central carbon metabolism
Model Topology
The model includes the major carbon catabolic pathways in mycobacteria: Glycolysis, pentose
phosphate pathway, Krebs cycle, glyoxylate shunt, the propionate catabolic methylmalonyl
and methylcitrate pathways as well as anaplerotic/gluconeogenetic reactions. Topological
information was collected from literature as well as the Tuberculist [101], KEGG [84] and
BRENDA [175] databases. All reactions are summarized in Appendix A.21 and depicted in
Figure 6.1. The same model topology was also used for backtracking and the thermodynamic
considerations in Chapter 5. As stated in the Methods Section 3.3, metabolomics data were
mapped to the network via observables (Appendix A.19).
The genes associated with each reaction were collected as described in the Methods Section 3.2
and are summarized in Appendix A.20. Each enzymatic reaction was modeled with simple con-
venience kinetics [104], as an automated way to set up kinetic laws with varying stoichiometry.
Please note, that the purely kinetic form of the rate law is used here, not the thermodynamic one
(for equations see Appendix A.22).
A condition dependent biomass reaction with a stoichiometry based on the backtracking results
was included. Backtracking only provides the stoichiometric coefficients for the biomass re-
action, the kinetic description in the dynamic model has to be defined additionally. Here, its
kinetics are described by a fixed rate rbio. The backtracked leak fluxes are given in mmol/gDW.
To convert them to the µM units representing intracellular concentrations that are used in the
further analyses, they need to be normalized to the dry weight and the volume of one cell (cf. Ta-
ble 4.1). The resulting conversion factor of 432 ·103 µMmmol/gDW would yield high stoichiometric
coefficients for the biomass reaction, which lead to numeric instabilities in the simulation.
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Figure 6.1: Summary of the enzymatic reactions contained in the CCMtb model. Reactions are shown as colored
arrows, according to the pathway they are associated with and labeled with the model reaction name (Appendix A.20
and A.21). All reactions are reversible, reaction arrows are depicted in their forward direction as implemented in
the model. Metabolites are shown in capital letters, their names are listed in Appendix A.18 along with further
annotations. Thick black arrows mark entry points of the experimental carbon sources to the network. Gray arrows
denote all occurring biomass leaks (width not to scale).
As the model is simulated in seconds, this can be avoided by including the conversion from
hours to seconds (1/3600) in the calculation, reducing the conversion factor to 120 µMmmol/gDW .
Accordingly, the rate of biomass production in the model will correspond to the value of rg in
1/h, also here resulting in numerically more favorable values (e.g. for a division time of td of 38
h the rate will equal 0.0182 1/s as opposed to 5.07 ·10−6 1/s.).
Some metabolites were allowed to be secreted, based on the BCG reference experiment (succi-
nate, acetate, isocitrate, see Appendix A.2) or on general biological behavior (phosphate, water,
carbon dioxide). The latter group was also allowed to be taken up from the media. Uptake rates
were modeled as fluxes with a fixed rate rup, depending on the nutritional condition. Secretion
reactions are equipped with Michaelis-Menten kinetics.
To convert between energy and redox species, a reduced version of the respiratory chain was
implemented as described in detail below. The network includes reactions that employ ATP
and GTP as well as NADH and NADPH. For thermodynamic consistency, the metabolites were
kept in the reaction, even though their turnover is drastically affected by reactions outside the
modeled network. To avoid over-constraining the model, two converting dummy reactions
Rresp_trd and Rresp_ndk were added for equilibrating NADH and NADPH as well as ATP and
GTP pools, respectively.
Respiratory Chain
The respiratory chain in M. tuberculosis is not fully understood yet. It plays a role in the patho-
genic context, for example in the adaptation to hypoxia [64, 204]. M. tuberculosis encodes
many different genes that can participate in respiration (for a summary see Cook et al. [41]).
Figure 6.2 shows the general structure as it is also implemented in the modified version of the
genome-scale metabolic model sMtb [159] which was used in the backtracking before. The
reactions can be summarized as:
NUO 5 H+ + NADH + MQ → 4 H+e + NAD+ + MQH2,
SDH SUCC + MQ + 2 H+e → MQH2 + FUM,
CYDB 6 H+ + O2 + 2 MQH2 → 6 H+e + 2 H2O + 2 MQ,
ATPs 3 H+e + ADP + Pi → ATP + H2O + 3 H+,
with the abbreviations as in Figure 6.2. Electrons are carried by menaquinols (MQH2) in the
mycobacterial cell membrane.
CCMtb includes a simplified version of the above respiratory chain. Simplifications were made
to ensure matching levels of detail between data and model and to avoid the introduction of
compartments. However, the simplified version should keep the overall energetic balance as well
as contributions of single pathways, as for example the Krebs cycle contribution via succinate
dehydrogenase (SDH). It was also intended to conserve the intracellular metabolite species to
guarantee comparability to the measured metabolite concentrations.
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Figure 6.2: Schematic representation of the respiratory chain in M. tuberculosis based on [24, 41]. Enzyme complexes
are shown in blue and named as in the sMtb model, the gray area represents the plasmamembrane.
Abbreviations: NUO - NADH:menaquinone oxido-reductase, SDH - succinate:menaquinone oxidoreductase, CYD -
cytochrome oxidase, ATPs - F1F0-type ATP synthase, MQ - menaquinone, MQH2 - menaquinol, SUCC -Succinate,
FUM - Fumarate, H+e - extracellular protons, H
+ - intracellular protons, Pi - inorganic phosphate.
As the reactions are encoded by a pleiotropy of different genes [24, 41], whose contribution
to respiration is not fully clarified, no gene association was included for the respiratory chain
reactions, i.e. the enzyme amount is implemented in the kinetic equation as vmax (see Ap-
pendix A.22). Nevertheless, the thermodynamic gradient can be accounted for by calculating
∆rG0 for the overall reaction from the eQuilibrator database [58].
The above reactions were hence simplified to three lumped reactions as:
Rresp_nadh NADH + 2.3 MQ ↔ NAD+ + 2.3 MQH2,
Rresp_atps H2O + ADP + Pi + MQH2 ↔ ATP + MQ ,
R17r_sdh SUCC + 0.3 MQ → 0.3 MQH2 + FUM.
The information about the extracellular protons is thereby stored in the MQ species. As 3 H+e
are required to synthesize one ATP and also 3 H+e can be pumped per MQH2 their number can
be directly related. Additionally, for each H+e produced or consumed by one of the reactions a
fraction of 0.3 additional MQH2 is produced.
Simulation and optimization generals
The model was implemented in the D2D framework, whereby the required data and model
files were written automatically by additional Matlab scripts to avoid introduction of typing
errors. Parameters were initialized within the default bounds as summarized in Table 4.2. For
fitting routines, the parameter space was searched logarithmically to improve convergence of
the fitting routines. The fitting routine for the detection of regulatory points as described below
was implemented in Matlab employing the fmincon optimizer. Concentrations were simulated
in logarithmic units. Mean active enzyme concentrations, as calculated from the proteomics
measurements, were included directly in the kinetic rate laws as fixed values.
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6.2 Minimum regulation in steady state
As mentioned before, cells can flexibly reroute their metabolic fluxes in changing conditions. For
mycobacteria, this flexibility is also a major pathological treat, allowing them to thrive in a vast
variety of host environments. How this redistribution is orchestrated on the mechanistic level has
been subject of many studies in various species, recently boosted by omics approaches. In the
following Section, a novel model and data driven approach is presented to identify a minimum
set of regulatory interventions to transition from one metabolic condition to another. Thereby,
the generated data is exploited to calibrate the developed CCMtb model to different metabolic
steady states. An optimization strategy is then used to find the least expensive transition between
those steady states, measured by the number of required regulatory actions.
6.2.1 How to detect regulatory interactions in metabolism
Previous methods
The quest to detect regulatory edges or likely regulated reactions in metabolic systems has
previously been undertaken by a number of experimental and theoretical approaches, which are
briefly summarized in the following Section.
Metabolic control analysis [70, 83] and supply-demand analysis [161] define regulatory points
based on an already existing, fully parameterized model. This fact is also the main drawback of
these methods, as such models are difficult to obtain in practice and available only for a small
set of well studied pathways. In the two methods, regulations are likely if control coefficients
are large or a significant change in the supply-demand characteristics of a metabolite occurs in a
pathway.
A method branching from metabolic control analysis is (time dependent) hierarchical regula-
tion analysis, dissecting between enzyme expression based hierarchical and substrate dependent
metabolic regulation [166, 189, 199]. Intended to complement metabolic control analysis to
changes in enzyme expression levels, the analysis is based on the decomposition of the reaction’s
kinetic law for the flux v into an enzyme dependent term f and a substrate dependent term g:
v = f (E) ·g(x,θ ) (see also Equation 2.4). By logarithmizing and normalizing to the total flux
v¯ of a linear pathway the hierarchical regulation coefficient ρh and the metabolic regulation
coefficient ρm in response to a local perturbation of the enzyme concentration are defined as:
ρh =
∆ ln f (E)
∆ ln v¯
ρm =
∆ lng(x,θ )
∆ ln v¯
(6.1)
Depending on the magnitude of each coefficient, the regulation of a reaction can be classified.
The analysis is again based on a detailed dynamic description of the reactions in question.
Chubukov et al. [36] experimentally tested the theory of the above regulatory coefficients across
a number of culture conditions representing large environmental perturbations based on flux
measurements in B. subtilis. They correlated the 13-C labeling derived fluxes with enzyme
concentrations estimated from transcript levels to calculate ρh. The study concluded that for
most of the central carbon metabolism, gene expression changes were insufficient to explain
flux changes. While enzymes in the Krebs cycle partly showed a correlation, split reactions
at metabolic branch-points were also not significantly expression regulated. Only enzymes
that were specifically switched on in single conditions (’On/off state enzymes’) showed strong
transcriptional regulation. An estimate of the effects of changing metabolite concentrations on
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the changes in flux was also calculated as the combined coefficient ρes, but was small for most
considered reactions.
Thermodynamic considerations are also frequently used to propose regulated reactions [71, 98].
The authors argue that the flux through reactions close to equilibrium is sensitive to changes in
metabolite concentrations and that these reactions are hence unlikely targets of regulation.
Regulations cannot only be facilitated by changes in enzyme or educt concentrations, but also
by modifying the enzyme posttranslationally to change its catalytic parameters. Current omics
techniques can for example measure phosphorylations of enzymes in different growth conditions,
a post translational modification (PTM) that is often found to have regulatory effects.
For mycobacteria, available phosphoproteomics data are summarized in Appendix A.23, data
on other PTMs, such as acetylations, methylations and others was not available. As PTM-sites
of proteins often share steric characteristics in specific domains, a domain search for potentially
posttranslationally modified enzymes in the Pfam database [55] was conducted, but did not give
any significant results in M. tuberculosis. Finally, known regulations of the orthologs of CCMtb
enzymes in other mycobacterial species were collected from the BRENDA data base [175] and
are summarized in Appendix A.24.
A new data and model driven approach
In the following, a method to predict regulated reactions as a minimum set of impact points to
transition from one metabolic phase to another, will be described. The approach combines the
experimental proteomics and metabolomics data with the powers of kinetic modeling. Thereby,
the contribution of enzyme kinetics to the redistribution will be addressed specifically, neglecting
the contribution of thermodynamics for the time being. This is done for reasons of simplification,
as thermodynamic-kinetic reaction equations are computationally expensive in the optimization.
The regulation detection method described here is based on the assumption that all flux control-
ling factors, enzyme concentrations, saturation state, thermodynamic gradients and regulatory
actions (see Equation 1.1), will be constant in an established steady state. It can hence be
assumed that the effects not included in a mathematical model, such as the thermodynamic and
regulatory terms for the CCMtb model here, take a fixed, potentially unknown value in this
steady state. Kinetic parameters for each reaction estimated under this assumption will then
circumscribe all their contributions. For another nutritional condition, the found parameters
will probably fail to describe the data, as the regulatory terms may have changed and are not
accounted for. Assuming that the cell, in order to save resources, optimizes to execute as few
as possible actions to reroute the flux while transitioning from one steady state to another, an
optimization problem can be formulated. Kinetic parameters are optimized to fit steady state
metabolite concentrations for several conditions, with regulation parameters introduced for
reactions where this is impossible. The number of regulation parameters is simultaneously
minimized, to account for optimality in terms of an efficient transition. Thereby, this work
focuses on the transition from the metabolic state on one experimental carbon source to another.
The different growth phases are neglected to simplify the approach (i.e. all glucose data were
merged), but could be represented in the same way in an extended study.
6.2.2 Mathematical formulation
Objective function
The best solution to the above described problem has to fulfill three objectives: (i) The model
has to reach a steady state, where all time derivatives of the metabolite concentrations x vanish.
This condition was realized by calculating the derivative at of x with regard to time and including
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the metabolite concentrations x as variables to the optimization. Via this derivative term, the
kinetic law enters the objective function. All enzymatic reactions are formulated as convenience
kinetics [104], as stated before. (ii) At the same time, the model observables y¯= f (x¯) have to
be close to the measured data in steady state ¯ˆy. (iii) The regulation is implemented in a very
simplified way, by multiplying scaling parameters θ s to each kinetic law in each condition as:
v j,i = f (E j,i, x¯,θ ) ·θ sj,i, (6.2)
with i and j as indices for the condition and the reaction, respectively. The objective function
punishes deviations from 1 for each of those parameters. Consequently, these parameters will
remain at a value of 1 unless their value is required to change to achieve a steady state or
agreement with the data. The objective function then reads as:
min
θ ,θ s,x
nc
∑
i=1
⎛⎜⎜⎜⎜⎝ ws ·
nx
∑
k=1
(
∂ x¯i,k
∂ t
/
x¯i,k
)2
  
(i) deviation from steady state
+ wy ·
no
∑
l=1
(
yi,l− ¯ˆyi,l
sdi,l
)2
  
(ii) deviation from data
+
2nr
∑
j=1
log10(θ
s
i, j)  
(iii) minimum regulation
⎞⎟⎟⎟⎟⎠ ,
subject to θ lb ≤ θ ≤ θ ub and
xlb ≤ x≤ xub (6.3)
The parameter vector θ contains catalytic activities, Michaelis-Menten constants as well as
uptake and growth rates for each condition. The indices nr, nx, no and nc are the identifiers for
enzymatic reactions, metabolites, observables per condition and conditions, respectively. There
are a total of 2nr scaling parameters to be optimized, one for the forward and the backward
direction of each enzymatic reaction. The boundaries θ /xub/lb restrict possible values for
parameters and metabolite concentrations (see Table 4.2). The glucose condition was defined as
a reference condition ire f for which all θire f , j were fixed at 1. ws and wy are the weights defining
the contribution of the steady state and the data term to the overall optimality. Weights were
adjusted manually to achieve a good convergence behavior of the optimizer. The deviations
from the steady state (i) and the data (ii) are squared sums normalized to the calculated standard
deviation of each observable in the steady state sdi,l and the current values of the metabolite
concentrations x¯i,k . This normalization avoids biases due to vastly different metabolite concen-
tration ranges.
Technical information
The optimization was conducted outside the D2D framework, as no dynamic simulation is
required for steady state estimation. Single functions to calculate the flux vector v were automat-
ically extracted from D2D to still benefit from the strong formalization and model organization
properties of the tool. The optimization procedure included a large number of fits with Latin
hypercube sampled initial parameter sets (∼500) and simulated annealing-like repetitions [91].
Specifically, for each initial point several subsequent fits were run (∼50), with the initial point
being the found optimum parameter set of the previous fit with some noise added. If no steady
state was found, the bounds on single parameters were extended, based on the distribution of
found parameter values of all fits. This procedure was repeated iteratively, until a satisfying
steady state was found (mean relative deviation from steady state smaller than 5 ·10−3).
90 Chapter 6. CCMtb: Modeling central carbon metabolism in mycobacteria
Statistical evaluation of found regulation parameters
To identify the reactions that required significant regulation, the distribution of estimated
logarithmic values of each scaling parameter was tested against the Null-Hypothesis that their
mean is 0 (i.e. the reaction is not regulated) with a t-test. A p-value cutoff of 10−5 was
chosen. In addition, also the extent of the regulation had to exceed a certain value, such that
the resulting mean fold change of the flux (MFC) would be larger than 1.6 (corresponding to
| log2(MFC)|> 0.9).
6.2.3 Results: A purely kinetic model is not enough
As a pre-calculation, the steady state of each nutritional condition – growth on glucose, pro-
pionate and glutamate – was fitted individually. Such a setup has the benefits of smaller
computational costs, as well as of providing a general feeling for the system and the parameter
space. Also, infeasibilities in a single condition can be detected easily. For this purpose, the
objective function in Equation 6.3 can be simplified as no regulatory term (iii) is required and
the sum over all nc conditions can be removed.
The three steady states could be fitted by iterative adjustment of general parameter boundaries as
described above. For the adjustment, histograms of all found parameter values for a fit series that
did not arrive at a feasible steady state can be used: Whenever all fitted values for one parameter
were close to a boundary, this boundary has to be changed appropriately. Such boundaries act as
limiting constraints in analogy to the shadow prices of the linear optimization problems.
The histograms for the final individual fits that resulted in a feasible steady state while being
in good accordance with the data can be found in Appendix A.25. From there it also becomes
apparent that for some parameters the optimum distributions do not overlap, i.e. that the parame-
ters have to take different values in different conditions. In such cases, regulation is required
to transit from one condition to another. Besides the histograms, it is often useful to examine
parameter correlations to identify dependencies between parameters. The examples in Figure
6.3 show different types of more or less well defined dependencies. Figure 6.3 D highlights that
these can also vary between the conditions, again hinting towards a requirement for regulation.
Figure 6.3: Examples for observed pa-
rameter correlations in the individual
steady state fits. Each dot corresponds
to one estimated parameter set, shown
are only the 100 best fits. The color
coding is according to the deviation
from steady state (term (i) in Equa-
tion 6.3). Red dots correspond to glu-
cose condition, blue to propionate and
gray to glutamate. Each plot shows
the estimated values for a pair of pa-
rameters. Please note that all axes are
in logarithmic scale. A weak depen-
dency, B strong linear dependency, C
strong nonlinear dependency, D de-
pendencies for one pair of parameters
of the fumarase reaction compared be-
tween the three nutritional conditions.
1
2
3
x 10
−6
1
2
3
4
x 10
−3
1
3
5
x 10
−5
0
2
4
lo
g 1
0(f
um
_k
m
p)
0
2
4
log10(GLC_glc)
lo
g 1
0(h
ex
_v
f)
2 2.5 3
2.5
3
3.5
log10(tpi_vr)
lo
g 1
0(t
pi
_k
m
p)
2 2.5 3
1
2
3
log10(fum_vf)
5 6
0
2
4
log10(rpi_vf)
lo
g 1
0(r
pi
_k
m
s)
2 3
1
2
3
glutam
ate
propionate
glucose
m
ean relative deviation from
 steady state
A
B
C
D
lo
g 1
0(f
um
_k
m
p)
lo
g 1
0(f
um
_k
m
p)
6.2 Minimum regulation in steady state 91
For consistency it was tested if the model with purely the kinetic reaction description and without
any regulation could reproduce the data of all conditions’ steady states. Most unsurprisingly,
this was not possible, consistent with the non-overlapping optimal ranges for some parameters
in different conditions (see again Figure 6.3 D).
6.2.4 Results: The most probable set of regulations
Likely regulated reactions
Starting from the parameter sets found in the individual steady state fits, the minimum regulation
fit was conducted. Regulation parameters were initialized with 1 (0 in logarithmic scale). The
final estimated regulation parameters θ s are summarized in Figure 6.4 A and mapped to the
CCMtb network in Figure 6.4 B. Most θ s remained at their initial value and did not contribute to
overall regulation. Significant regulations were found in upper glycolysis and the Krebs cycle.
Biological recovery of known regulatory points in Mtb
Compared to known regulatory points in M. tuberculosis (Figure 6.4 C) the approach could
recover only a subset of regulations. Part of the Krebs cycle (fumarase, malate dehydrogenase,
citrate synthase, isocitrate dehydrogenase and alpha-ketoglutarate decarboxylase) as well as
glycolytic reactions (fructose-1,6 bisphosphate (FDP) aldolase, triosephosphate isomerase and
pyruvate kinase) are contained in both sets. Especially regulation in the pentose phosphate
pathway and the anaplerotic reactions could not be detected here.
Explanations for this discrepancy could be that most of the known regulations were measured in
conditions very different from the experimental ones in the datasets used here. Inhibitions and
activations are mostly characterized by in vitro enzyme assays and might just be inactive in the
conditions considered here. The same holds for the phosphorylations, that are additionally only
candidates for regulation – their real function is often unknown.
Although there are some discrepancies, some common features of regulation occur in both
the known and the here predicted set of regulations. The PEP-pyruvate-oxaloacetate node, for
example, has been characterized as important flux control point in bacteria [172] and was also
found to be regulated in mycobacteria in various ways (see Figure 6.4 C). Here, its Krebs-cycle
part is found to be regulated along with the glycolytic pyruvate kinase reaction.
The gluconeogenetic fructosebisphosphatase glpX is inhibited by methylcitrate [51]. Despite
the vastly different concentrations of this inhibitor measured by metabolomics here, the reac-
tion is not classified as regulated in propionate conditions. However, both adjacent reactions
(FDP aldolase and phosphoglucose isomerase) are found to be regulated. This could hint to
identifiability issues of the optimization, where the specific reaction in this linear stretch cannot
be detected, but the overall need for regulation is conserved. As a last example, FDP has been
characterized as a global sensor for glycolytic flux in bacteria [35, 96]. Also here its producing
and consuming reactions are consistently regulated between glycolytic and gluconeogenetic
conditions.
6.2.5 Discussion
An automatized method to predict regulatory impact points
The presented approach combines high resolution metabolite and proteomic data with mathemat-
ical modeling and a cellular optimality concept to detect regulatory impact points. In contrast
to other experimentally based methods, no expensive flux measurements are required. Also
no model fully covering the dynamic behavior is needed as in previous approaches, but rather
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Figure 6.4: Minimum set of regulatory interventions as found by the optimization. A Volcano plot of the regulation
parameters θ s, plotted is the mean of the distribution of all found values against the p-value obtained as described
in the text. Parameters in the gray area are not significantly regulating their corresponding reactions. Significant
parameters are labeled with the name of the reaction and its direction (vf - forward, vr - backward). B Significant
regulations mapped to the network, color code as above. As before, squares denote metabolites, circles denote
reactions. C Known regulations from literature mining, a detailed list can be found in Appendix A.23.
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a range of feasible parameterizations is explored. Thereby, the reduction to the steady state
drastically reduces the computational effort – at the cost of neglecting dynamic information on
regulations. The method can also not dissect thermodynamic or regulatory actions, which will
both affect the reaction flux in addition to the kinetics. Enzyme expression changes are directly
included via proteomics measurements and do hence not confound the results.
The approach is easily extendable to other metabolic systems, organisms or additional data sets,
as it is highly formalized and therefore easy to reproduce. Due to the employment of convenient,
scalable kinetic laws, no prior knowledge on the enzyme kinetics was required.
The fact that not even the steady state of the central carbon metabolism, as a very reduced
system, can be described by a purely kinetic model, highlights the necessity of knowing and
including regulatory actions in kinetic models. Regulation can there, as well as probably in the
cell, also be seen as a way to overcome strict substrate dependencies of the fluxes and allow
for a larger spectrum of possible flux distributions. The results presented here allow for their
detection in an integrative and scalable way. The found regulatory points can now be tested
experimentally as a proof of their functionality or existence. Such a targeted approach requires
much less experimental effort than for example metabolome wide screenings.
The steady state results constrain the parameter space
Computationally, the estimation of parameters for a system in steady state is much less expensive
than calibrating the model’s dynamics. For each optimizer step, the derivative function (Equa-
tion 2.3) has to be evaluated only once, while in the dynamic case, its whole time evolution has
to be simulated numerically. However, as the steady state problem is much less constrained than
the dynamic one, it usually has many feasible solutions, which contain less information on the
system. In other words, many of the parameters will be non-identifiable and directly dependent
on each other. Nevertheless, the fact that the solutions to the dynamic problem have to also
comply with the steady state solutions can be exploited to constrain the feasible parameter region
of the dynamic problem. The simplest way to do so would be to use the estimated steady state
parameter sets as initial points for the dynamic parameter estimation, alongside a formulation for
the steady state constraint at t = 0 of the dynamic simulation (before the nutrient shift occurs). A
more sophisticated way would be to reformulate the model equations, such that each dependent
parameter is expressed as an algebraic equation of the corresponding independent parameter.
However, this requires the correct mathematical description of the dependency, for example an
equation for the apparent curves in Figure 6.3, which is a non-trivial problem.
Possible extensions and improvements
The approach as shown here can be easily extended to cover transitions between distinct envi-
ronmental conditions, not limited to switching nutrients. For example with the data acquired in
this work, also the transition between different growth phases could be investigated.
The method could also be extended to directly include thermodynamic effects via a suitable rate
law, which would allow to separate thermodynamic from regulatory effects directly. Further-
more, mechanistic accuracy can be improved by not only scaling the entire forward or backward
flux, but also by scaling of the Michaelis-Menten constants. Especially allosteric regulation and
competitive inhibitions change the substrate affinities and hence the saturation behavior.
A further evolutionary aspect could be to link regulatory parameters between the conditions.
If the cell already implemented the regulation in one condition, it is more likely to appear in
another, as probably not every enzyme has evolved to be regulated.
Technically, the detection of significant parameters could be better assured by profile likeli-
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hoods, relieving the bias of a potentially insufficient number of fits conducted. However, their
calculation is computationally expensive, as an additional optimization has to be carried out for
each point of the profile of each parameter. To resolve the bias introduced by the weights of the
single components of the objective function, the steady state and data compliance could also
be implemented as constraints on the optimization problem, resulting in only one objective of
minimizing regulation. However, the information of the distribution of the measured metabolite
concentrations would then be lost.
7. Pdtx: Propionate detoxification
in mycobacteria
Which concepts facilitate metabolic flexibility in mycobacteria?
While the previous Chapters focused on metabolic steady states and what can be learned from
them, metabolite dynamics are considered in the following Chapter. Dynamic data usually
contains more information on a system in question, but is also more difficult to attain. Here, the
dynamic metabolite data from the shift experiments will be used to characterize the individual
treats of two seemingly redundant metabolic pathways relevant for the pathogenicity of M. tu-
berculosis. The findings highlight the capabilities of integrated kinetic modeling in contrast to
steady state approaches: While based on steady state thermodynamics and measured enzyme
concentrations, the distinct functionalities of both pathways cannot be resolved, thermodynamic-
kinetic modeling identifies one pathway as a thermodynamically limited but highly responsive
rescue pathway while the other is classified as a high-capacity catabolic route.
The presented analyses thereby combine known methods, of which each is adapted and im-
proved for their purpose here, to fully characterize both pathways. The kinetic model integrates
dependencies of the flux on the saturation state, the thermodynamic gradient as well as on the
measured enzyme abundances (cf. Equation 1.1). Especially thermodynamics are neglected in
many published kinetic models of metabolism, such that – together with the high data coverage
– the model presented here advances the field of metabolic modeling. The described set of
analyses can therefore be used as a road-map for the study of similar metabolic systems.
7.1 Propionate metabolism in mycobacteria
Lipids as carbon sources
The major carbon source of intracellular mycobacteria is unknown, but experimental evidence
suggests a mixed diet of amino acids and other unknown substrates containing two or three car-
bon atoms [22]. Such compounds are for example the end products of fatty acid and cholesterol
catabolism, which has been characterized as an important intracellular nutrient, especially during
dormancy [142, 202]. Pathways required for the catabolism of intracellular carbon sources are
promising targets for drug development [22, 138, 202].
Two parallel pathways for propionate catabolism
Propionyl-CoA (PCO) is an exemplary three carbon compound. It can feed carbon and energy
metabolism, but is also required to produce relevant mycobacterial lipids and hence has to be syn-
thesized de novo if it cannot be scavenged from the carbon source [108]. PCO can be catabolized
via two parallel pathways in mycobacteria, the methylcitrate (MCIT) and the methylmalonyl
(MMCO) pathway (Figure 7.1). These two seemingly redundant pathways can both fulfill the
task of fueling the central metabolism from this non-canonical carbon source. However, in most
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experimental scenarios requiring this catabolic activity, M. tuberculosis prefers the MCIT over
the MMCO pathway. Accordingly, the MCIT pathway has been subject of extensive study as an
anti-tubercular drug target, encouraged by the lack of a homologue pathway in the human host.
Both pathways can maintain flux from PCO to succinate, an intermediate of the Krebs cycle,
using different mechanisms. The MMCO pathway depends on ATP activation in the first reaction
step (Figure 7.1, pcc) allowing for the fixation of one molecule CO2. The pathway includes
one strictly vitamin B12 dependent reaction, a complex cofactor that can be synthesized by the
bacteria themselves [173, 211]. The ATP is regained in the last step of the pathway, which
produces succinate. The pathway also fulfills biosynthetic tasks in the production of surface
exposed lipids [80], for which S-methylmalonyl-CoA is used as a building block.
The MCIT pathway, in analogy to the glyoxylate cycle in the central carbon metabolism, invests
one oxaloacetate molecule to convert PCO to pyruvate under the release of succinate, which feed
back into lower glycolysis and the Krebs cycle, respectively. It was found to be up-regulated
in intracellular bacteria in vivo (mouse lungs and human macrophages [160, 174, 183, 188]),
in dormancy models [177], on in vivo-like carbon sources such as cholesterol [68] and is es-
sential in various other experimental contexts [21, 74, 126]. Recently, also its role in antibiotic
tolerance by specifically rerouting central carbon metabolic fluxes was described [130]. The
MCIT pathway also occurs in other pathogens and is up-regulated upon exposure to propi-
onate, which is often part of their diet in the pathological context (Salmonella enterica [140],
Toxoplasma gondii [107]).
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The regulation of cytosolic levels of the intermediates of the MCIT pathway is crucial, as they can
become cytotoxic at high concentrations: Two studies [198, 202] showed that inhibition or knock-
out of early MCIT enzymes can restore growth of mutants lacking an enzyme for a downstream
MCIT reaction (mcl) in media containing propionate, arguing for a more prominent effect of
the MCIT pathway intermediates’ toxicity than the loss of its carbon acquiring function caused
by the knock out. Mechanistically, MCIT intermediates at high concentrations inhibit pyruvate
dehydrogenase activity [99], which could be the main reason for their toxicity. While all other
reactions of the two pathways are catalyzed by a dedicated enzyme, the two final reactions of
the MCIT pathway are carried out by central metabolic enzymes: isocitrate lyase (aceA/B, [67])
from the glyoxylate shunt and aconitase (acn) from the Krebs cycle, highlighting the tight
interconnection of the MCIT pathway and the control of its intermediate levels with the central
carbon metabolism.
The interplay between the two pathways
If the predominant MCIT pathway is lost, as for example in knock-out experiments, the MMCO
pathway can partly compensate for the loss [51, 173]. This compensation can, however, only
be achieved if its flux is increased, for example by the addition of vitamin B12, an essential
cofactor of the mcm reaction. Similarly, vitamin B12 can boost the growth of the wild type on
propionate, by facilitating an additional carbon feed. However, even with the addition of vitamin
B12, growth limiting intracellular PCO concentrations are reached if more propionate is added to
the medium [51], arguing for a upper capacity limit of the MMCO pathway. This compensating
behavior could explain why the deletion of the first two enzymes of the MCIT pathway abrogates
the ability to grow on propionate in vitro, but not in in vivo mice studies [128], where the cells
are likely exposed to lower PCO concentrations, which can still be catabolized via the MMCO
pathway.
As mentioned before, the methylmalonyl-CoA pool controls the synthesis of virulence relevant
surface exposed lipids, such as phthiocerol dimycocerosates (PDIMs) and Sulfolipid-1 . Hence,
the MMCO pathway could possibly "buffer away" the excess PCO in cells with a dysfunctional
MCIT pathway towards the production of those lipids. Accordingly, also other genes of
the draining pathways into these lipids were found to be essential in media requiring PCO
detoxification [80]. As the diverted carbon could then not be used in the central metabolism,
utilization of this metabolic route would contribute less to the bacterial growth. As a limitation,
also fatty acid precursors derived from acetyl-CoA are required for this detoxification [99].
7.2 A model for robust detoxification via two parallel pathways
In the following the question why mycobacteria keep two seemingly redundant pathways for
the same task of propionate catabolism is addressed by means of thermodynamic and kinetic
modeling on different levels of resolution, integrating high quality proteomics and metabolomics
data. Unique traits of each pathway are characterized to explain why both are required and why
the bacteria favor the MCIT pathway despite the danger of self-intoxication by its intermediates.
The flux through a reaction or pathway is shaped by the enzyme expression but also by metabolite
dependent enzyme saturation and reaction thermodynamics and regulation (see Equation 1.1
and other works [46, 48, 57, 92, 134]). Sub-optimality in any of those factors in the cellular
context can render a pathway unfavorable.
Here, established modeling approaches are used to test the significance of each of them for
the two pathways in question. Firstly, pathway thermodynamics [134] are employed to show
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that the thermodynamic gradient alone is insufficient to explain the preference of the MCIT
over the MMCO pathway in intracellular conditions. Also, the subsequent inclusion of specific
enzyme masses, with heavier enzymes signifying a higher cellular cost per unit of flux, does
not characterize the MCIT pathway as preferable. Therefore, a full dynamic description was
developed based on the nutrient switch experiments and thermodynamic-kinetic modeling. The
model includes enzyme expression, thermodynamics and saturation and allows to identify the
specific traits of each pathway: While the MMCO pathway can quickly react to sudden changes
in the propionate concentration and detoxify the cell accordingly, the MCIT pathway can reach
a higher overall flux capacity.
7.2.1 Results: Pathway thermodynamics and enzyme costs dissected
The MMCO pathway has a higher thermodynamic driving force and can run reversely
First, to test whether the MCIT pathway might be preferred in vivo due to a higher thermody-
namic driving force, the thermodynamic gradients within the two pathways were analyzed. The
maximum-minimum driving force, as introduced in Chapter 5.2, (MDF, [134]) describes the
maximum of the thermodynamic driving force -∆rG′ of the least favorable reaction within a
metabolic pathway. It is used to identify thermodynamic bottlenecks within a pathway context,
based on optimizing metabolite concentrations within sensitive, physiological bounds (see
Table 4.2). Extending the original method, uncertainties of the Standard Gibbs Energies ∆rG0 as
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well as the concept of observables were included here, resulting in a nonlinear optimization
problem (Appendix A.26).
The MDF for each of the two pathways was calculated under three different conditions charac-
terized by a set of specific metabolite concentrations: First unbiased metabolite concentration
bounds in the default range of 1 µM - 50 mM (see Table 4.2) were applied. To capture specific
traits of catabolic and biosynthetic conditions, measured steady state metabolite concentrations
of the propionate or glucose cultures were included as two additional sets of environment
specific concentration bounds.
Both pathways show comparable MDFs in forward (catabolic, propionate consumption) di-
rection but only the MMCO is feasible in the backward (biosynthetic, glucose consumption)
direction under physiological conditions (Figure 7.2, red and blue lines). The prohibiting
reaction of the reverse MCIT pathway is the final splitting of methylcitrate into PCO and
oxaloacetate by the mcs reaction. Notably, only the measured metabolite concentrations reveal
the infeasibility, under default concentration bounds the MCIT could run reversely (Figure 7.2,
lower right, gray line).
Its lower MDF in the catabolic direction would argue for the predominant usage of the MMCO
pathway, contradicting the previously described preference for the MCIT pathway. However,
the MDF differences are not very prominent, especially given the uncertainties in metabolomics
and ∆rG0 measurements.
Protein costs are condition dependent and favor different pathways in different nutri-
tional conditions.
As the thermodynamic gradient alone cannot explain the pathway preferences, the enzyme
mass was included additionally in the optimization, to asses if higher protein costs due to large
enzymes could be limiting the MMCO pathway. Protein cost optimization has been studied
in many contexts before [48, 57, 92], here the method of Flamholz et al. [57] was adapted,
dissecting the effects of enzyme expression, saturation and thermodynamics. The optimization
is based on a decomposition of the Michaelis Menten rate law for the flux v into multiplicative
contributions of the enzyme amount E, the catalytic activity kcat , a purely educt dependent
saturation term and an educt and ∆rG0 dependent thermodynamic term that quantifies the extent
of futile backward flux ([136], cf. Equation 1.1).
v= E
enzyme
· kcat+
catalytic activity
·
(
∏i(Si/kMs,i)
∏i(Si/kMs,i)+∏ j(Pj/kMp, j)+1
)
  
saturation term
· (1− e∆rG′/RT )  
thermodynamic term
(7.1)
Based on this decomposition, optimal protein costs can be estimated as the minimum possible
enzyme investment per unit of flux. This cost will increase if the enzyme is under-saturated
or has a shallow thermodynamic gradient, both depending on the metabolite concentrations.
The original method as applied by Flamholz et al. did not account for different enzyme masses,
which were included here specifically as well as the contribution of product saturation to the
kinetic term (for the mathematical formulation of the optimization problem see Appendix A.27).
As the MCIT pathway was characterized as infeasible in the biosynthetic direction in the MDF
optimization, only the catabolic, propionate consuming direction was analyzed here.
The enzyme costs are comparable between the pathways (Figure 7.3 A) in physiological
conditions. The MMCO pathway requires slightly less protein under glucose conditions, whereas
the MCIT pathway would be preferable under propionate conditions. For all reactions, the
100 Chapter 7. Pdtx: Propionate detoxification in mycobacteria
contributions to the total protein costs arising from the cost of under-saturation (green bars)
are higher than from the cost of backward flux (yellow bars), which would indicate a kinetic
limitation rather than a thermodynamic one. The saturation term is, however, largely biased
by the assumption of uniform kinetics for all the enzymes involved (all kcat= 100 s−1, all
kM= 100 µM, [57]), as there are no measured kinetic parameters for the pathways’ enzymes (with
the exception of pcc and mcl). Consistently, the calculated minimal cost enzyme abundances λ
do not correlate with protein abundances measured in the two culture conditions (Figure 7.3 B).
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Flux maximization with limited enzyme availability
An approach complementary to the enzyme cost calculation would be to maximize the flux
through a pathway given a limited amount of enzyme available (Appendix A.28). If the constraint
on the enzyme amount is applied two both pathways simultaneously, interdependencies in the
flux distributions of the two pathways can be detected. For example, a change in a metabolite
concentration could slightly lower the flux through one pathway, but dramatically increase the
flux through the other due to the differences in ∆rG′ of the reactions consuming and producing
that metabolite. In this scenario, the optimum solution would favor a metabolite concentration
that increases the total flux, while accepting a lower flux in one of the pathways – a scenario
that would not be detectable when optimizing the protein cost for one pathway alone.
Accordingly, the total flux through both pathways with the three above used metabolic conditions
was optimized by scanning a range of possible ratios of enzyme mass distribution between them
(Figure 7.4). The same preference for the MMCO pathway under glucose conditions and for
the MCIT under propionate conditions can be seen as a result, consolidating the findings from
the protein cost optimization (including the same biases with regard to the assumed kinetic
parameters). The total flux through both pathways depends linearly on the ratio of total enzyme
mass and no interdependency effects could be detected, consistent with their additive behavior
in wild type M. tuberculosis cultures [51].
7.2.2 Results: Dynamics make the difference
Dynamic detoxification of propionate pulses
The insufficiency of the thermodynamic and enzyme optimality approaches to describe the path-
way preferences satisfactorily, suggests that the functional differences might only be detectable
in the dynamic response of the two pathways. To test this hypothesis, the dynamic shift data
between the two above used conditions were used: From steady state growth on propionate to
glucose media, in which reverse flux through the pathway in the biosynthetic direction will be
required, and from growth on glucose to propionate media, where a fast detoxification of rising
PCO levels will be required.
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From the data (Figure 7.5, dots), it becomes evident that only the MMCO pathway (Figure 7.5 B)
reacts dynamically to sudden increases as well as decreases in the PCO concentration (Fig-
ure 7.5 A). The MCIT pathway shows only a minor dynamic reaction, but its overall metabolite
levels strongly change with the carbon source (Figure 7.5 C).
To explain the observed behavior in detail, a full dynamic model with thermodynamically
consistent rate laws was developed (for details see Appendices A.29, A.30). The model was
fitted to the dynamic metabolomics data and included also the measured protein concentrations
for each nutritional condition. It was able to reproduce the experimental behavior (Figure 7.5,
lines and shaded areas as error estimates, corresponding fluxes are shown in Appendix A.31).
Analysis of the calibrated model
Parameter profile likelihoods [97] reveal that most parameters are non identifiable (Appen-
dices A.32, A.33), which is surprising, given the good data coverage. The data situation does
hence not allow to pinpoint values for most of the enzymatic parameters. However, general
features can be computed from a large number of parameter sets that achieve objective values
smaller than the likelihood threshold LL∗+∆α , even if single parameters are not identifiable.
The forward catalytic efficiencies, signifying the quotient of kcat+ and k
M for a given reaction
substrate pair, are for example well defined for all model reactions (Figure 7.6). Consequently,
it is possible to assign a value for them with high confidence, while the individual parameters
stay non-identifiable.
The error model parameters θ e are usually well defined and easy to estimate. Cases where they
are not identifiable within the given bounds, which are commonly based on the experimental
error estimates, could hint to a biological behavior which is not accounted for in the model.
Here, this was observed for the CoA species, where the estimated error hits its upper bound (see
appendix A.32). This discrepancy occurs because this cofactor is held constant in the model,
but shows dynamic changes in the glucose measurements (Figure 7.5 E).
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The decay of MMCO intermediates is not well captured by the model (Figure 7.5 A/B light blue
lines). While the data points seem to show a roughly linear decrease in concentration, the model
trajectory describes a faster adaptation to the new steady state. A reason for this could be that
the step input function does not approximate the propionate depletion well, i.e. that the removal
of propionate in the medium does not translate directly to zero influx into the PCO pool.
Thermodynamics limit the MMCO pathway flux
The calibrated model allows to analyze the functional flux distribution of the two pathways in
detail, to identify the limiting factors for each pathway and condition. To understand how a
change in the PCO concentration would impact on the flux in a given metabolic background, the
parameterized kinetic equations can be exploited. Here, the Michaelis-Menten curves of the first
enzyme of each of the two pathways were examined (Figure 7.7 A), which already highlight
the limitations of each pathway. The modular character of the thermodynamic rate law also
allows to dissect the contributions of changes in enzyme concentration, enzyme saturation and
thermodynamic limitations to the curve (Figure 7.7 B). To avoid a bias due to a local optimum of
the parameter estimation, the mean curve of all feasible (LL< LL∗+∆α ) parameter sets found
during the calculation of parameter profile likelihoods was calculated (see Appendix A.32).
From the Michaelis-Menten curves it becomes evident that under biosynthetic conditions
(glucose consumption, Figure 7.7, left), the MMCO flux (orange) tightly follows the PCO
concentration, with the potential to quickly switch from negative, biosynthetic to positive,
catabolic rates around the measured PCO concentration (gray dotted line). This switch is solely
facilitated by the adaption of the thermodynamic gradient of the reaction (Figure 7.7 B, upper
left, yellow line). The flux through the MCIT pathway is almost insensitive to changes in the
PCO concentration as the first enzyme is strongly under-saturated at the lower PCO levels
(Figure 7.7 B, lower left, green line). Hence, a sudden PCO pulse, as in the experiments, will be
solely drained via the MMCO pathway, which rapidly shifts its reaction direction.
Under catabolic conditions (Figure 7.7, right), the MCIT reaction has a higher capacity due
to a drastically increased enzyme level (Figure 7.7 B, lower right, dark blue line) and hence
out-competes the MMCO reaction. In the catabolic background, the pcc reaction has a shallow
thermodynamic gradient (Figure 7.7 B, upper right, yellow line), most likely due to the decreased
level of the co-substrate ATP. It would even invert its direction upon a slight decrease in the PCO
concentration, consequently not fulfilling any catabolic tasks. Here, as well as in the biosynthetic
case, the MMCO flux quickly saturates at increasing PCO concentrations in the physiological
range, explaining the upper capacity bound for the pathway observed experimentally [51].
The corresponding MCIT enzyme is still in the linear regimen of the Michaelis-Menten curve,
guaranteeing a proportional change of the flux with the PCO concentration.
In summary, the thermodynamic properties allow the MMCO pathway to react quickly to
changes in the PCO concentration, but also limit its overall capacity, rendering it insufficient
to supply enough carbon for bacterial growth. The MCIT pathway, on the other hand, gains
momentum only if its enzyme expression is increased, thereby reaching a higher capacity and
avoiding saturation effects to efficiently channel carbon to the central carbon metabolism.
Metabolic control is executed mainly by the first enzyme of the MCIT pathway
Employing metabolic control analysis [70] also the question why the bacteria tune the metabolic
flux distribution by up-regulating prpC, the enzyme of the mcs reaction, can be answered. As
becomes clear from the flux control coefficients, the only significant control under biosynthetic
conditions is exerted by mcs (Figure 7.8, lower left). Hence, only an up-regulation of mcs
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can significantly increase the steady state catabolic flux as required when propionate is to
be used as a carbon source. The flux through MMCO reactions is only passively following
the propionate uptake rate (Figure 7.8, first column, RUP_PRO). Under catabolic conditions
(Figure 7.8, lower right) the control shifts also to the reactions of the MMCO pathway, consistent
with the pathway’s compensating function as described before [51, 173]. The mcs reaction,
not surprisingly, executes also the strongest control on the concentration levels of the toxic
intermediate methylcitrate (Figure 7.8, MCIT, upper left), highlighting the pathway’s role in
embanking those concentrations.
7.2.3 Discussion
Professional high-capacity catabolism vs. flexibility for rapid detoxification
The presented analyses characterize the MCIT pathway as a high-capacity catabolic pathway
that exploits thermodynamically beneficial reaction steps, which operate below saturation in
physiological scenarios. The MMCO pathway acts as a flexible pathway capable of rapid
PCO detoxification but also of biosynthetic tasks. This flexibility is facilitated by a fine-tuned
thermodynamic balance at the cost of an upper catabolic flux capacity limit.
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This distinct functionalities render it beneficial for the cell to retain both pathways despite their
redundancy in channeling carbon from PCO to the central carbon metabolism. Implementing
both in one pathway would reduce the efficiency of either functionality, as a high forward flux
capacity with a steep thermodynamic gradient contradicts the ability to quickly invert the flux
direction.
Further metabolic tasks of each pathway could be seen as downstream of the described func-
tionalities. The constitutively expressed MMCO pathway also supplies precursors for virulence
relevant lipids, which are required under all environmental conditions. The MCIT pathway,
as an additional metabolic advantage, directly feeds pyruvate into lower glycolysis, thereby
skipping potentially expensive gluconeogenetic reactions.
The plasticity of this crucial lipid biosynthetic and catabolic node has recently been shown to
be relevant in eukaryotes, with implications on human metabolic diseases [206], arguing for a
general metabolic strategy.
Implications on treatment strategies
Eoh and Rhee [51] as well as Savvi and coworkers [173] show that the MMCO pathway can
compensate for the loss of MCIT pathway functionality in mutants lacking mcl activity in terms
of survival but cannot support growth in an equally efficient manner. However, Van der Ven et
al. [202] and Upton and coworkers [198] pointed out that the inhibition of the upstream enzyme
prpC can reverse this effect, implying that the growth defect is due to the accumulation of toxic
MCIT intermediates rather than due to a less efficient metabolic processing of carbon through
the MMCO pathway. This argument can be supported by the extremely negative ∆rG0 of the
corresponding mcs reaction, which results in rather high concentrations of the toxic product
methylcitrate even if the downstream flux is blocked. Consequently, the optimum bactericidal
strategy would be to inhibit both a downstream MCIT reaction such as mcl as well as the first
enzyme of the MMCO pathway, thereby increasing toxic intermediate levels and abrogating the
buffering flux bypass completely.
Dynamics and quantitative data make the difference
The thermodynamic analyses clearly highlight the condition dependent nature of protein cost
optimality: The cheapest pathway in one condition might be out-competed by an alternative
route under different conditions. Despite the usefulness of optimum protein cost considerations
in previous applications, they seem insufficient to fully explain the interplay between the two
pathways in question here. One reason could be the low level of interdependency between the
reactions on the metabolite level, i.e. they employ an almost disjunct set of metabolites, resulting
in many degrees of freedom for the optimization. This means that metabolite levels can be tuned
independently to achieve a low overall cost due to backward flux (i.e. the thermodynamic term,
yellow bars in Figure 7.3) and only the unknown kinetic parameters elevate the cost in a way
that might not be representative of the saturation state in vivo. Accordingly, these results argue
for the importance of enzyme kinetics for the understanding of pathway flux.
Furthermore, protein distribution and cost optimality approaches are limited by their focus
on time-scales that allow for equilibration of the metabolism for describing the evolutionary
benefit of reducing resources and increasing metabolic outcome [48, 57, 92, 214]. However, as
M. tuberculosis invests only a small fraction of its resources in proteins (see Chapter 4), the
evolutionary pressure of reducing protein cost might not be high for the bacteria. In addition,
the cells might have other objectives for pathway functionality that are not detectable by op-
timizing for a constant condition, especially for bacteria subjected to variable environmental
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conditions like M. tuberculosis has to face in the human host. In this context, multi-objective
Pareto optimality has been found to describe the overall behavior of systems well [48, 179].
Here, a distinct, temporal objective is added, describing metabolic non-steady state optimality.
The transient behavior in response to sudden metabolic challenges has proven to be essential for
the system in question here.
The results also highlight the importance of concentration constraints based on metabolite mea-
surements: Using only free metabolite concentrations within physiologically sensitive bounds,
the protein cost optimization would prefer the MCIT pathway, entirely based on its lower weight
enzymes. The actual intracellular concentrations are far more strict constraints on the feasible
flux space, which underlines the importance of high quality metabolomics data to understand
the underlying mechanisms.
Kinetic models in the -omics era
Despite the surely occurring flaws of modeling approaches – here for example the failure to
resolve the dynamics of propionate decay with high confidence – mechanistic conclusions can
be drawn from carefully calibrated models. However, they can only yield predictions up to
the level of accuracy and coverage of the data. Based on that, they can identify gaps in the
knowledge about the system in an unbiased manner. With the help of the model, parts of the
system are still ill-defined can be pinpointed. This can, for example, be done by identifying
parameter non-identifiabilities which were present for the majority of the model parameters,
despite the high number of data points included. Targeted follow-up experiments can then
resolve those knowledge gaps.
The availability of high quality metabolomics data allows for the integration of thermodynamic
principles into kinetic metabolic models, which has been shown to be very insightful here.
However, despite the availability of several kinetic-thermodynamic rate laws (see Methods
Section 2.2.3), the vast majority of published kinetic metabolic models does not take into
account thermodynamics.
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8. Conclusions
The previous Chapters presented the major findings and discussed them individually with regard
to their accuracy, biological recovery, possible sources of error, potential improvements and
others. This concluding Chapter takes up these threads and orients the presented results in
the larger scientific context. The novel findings and their implications are highlighted, their
contribution to open scientific problems is explained.
8.1 Strategies for modeling large metabolic networks
Driven by the increasing availability of omics data, systems biological modeling approaches
strive for larger coverage of cellular processes while increasing mechanistic accuracy. Especially
in metabolic modeling, previous studies either cover a small part of metabolism in great de-
tail [31, 94, 145, 201] or the entire metabolic network on a stoichiometric level [23]. Increasing
coverage of the former and mechanistic detail of the latter approaches are frontiers in the systems
biology of cellular metabolism, which are also tackled in the work presented here.
The right granularity for modeling
Besides their predictive power, mathematical models can be seen as a formalization of the
current state of knowledge on a given system. All available data can be integrated in and form
the basis of this formalization. Accordingly, the resolutions of model and data have to match.
If for example only a pool of metabolites can be measured together, modeling efforts will not
be able to reveal the properties of reactions inter-converting between the pooled metabolites.
However, predictions on the overall behavior of this metabolite pool can be drawn with high
accuracy. From this point of view, modeling efforts also identify missing knowledge, which can
in no case be extracted from the available data. At the same time, they can be used to propose
meaningful experiments, capable of specifically filling the knowledge gaps.
In this thesis, the system in question – the central carbon metabolism in mycobacteria – is
interrogated at different levels of granularity, exemplifying the interdependency of models and
their data. Specifically, in Chapter 5.2 steady state metabolite concentrations were used to
identify thermodynamic bottlenecks in glycolysis in the overall metabolic context, without the
need for specific kinetic information. However, also the bias of missing metabolite data was
highlighted, locating boundaries of the information available on the system.
In Chapter 6.2, protein data and enzyme kinetic formulations were included to detect regulatory
points from the steady state data. With the assumption of the cell’s striving for minimality, they
could be identified without pinpointing the values for the kinetic parameters in a multi-fitting
approach. While the information density was not high enough to predict the kinetic behavior of
the metabolic network, dependencies among the kinetic parameters could be disclosed, to which
all sets of feasible kinetic parameters will have to obey (see for example Figure 6.3).
Similar statements could be made for the full dynamic model of propionate detoxification in
Chapter 7: Despite the high coverage of time-resolved data, many of the model’s parameters
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remained non-identifiable after the model calibration. The conclusions that could be drawn
nevertheless, such as information on the catalytic efficiencies or on the kinetic behavior common
to all feasible parameterizations, is then soundly backed by the data (see Figures 7.6 - 7.8).
Together these findings show how to exploit available data, while revealing and adhering to
their intrinsic limitations. The strength of the mathematical modeling efforts is thereby to
mechanistically back the data and reveal causal relationships from them, such as bottleneck
reactions (Chapter 5.2), required regulatory points (Chapter 6.2) and reasons for flux capacity
bounds (Chapter 7).
The context makes the difference
Metabolism is densely interlinked to all other cellular functionalities. Cell growth, DNA replica-
tion, transcription, translation, signaling and cellular maintenance require functional biomass as
well as energy, both supplied by metabolism. All these processes also feed back on their fueling
fluxes in a condition dependent manner. Accordingly, metabolism is highly context dependent.
In addition to those supply-demand constraints, metabolism also has to obey basic principles of
thermodynamics and chemical transformations. Formalizing all those aspects into mathematical
models yields highly constrained systems. On one hand, this increases biological accuracy and
therefore predictive power of models. On the other hand, model calibration becomes a highly
complex problem, requiring to search a high-dimensional parameter space that is strongly and
nonlinearly constrained.
The results presented here show how to benefit from information about the network context and
provide novel ways to tackle the practical problems arising from contextualization. Biomass
backtracking provides a method to integrate knowledge from well curated genome-scale models
as a context for small kinetic models (Chapter 5.1). Those small models are easier to calibrate
and simulate, as is shown for example in Chapter 7 for mycobacterial propionate catabolism,
but still include information on the surrounding network. Thereby also sufficient flux for the
generation of biomass is guaranteed.
Furthermore, context dependencies of the intracellular thermodynamic landscape (Chapter 5.2),
metabolic regulation (Chapter 6.2) and the cost of protein production (Chapter 7) were described,
highlighting the importance of considering cellular contexts in metabolic modeling efforts.
On steady states and dynamics
Most metabolite data are measured in steady state, as the very fast transient time-scales of
metabolic reactions are difficult to access experimentally. In the dynamic metabolite data presen-
ted here, many metabolites reached a new steady state after less than one minute (see Figure 7.5
and Appendix A.7), a very short time span for complex experimental measurements. Proteomes
change on much slower time-scales and are hence measured in larger intervals corresponding to
distinct metabolic steady states.
For those reasons, steady state methods are a major focus of this work, yielding widely ap-
plicable methods for similar data. While important insights can be gained from the system
neglecting enzyme kinetics, such as the thermodynamic bottlenecks in Chapter 5.2, kinetic
terms can additionally be included in steady state models to improve performance. In existing
methods [29, 59] as well as in the results presented in Chapter 6.2, the consideration of enzyme
saturation via suitable kinetic laws increases the level of mechanistic detail compared to merely
stoichiometric or thermodynamic methods. For unknown parameters, sampling approaches are
frequently used, as opposed to the multiple start point optimization presented here.
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Steady state problems usually have a set of solutions, rather than an unique one, resulting in
parameter non-identifiabilities and dependent parameters (see Figure 6.3). These information
can be exploited for the calibration of the time-resolved behavior of the model to dynamic
data: All feasible parameterization will have to lie within the set of solutions to the steady state
problem.
However, if kinetic data can be obtained, it will likely contain more information than steady
state measurements. As shown in Chapter 7, some mechanisms only reveal themselves on
the dynamic time-scale. While considering thermodynamics and enzyme costs in steady state
were not able to explain pathway preferences, a model fitted to time-resolved metabolite data
succeeded. Accordingly, if time resolved data are available, they should be exploited, but a lot
can be learned from steady state data and modeling already.
8.2 Metabolic flexibility confirmed
Together all described methods and results add to the understanding of M. tuberculosis biology
in the pathological context. Especially the open question of how the bacteria reroute their flux in
changing environmental conditions was addressed. The results likely represent general strategies
to deal with harsh nutritional and environmental conditions
Backup pathways were proven to be an effective way to overcome thermodynamic limitations
when efficient catabolism is required, while retaining the potential to react quickly to sudden
metabolic challenges, using the example of propionyl-CoA catabolism (Chapter 7). Both
functionalities implemented in one pathway would lower either efficiency, as was observed
for the glycolytic/gluconeogenetic pathway in Chapter 5.2. Glycolysis was identified there as
thermodynamic bottleneck in both directions, based on the measured metabolite concentrations.
Why there is no set of parallel pathways for glycolysis and gluconeogenesis can be hypothesized:
There might not be a sufficiently good alternative, as glycolysis is generally considered a minimal
pathway [135]. Another explanation might be that very little gluconeogenesis is required in
vivo, potentially due to sugars scavenged from the host, as has been shown to be relevant during
persistence [114].
The high level of conservation of protein amounts (Figure 4.2 B) and biomass leaks (Figure 5.4 C
and Appendix A.10) between the conditions indicated that only a small, targeted set of changes
is executed by the cells to transit from growth on one nutrient to another. While protein
changes cannot explain this transition fully, their combination with metabolite concentrations
in Chapter 6.2 revealed possible points of regulation, which can now be targeted by specific
experiments.

9. Outlook
As a final part of this work, an outlook is given in the following Chapter, covering ongoing work
and future implications of the presented findings.
9.1 Towards modeling larger metabolic networks in more detail
Integration of all available data
With the era of big data advancing, modeling efforts will aim to include more and more diverse
datasets to confine the metabolic solution space further and further [157]. Especially for large
scale or even whole cell modeling, metabolism gives context for other cellular processes and at
least for simpler organisms, cellular function is to a large extent governed by the metabolic state.
Accordingly, the need for large, high-accuracy metabolic models will increase. The presented
methods may find application in the construction and calibration of such models. Especially
backtracking is a handy tool for consistently generating sub-models that are easily integrable
into larger frameworks and well parameterizable, fulfilling the needs of modular modeling
approaches. The method also allows to transmit information on increasingly available patient
proteomes and metabolomes via sophisticated FBA methods to detailed dynamic models and
can hence have applications in personalized medicine [33].
Towards a thermodynamic-kinetic CCMtb
Based on the results of the thermodynamic-kinetic model in Chapter 7, ongoing efforts are
elated about the expansion of the method to the entire mycobacterial central carbon metabolism,
thereby fully exploiting the dynamic metabolite data. However, in a dynamic model of that size
the pitfalls of full thermodynamic-kinetic equations become evident. They are highly nonlinear,
which results in an expansion of the derivative matrices used for numerical computation and
extremely long simulation times. Optimization routines accordingly struggle with the uncom-
fortable objective function as well as with the high dimensional parameter space, covering
kinetic parameters, initial conditions, uptake and secretion parameters, Gibbs energies and error
model parameters. On the way to a calibrated model, automatized model and data setup scripts
have proven useful to ensure mathematical consistency. Also a separate biomass flux for each
backtracked compound improved numeric stability.
While the model is far from finished, first simulations in good accordance with the data can be
obtained (example in Appendix A.35). An interesting aspect is the multi-objective of the model
to comply with dynamic experimental data on one hand, but also arrive at a valid steady state. A
steady state pre-fit, similar to the workflow in Chapter 6.2, has proven useful in constraining
the feasible parameter space. Another focus of ongoing work is the improvement of algorithms
capable of estimating parameters in steady state systems efficiently.
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Especially in the context of genome-scale metabolic data becoming available, this ongoing study
exemplifies the need for an automated generation of dynamic models, which does not require
detailed measurement of each involved enzymes kinetics and tackles the issues arising from the
large size of the system.
Frontiers in modeling large metabolic network
Kinetic modeling on the genome-scale is largely limited by the availability of efficient parameter
estimation techniques. Computational costs of estimating hundreds of parameters in an highly
nonlinear parameter space are humongous and fitting routines do not converge well. Especially,
the finding of beneficial initial points for the optimization would ease the task.
In addition also high resolution data is only available for a small subset of the entire metabolic
system. The data used in this work have an exceptionally high coverage and (time-)resolution
– more remote pathways in other organisms cannot be studied equally well due to the lack
of available data. Nevertheless, most of the model parameters stay non-identifiable, arguing
again for a close coordination of experimental and modeling efforts. The mathematical models
can thereby identify measurement scenarios (time-points or perturbations) that will contain
maximum information. Even though, omics data are created by the hour and their quality is
steadily improving, there is a lack of data tailored to modeling. This holds also for measured
kinetic parameters of enzymes, which are key to kinetic models. For example, for none of the
enzymes of the model organism E. coli a full set of kinetic parameters and educt concentrations is
available from literature [46]. Despite the fact that almost all data can be exploited by modeling
efforts, they have a much higher power with the right kind of data: Quantitative measurements
of the specifically involved compounds and their kinetic parameters.
9.2 Tuberculosis on the verge of extinction?
The World Health Organization has transited from their "Stop TB" to the "End TB" strategy in
2015, counting major successes in the fight against tuberculosis around the world: 43 million
lives were saved in the 15 years before, owing to improved diagnosis and treatment, with an
86 % treatment success rate for newly-diagnosed patients. However, they also clearly state that
"[n]ew diagnostics, drugs and vaccines will be needed to achieve the targets set in the End TB
Strategy" [209].
Global tuberculosis control faces mostly practical problems, such as to guarantee the duly
administration of drugs in weak infrastructure countries, the low efficacy of vaccination and the
reduced antibiotic impact in HIV-co-infections. Tuberculosis is in this sense different from other
fast progressing pandemics. Fighting tuberculosis requires long and expensive public health
campaigns that show success only after years or decades.
Speeding things up with more efficient antibiotics and vaccination strategies is therefore a
major concern of basic research on M. tuberculosis and the relevant host immune mechanisms.
The practical problem is to reveal the details and complex mechanisms of M. tuberculosis’
pathology to understand where and why currently available treatments are failing – and to
find novel ways to overcome these obstacles. In this required systemic research, systems
biology and computational modeling will lead the way, equipped with on-target, high quality
experimental data.
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A.1 Normalization and correlation of ALF and AQUA datasets
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Figure A.1: A Correlation of the ALF and the Aqua datasets. Distributions for both data sets are plotted on the
margins. Proteins strongly deviating between the two methods are colored and labeled with their gene names. Please
note that the marginal distribution of the ALF dataset contains all measured proteins, whereas the scatter-plot only
the ones that were found in both datasets. B Summary of the normalization of the protein data, showing the overall
distribution (gray bars) and the distributions for the individual samples (colored lines). Upper panel shows the raw
data with clearly deviating means, lower panels the data after normalization to the mean of either ALF or AQUA
measurements. The normalization shown in the middle was applied for the subsequent use of the data.
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A.2 BCG reference experiment
General bounds for growth and uptake rates were estimated based on data from batch growth
of M. bovis BCG in media containing glycerol and glutamate (BCG reference experiment).
The growth rate as well as the uptake and secretion rates of several media constituents
were estimated using an exponential growth model and cell number dependent secretion or
uptake. Only the measurements that could clearly be associated with exponential growth were
considered. Errors for each component were estimated (sd as the % standard deviation, uniting
experimental and biological variation). The results are summarized in Figure A.2 and Table A.2.
The division time calculates as 37.9 h from td = ln(2)/rg. For the default bound on uptake and
secretion fluxes (Table 4.2), the below rates were normalized by the number of cells per mL at
OD600=1, the molecular weight of the compounds and the intracellular volume (cf. Table 4.1).
Table A.2: Estimated growth, uptake and secretion rates, initial concentrations and an estimator for the experimental
error. For the media compounds, negative rates signify an uptake, positive ones secretion.
unit initial concentration rate k [1/min] error estimate sd
glycerol g/L 3.55 -9.93·10−5 4
glutamate g/L 0.37 -9.82·10−5 30
succinate g/L 0.00133 2.23·10−13 17
aconitate g/L 0.00005 2.30·10−6 23
cit_isocit g/L 0.21 9.39·10−7 6
isocitrate g/L 0.00 2.81·10−6 30
citrate g/L 0.21 -1.85·10−6 6
OD600 OD600 0.12 0.00030437 13
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Figure A.2: BCG Reference experiment, data (dots) alongside model fit (lines) with error estimate (shaded area).
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A.3 Growth rate dependency on ribosomal fraction
Organism rg [1/h] td (min) Ribosomal
percentage
fR %(w/w)
translational
capacity rT
(aa/s)
fR · rT
(aa/min/
proteome)
Reference
E. coli 1.73 24 21.1 21 7.39 BNID 102345
1.39 30 17.5 20 5.83
1.04 40 14.8 18 4.44
0.69 60 11.4 16 3.04
0.42 100 9.0 12 1.80
M. bovis BCG 0.03 1200 3.0 2 0.10 [43],
proteomics
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Figure A.3: Translational capacity as a function of the division time for E. coli cultures with different growth rates
and for M. bovis BCG, based on the experimental data, explaining the slow growth rate of the mycobacteria.
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A.4 GO enrichment of differentially expressed proteins
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Figure A.4: Gene ontology terms enriched in the sets of differentially expressed genes for each of the four culture
conditions. Significant terms are listed on the y-axis, larger dots indicate stronger enrichment, the color of the dots
represents the statistical significance (red - low p-value, blue - higher p-value).
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A.5 Principal component analysis metabolite concentrations
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Figure A.5: Principal component analysis of the acquired metabolite data revealing similar culture conditions. Later
growth phase samples (glucose - light red and glutamate - gray) cluster together. In the principal component analysis
missing metabolite values were substituted with zeros. The first four principle components are shown, explaining
83.9, 12.6, 2.7 and 0.3 % of the total variance, respectively. The first component is shown in zoom in, maximum
values reach up to 3.9·104.
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A.6 Condition dependent metabolite concentrations - controls
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Figure A.6: A very busy figure on the steady state metabolite concentrations. A Clustered heatmap of all samples
corresponding to a metabolic steady state (control experiments, samples at t=0), color represents the fold change
to the mean of all shown samples. White regions indicate lacking data. Rows are labeled with sample names.
B Histogram of all values in A. C Mean of the values in A for each condition and metabolite, colors correspond to
the label groups in A. Errobars indicate the standard deviation.
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A.7 Dynamic change in metabolite concentrations at t = 160s
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Figure A.7: Change in metabolite concentrations between the steady state and the perturbed state after 160s.
A Clustered heatmap of all samples corresponding to the final measurement point after 160 s in the new media,
color represents the log2 fold change to the mean of the respective steady state concentration of the metabolite in the
specific culture condition (FC = log2[yˆss/yˆ(t = 160s)]). Rows are labeled with sample names. Fold changes with an
absolute value smaller than one are shown in gray. B Histogram of all values in A. C Boxplot of the values in A for
each metabolite.
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A.8 Dynamic change in metabolite concentrations - all timepoints
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Figure A.8: Change in metabolite concentrations between the steady state and the dynamic measurements time
points. Heatmaps are as in Appendix A.7 A, but for all timepoints as indicated.
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A.9 List of modifications to sMTB
• The respiratory chain was amended according to the literature to guarantee its functionality:
CYDB reaction did not pump protons, protons were added
SDHA reaction was amended to charge one quinone under the consumption of two external
protons (see Chapter 6.1)
• Net uptake of external protons Hr[e] was not allowed to avoid generation of energy without
cost. As only Hr[e] are used in the ATPase-reactions, the import of the additional proton
species H[e] does not need to be considered as it implements only an energy neutral release
of excess protons (leakage).
• Excretion of carbon monoxide (CO[e]) was limited and nitrate respiration was prohibited,
which was required for a meaningful flux distribution in glutamate conditions.
• The reactions PCA and PCKA were made reversible to allow for gluconeogenesis. They were
only anaplerotic in sMtb.
• The presence of pyruvate dehydrogenase in M. tuberculosis is debated. It was added here to
the sMtb model (as PYD), as its components are present in the proteomics data and based on
literature evidence [194, 183, 13]
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A.10 Biomass leaks from CCMtb
Table A.10: Leaks from CCMtb to produce biomass in mmol/gDW.
metKEGGID Model Metabolite Glucose Propionate Glutamate
C00001 H2O 9.71 25.52 -17.32
C00002 ATP -10.04 -35.25 -35.26
C00003 NAD 10.23 8.18 -6.87
C00004 NADH -10.23 -8.18 6.87
C00005 NADPH -2.22 0 -13.23
C00006 NADP 2.22 0 13.23
C00008 ADP 10.04 35.25 35.26
C00009 PI 22.24 32.04 32.05
C00010 COA 0.73 1.44 1.43
C00011 CO2 6.74 5.66 5.66
C05819 MQH2 0 0 0
C00022 PYR -7.36 -6.16 -6.16
C00024 ACCOA -0.28 0 0
C00026 AKG -0.62 -0.62 -0.62
C00031 GLC -0.65 0 0
C00035 GDP 9.39 -6.67 -6.67
C00036 OA -1.04 -1.04 -1.04
C00042 SUCC 0.18 0.19 0.18
C00044 GTP -9.39 6.67 6.67
C00048 GLX 0 0 0
C00074 PEP -0.36 -0.36 -0.36
C00085 F6P -0.35 -1.00 -1.00
C00091 SUCCOA -0.18 -0.19 -0.18
C00092 G6P -0.48 -0.48 -0.48
C00100 PROPIONYLCOA -0.26 -1.13 -1.13
C00111 DHAP -0.21 -0.21 -0.21
C00117 R5P -0.71 -0.71 -0.71
C00118 G3P -1.14 -1.14 -1.14
C00122 FUM 0.46 0.46 0.46
C00149 MAL 0 0 0
C00158 CIT 0 0 0
C00197 3PG -0.62 -0.62 -0.62
C00199 RL5P -0.03 -0.03 -0.03
C00231 X5P 0 0 0
C00232 SUCCSAL 0 0 0
C00236 13PDG 0 0 0
C00279 E4P -0.11 -0.11 -0.11
C00288 HCO3 0 0 0
C00311 ICIT 0 0 0
C00345 D6PGC 0 0 0
C00354 FDP 0 0 0
C00417 CISACONITATE 0 0 0
C00631 2PG 0 0 0
C00683 SMMALONYLCOA -5 -0.12 -0.12
C01213 RMMALONYLCOA 0 0 0
C01236 D6PGL 0 0 0
C00828 MQ 0 0 0
C02225 2METHYLCITRATE 0 0 0
C04225 METHYLACONITATE 0 0 0
C04593 METHYLISOCITRATE 0 0 0
C05382 S7P 0 0 0
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A.11 Leaks from CCMtb under propionate and glutamate conditions
propionate
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total consumed 50.9165 Cmmol/gDW
Figure A.11: Distribution of leaks from CCMtb intermediates (left side labels) to biomass constituents (right side labels) for propionate and glutamate conditions. For a more
detailed explanation see Figure 5.4.
154 Appendix
A.12 Released metabolites during the production of biomass
Figure A.12: Leaks of metabolites re-entering the central carbon metabolism from biosynthetic paths in mmol/gDW,
corresponding to the stacked bars in Figures 5.4 and A.11. Mainly CO2is released in decarboxylation reactions, larger
amounts of fumarate (FUM[c]) get released during the synthesis of arginine and nucleotides via 5-Aminoimidazole-
4-carboxamide ribonucleotide (AICAR).
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A.13 Comparison between whole biomass and component backtracking
full biomass backtracking leaks [mmol/gDW]
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Figure A.13: Correlation of leak fluxes calculated by backtracking of the whole biomass (x-axis) and of the single
biomass components (y-axis, corrsponding to the leaks shown in the distribution Figures 5.4 and A.11). Inset shows
a close up of smaller leaks.
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A.14 Loss of acquired carbon via different routes
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Figure A.14: Relative loss of acquired carbon via carbon dioxide and secretion of other metabolites in sMtb in the
three growth conditions. For each biomass constituent, the gray bar represents the fraction of the carbon required
from the central carbon metabolism that ends up in the biomass. Blue bars represent a release of carbon dioxide,
either in the central carbon metabolism itself (dark blue) or along the remote biosynthetic paths (light blue). Light
red bars imply loss of carbon due to the secretion of other metabolites into the medium and dark red bars represent
unexplained carbon, hinting to an inconsistency in the genome scale model. Bars represent one biomass component
each, are normalized to the number of carbons taken up to from one mole of each compound and ordered according
to the fraction of carbon incorporated in the biomass in the glucose condition. Please note that the CO2 leaks (blue)
can be negative, representing reactions that fix CO2 from the environment.
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A.15 Michaelis-Menten constants of CCMtb reactions from literature
Table A.15: kMvalues found in the literature for mycobacterial species. Mtb- M. tuberculosis, Msmeg - Mycobac-
terium smegmatis, Mphl - Mycobacterium phlei. * data measured by collaboration partners within the SystemTb
Project (Davide Ferraris, Menico Rizzi, Università del Piemonte Orientale "A. Avogadro", Novara, Italy). Metabolite
concentrations are as in Table A.18.
Reaction EC number Substrate Value (mM) Species Reference
R02f_pgi 5.3.1.9 F6P 0.27 Mtb [115]
R04f_fba 4.1.2.13 FDP 0.02 Mtb [152]
R05f_tpi 5.3.1.1 G3P 84 Mtb [116]
R05f_tpi 5.3.1.1 DHAP 0.0025 Mtb [39]
R09_pyk 2.7.1.40 PEP 0.04 Msmeg [85]
R09_pyk 2.7.1.40 ADP 0.23 Msmeg [85]
R11f_cis 2.3.3.1, 2.3.3.3 OA 0.057 Mtb *
R11f_cis 2.3.3.1, 2.3.3.3 ACCOA 0.16 Mtb *
R13f_aco_2 4.2.1.3 ICIT 0.56 Mtb [10]
R14f_idh1 1.1.1.42 ICIT 0.01 Mtb [9]
R14f_idh1 1.1.1.42 NADP 0.125 Mtb [9]
R17f_fum 4.2.1.2 FUM 2.63 Mtb *
R18f_mdh 1.1.1.37, 1.1.1.299 NADH 0.0286 Mphl [197]
R18f_mdh 1.1.1.37, 1.1.1.299 OA 0.0443 Mphl [197]
R18f_mdh 1.1.1.37, 1.1.1.299 NAD 1.31 Mtb *
R18f_mdh 1.1.1.37, 1.1.1.299 MAL 3.75 Mtb *
R19f_pcx 6.4.1.1 PYR 0.3 Msmeg [125]
R19f_pcx 6.4.1.1 ATP 1.26 Msmeg [125]
R19f_pcx 6.4.1.1 HCO3 3 Msmeg [125]
R20f_kgd 4.1.1.71 AKG 0.48 Mtb [193]
R21f_gab 1.2.1.16, 1.2.1.79 SUCCSAL 0.0133 Mtb [47]
R21f_gab 1.2.1.16, 1.2.1.79 NADP 0.0613 Mtb [47]
R22af_icl1 4.1.3.1 GLX 0.14 Mtb [124]
R22af_icl1 4.1.3.1 SUCC 0.412 Mtb [124]
R22af_icl1 4.1.3.1 ICIT 0.045 Mtb [124]
R23f_mls 2.3.3.9 ACCOA 0.01/0.03 Mtb [185, 149]
R23f_mls 2.3.3.9 GLX 0.03/0.057 Mtb [185, 149]
R28f_pck 4.1.1.32 GTP 0.017 Msmeg [110]
R28f_pck 4.1.1.32 OA 0.168 Msmeg [110]
R28f_pck 4.1.1.32 GDP 0.072 Msmeg [110]
R28f_pck 4.1.1.32 PEP 0.213 Msmeg [110]
R28f_pck 4.1.1.32 CO2 18.2 Mtb [110]
R43_fbp 3.1.3.11 FDP 0.015 Mtb [110]
R49f_rpi 5.3.1.6 R5P 1/1.8/3.7 Mtb [162, 163, 164]
R50f_tkt1 2.2.1.1 R5P 0.8 Mtb [60]
R52f_tkt2 2.2.1.1 F6P 0.6 Mtb [60]
R52f_tkt2 2.2.1.1 X5P 0.4 Mtb [60]
R54f_pcc 6.4.1.3 PROPIONYLCOA 0.24 Mtb [62]
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A.16 Comparison of different objective functions
Table A.16: Summary of the objective functions tested for resolving infeasibilites in the thermodynamic landscape
of the central carbon metabolism. ∑z denotes the number of infeasible reactions, ∑w the total flux through all
infeasible reactions, wpFBA is the weight of the sum of fluxes in the overall objective, not converged - the algorithm
did not find an optimum solution within 20 minutes of computation time.
Method Glucose,early
Glucose,
late
Glutamate
late
Propionate
early
MDF,
wpFBA =0.01
# unfeas.
reactions 1 (tpi) 0 1 (pgk)
9 (fum, mdh,
mez, pck, pcx,
eno, gpm, pgk,
gpd)
runtime [s] 1.20 0.63 7.207938 0.91
loops no no no no
∑z
# unfeas.
reactions 1 (tpi) 0 1 (pgk) 1 (pgk)
runtime [s] 0.92 0.71 0.57 0.79
loops yes yes no yes
∑z,
wpFBA =0.001
# unfeas.
reactions 1 (tpi) 0
9 (rpe, tkt, gpd,
pgk, gpm, pcx,
mdh, aco2, idh)
1 (pgk)
runtime [s] 1.3 0.3 1.8 1.2
loops no no no no
∑z, MDF
# unfeas.
reactions 0 - 1 (pgk) 1 (pgk)
runtime [s] 21.95 not converged 2.620 1.71
loops yes - yes yes
∑w
# unfeas.
reactions 0 - - -
runtime [s] 1.5 not converged not converged not converged
loops yes - - -
∑w,
wpFBA =0.001
# unfeas.
reactions 0 0
11 (scs, idh,
aco2, aco1, cis,
mdh, pcx, pgk,
gpd, tkt1, rpe)
1 (pgk)
runtime [s] 117.1 0.39 148.29 13.21
loops yes no no no
∑w, MDF
# unfeas.
reactions - - - -
runtime [s] not converged not converged not converged not converged
loops - - - -
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A.17 Optimal, thermodynamically feasible metabolite concentrations
H2O
ATP
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X5P
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E4P
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S7P
metabolite concentration [μM]
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GC1
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optimum Figure A.17: Optimum metabolite concentra-
tions (dots) for the thermodynamically feasi-
ble system for the four experimental condi-
tions (dark red - glucose, early; light red - glu-
cose late; gray - glutamate, late; blue - propi-
onate, early) along with their allowed ranges
(lines). Metabolites without experimental mea-
surements were allowed to vary within the de-
fault concentration bounds (1 µM - 50 mM, see
Table 4.2).
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A.18 Summary of model metabolites
Table A.18: Metabolites included in the CCMtb model and Pdtx models. #C indicates the number of carbons.
ID Name Sum formula ChEBI ID KEGG ID ∆ f G0 #C
H2O Water H2O 15377 C00001 -156.1 0
ATP Adenosine nucleotide
triphosphate
C10H16N5O13P3 15422 C00002 -2292.4 10
NAD Nicotinamide adenine
dinucleotide (oxidized)
C21H28N7O14P2 15846 C00003 1053.6 21
NADH Nicotinamide adenine
dinucleotide (reduced)
C21H29N7O14P2 16908 C00004 1115.0 21
NADPH Nicotinamide adenine
dinucleotide phosphate
(oxidized)
C21H30N7O17P3 16474 C00005 235.2 21
NADP Nicotinamide adenine
dinucleotide phosphate
(reduced)
C21H29N7O17P3 18009 C00006 173.0 21
ADP Adenosine nucleotide
diphosphate
C10H15N5O10P2 16761 C00008 -1425.8 10
PI Orthophosphate H3PO4 18367 C00009 -1059.2 0
COA Coenzyme A C21H36N7O16P3S 15346 C00010 1238.9 21
CO2 Carbon dioxide CO2 16526 C00011 -386.0 1
MQH2 Menaqinol C16H18O2(C5H8)n 18151 C05819 -353.2 16
PYR Pyruvate C3H4O3 32816 C00022 -351.2 3
ACCOA Acetyl-CoA C23H38N7O17P3S 15351 C00024 1180.3 23
AKG 2-Oxoglutarate C5H6O5 30915 C00026 -633.7 5
GLC D-Glucose C6H12O6 4167 C00031 -429.3 6
GDP guanosine nucleotide
diphosphate
C10H15N5O11P2 17552 C00035 -248.3 10
OA Oxaloacetate C4H4O5 30744 C00036 -714.6 4
SUCC Succinate C4H6O4 15741 C00042 -530.7 4
GTP guanosine nucleotide
triphosphate
C10H16N5O14P3 15996 C00044 -530.7 10
GLX Glyoxylate C2H2O3 16891 C00048 -428.7 2
PEP Phosphoenolpyruvate C3H5O6P 44897 C00074 -1188.6 3
F6P D-Fructose 6-phosphate C6H13O9P 61553 C00085 -1317.4 6
SUCCOA Succinyl-CoA C25H40N7O19P3S 15380 C00091 894.2 25
G6P D-Glucose 6-phosphate C6H13O9P 4170 C00092 -1320.6 6
PROPIONYLCOA Propanoyl-CoA C24H40N7O17P3S 15539 C00100 1270.7 24
DHAP Glycerone phosphate C3H7O6P 16108 C00111 -1096. 3
R5P D-Ribose 5-phosphate C5H11O8P 17797 C00117 -1233.7 5
G3P D-Glyceraldehyde 3-phosphate C3H7O6P 29052 C00118 -1088.4 3
FUM Fumarate C4H4O4 18012 C00122 -523.2 4
MAL (S)-Malate C4H6O5 30797 C00149 -682.9 4
CIT Citrate C6H8O7 30769 C00158 -965.6 6
3PG 3-Phospho-D-glycerate C3H7O7P 17794 C00197 -1347.3 3
RL5P D-Ribulose 5-phosphate C5H11O8P 17363 C00199 -1233.3 5
X5P D-Xylulose 5-phospate C5H11O8P 16332 C00231 -1106.7 5
SUCCSAL Succinate semialdehyde C4H6O3 16265 C00232 -1106.7 4
13PDG 3-Phospho-D-glyceroyl
phosphate
C3H8O10P2 16001 C00236 -2206.0 3
E4P D-Erythrose 4-phosphate C4H9O7P 48153 C00279 -1316.5 4
ICIT Isocitrate C6H8O7 30887 C00311 -959.0 6
D6PGC 6-Phospho-D-gluconate C6H13O10P 48928 C00345 -1565.0 6
FDP D-Fructose 1.6-bisphosphate C6H14O12P2 16905 C00354 -2205.9 6
CISACONITATE cis-Aconitate C6H6O6 32805 C00417 -801.0 6
2PG 2-Phospho-D-glycerate C3H7O7P 17835 C00631 -1341.4 3
SMMALONYLCOA (S)-Methylmalonyl-CoA C25H40N7O19P3S 15466 C00683 -1085.9 25
RMMALONYLCOA (R)-Methylmalonyl-CoA C25H40N7O19P3S 15465 C01213 -812.0 25
D6PGL D-Glucono-1.5-lactone
6-phosphate
C6H11O9P 16938 C01236 -1383.8 6
MQ Menaquinone C16H16O2(C5H8)n 16374 C00828 -378.7 16
2METHYLCITRATE 2-Methylcitrate C7H10O7 30836 C02225 -1024.6 7
METHYLACONITATE 2-Methylcisaconitate C7H8O6 16717 C04225 -1313.2 7
METHYLISOCITRATE (2S.3R)-3-Hydroxybutane-
1.2.3-tricarboxylate;
C7H10O7 15607 C04593 740.4 7
S7P Sedoheptulose 7-phosphate C7H15O10P 15721 C05382 -979.1 7
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A.19 Observables of the model
Table A.19: Summary of the available data and their mapping to the model entities (see Appendix A.18) via observables. The last four columns show mean steady state
measurements for the experimental conditions in µM. Values without internal standard are shown in italics.
Observable name Corresponding species in CCMtb Glc, late Glc, early Glu, late Pro, early
6PG D6PGL 133.0 ± 15.2 219.2 ± 33.8 71.0 ± 19.6 117.4 ± 17.9
AcCoA ACCOA 75.3 ± 7.4 90.9 ± 13.4 46.4 ± 5.3 26.0 ± 1.5
Aconitate CISACONITATE 11.5 ± 2.9 6.8 ± 1.4 24.7 ± 8.3 8.9 ± 0.8
ADP ADP 677.5 ± 39.7 1629.8 ± 189.0 724.4 ± 208.8 763.6 ± 34.5
alphaketoglutarate AKG 165.9 ± 29.2 230.0 ± 36.2 287.9 ± 70.7 67.1 ± 10.9
ATP ATP 2509.6 ± 186.8 4850.0 ± 604.8 2837.0 ± 233.7 1497.3 ± 315.9
BPG 13PDG 6.0 ± 0.7 7.4 ± 1.1 13.2 ± 2.6 1.7 ± 0.3
CoA COA 128.3 ± 41.8 330.6 ± 24.0
DHAP DHAP 49.7 ± 4.0 75.4 ± 5.7 69.7 ± 11.8 21.1 ± 3.2
F6P F6P 229.5 ± 25.4 175.3 ± 15.6
FBP FDP 14.0 ± 2.9 25.9 ± 4.8 17.1 ± 5.5 7.4 ± 2.2
fumarate FUM 23.6 ± 6.8 15.9 ± 3.4 125.1 ± 24.4 19.6 ± 3.4
G6P G6P 242.9 ± 8.8 411.3 ± 64.3 184.1 ± 20.9 316.0 ± 40.4
GAP G3P 140.1 ± 39.1 102.2 ± 22.2
GDP GDP 86.5 ± 10.6 274.3 ± 53.9 83.1 ± 21.1 224.7 ± 18.7
Glyoxylate GLX 668.1 ± 42.2 504.9 ± 129.1
GTP GTP 217.3 ± 11.0 882.3 ± 91.9 244.3 ± 23.4 201.6 ± 17.2
isocitrate ICIT 6.2 ± 1.6 7.5 ± 1.0
Malate MAL 86.9 ± 31.4 240.1 ± 91.2 556.7 ± 103.2 164.3 ± 81.7
methylcitrate_methylisocitrate 2METHYLCITRATE + METHYLISOCITRATE 12.2 ± 1.4 365.6 ± 15.9
mMalonate/Suc* SUCC 222.7 ± 64.6 104.2 ± 27.9
mMalonylCoA SMMALONYLCOA + RMMALONYLCOA 4.6 ± 0.4 51.0 ± 9.5 1.9 ± 0.7 160.8 ± 16.5
NAD NAD 754.1 ± 105.4 671.7 ± 173.3 914.4 ± 78.1 761.1 ± 146.0
NADH NADH 14.3 ± 7.0 18.8 ± 12.7
NADP NADP 183.5 ± 15.7 188.7 ± 43.3 245.3 ± 30.5 166.5 ± 43.3
NADPH NADPH 64.1 ± 9.2 73.7 ± 14.7 92.6 ± 73.8 97.0 ± 24.0
PEP PEP 75.6 ± 12.0 74.8 ± 8.6 77.7 ± 11.9 44.0 ± 8.0
PropCoA PROPIONYLCOA 23.1 ± 4.6 130.9 ± 15.3
R5P R5P 741.0 ± 63.9 49.3 ± 5.7 1033.8 ± 216.6 23.9 ± 4.2
Ru5P RL5P 1208.4 ± 567.1 126.8 ± 241.4 1851.1 ± 654.6 42.2 ± 18.5
S7P S7P 84.7 ± 6.2 247.1 ± 37.2 50.2 ± 5.7 190.8 ± 25.3
Suc/mMalCoA SUCCOA + SMMALONYLCOA + RMMALONYLCOA 100.7 ± 16.5 222.7 ± 16.9
Succinate SUCC 154.4 ± 37.1 391.8 ± 66.6
SucCoA SUCCOA 4.1 ± 0.4 5.1 ± 2.2
xPG 3PG + 2PG 161.5 ± 13.3 246.3 ± 18.5 171.1 ± 23.4 103.7 ± 17.4
Xu5P X5P 57.0 ± 6.6 37.6 ± 5.8
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A.20 Enzyme complexes of CCMtb
Table A.20: Summary of enzyme complexes in CCMtb. * Values and information were extracted from the BRENDA database [175]. A complex stoichiometry of 1 was assumed
for all unknown enzyme structures.
ID Name KEGGID EC
Number
RvNumber Gene
name
Comments Ref. Structure Monomers/
active site
R01f_hex glucokinase R00299 2.7.1.2 Rv2702 ppgK Poly-P or ATP can be used by Rv2702.
Not sure if this is the correct reaction for
1stglycolytic step, also annotated with
Rv0650, but much less information
[77] unknown 1
R02f_pgi glucose-6-phosphate isomerase R00771 5.3.1.9 Rv0946c pgi [5] dimer 2
R03_pfk phosphofructokinase R00756 2.7.1.11 Rv3010c pfkA Also Rv2029c (pfkB) but only pfkA de-
tected in samples.
* unknown, tetramer in
many other species
4
R04f_fba fructose-biphosphate aldolase R01070 4.1.2.13 Rv0363c fba [144] class II aldolase with 4
monomers
4
R05f_tpi triosephosphate isomerase R01015 5.3.1.1 Rv1438 tpiA [207] dimer with one active site 2
R06f_gpd glyceraldehyde-3-phosphate
dehydrogenase
R01061 1.2.1.12 Rv1436 gap * unknown, tetramer in
many other species
4
R07f_pgk phosphoglycerate kinase R01512 2.7.2.3 Rv1437 pgk * unknown, monomer in
many other species
1
R08f_eno phosphopyruvate hydratase R00658 4.2.1.11 Rv1023 eno * unknown, dimer in E.coli 2
R09_pyk pyruvate kinase R00200 2.7.1.40 Rv1617 pyk * unknown, tetramer in
many other species
4
R10_pyd pyruvate dehydrogenase R00209 1.2.4.1,
1.8.1.4,
2.3.1.12
Rv2241 aceE E1, was also Rv2496c AND Rv2497c
(branched-chain alpha-keto acid dehy-
drogenase complex)
1
Rv0462 lpdC E3, also in kdh complex (was also
Rv0794c AND Rv3303c)
1
Rv2215 dlaT E2, was also Rv2495c [194] 1
R11f_cis citrate synthase R00351 2.3.3.1 Rv0889c citA [54] dimer with one active site 2
2.3.3.1 Rv0896 gltA2 unknown 1
R12f_aco_1 aconitate hydratase R01325 4.2.1.3_a Rv1475c acn [10] monomer 1
R13f_aco_2 aconitate hydratase R01900 4.2.1.3_b Rv1475c acn 1
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ID Name KEGGID EC
Number
RvNumber Gene
name
Comments Ref. Structure Monomers/
active site
R14f_idh1 isocitrate dehydrogenase R00267 1.1.1.42 Rv3339c icd icd1 [150] homodimer 2
Rv0066c icd2 icd2 [9] homodimer 2
R15f_scs succinyl-CoA synthase R00405 6.2.1.5 Rv0952 sucD * in E. coli: heterodimer or
2*dimer
1
Rv0951 sucC 1
R17f_fum fumarate hydratase R01082 4.2.1.2 Rv1098c fumC * unknown, dimer or
tetramer in many other
species
2
R53_frd fumarate reductase R02164 1.3.5.4 Rv1552 frdA flavoprotein subunit, frdA unknown 1
Rv1553 frdB iron-sulfur subunit, frdB 1
Rv1554 frdC membrane anchor, frdC 1
Rv1555 frdD membrane anchor, frdD 1
R18f_mdh malate dehydrogenase R00342 1.1.1.37 Rv1240 mdh [54] dimer with one active site
(?)
2
R19f_pcx pyruvate carboxylase R00344 6.4.1.1 Rv2967c pca [125] tetramer in Msmeg, 4
R20f_kgd 2-oxoglutarate decarboxylase R00272 4.1.1.71 Rv1248c kgd [203] homodimer with one
active site
2
4.1.1.71 Rv0555 menD menD has also been found to have this
function, but is not annotated in KEGG
2
R20f_mez malate oxidoreductase R00214 1.1.1.38 Rv2332 mez can also catalyze R00217 [54] dimer 2
R21f_gab succinate-semialdehyde
dehydrogenase
R00714 1.2.1.16 Rv0234c gabD1 also annotated in 1.2.1.79 (NADP) unknown, tetramer in
Ecoli
4
1.2.1.16 Rv1731 gabD2 gabD2 4
R22af_icl1 isocitrate lyase R00479 4.1.3.1 Rv0467 icl [67] tetramer (icl1) 4
4.1.3.1 Rv1915 aceAa icl2a unknown, assume same as
icl1
2
Rv1916 aceAb icl2b 2
R23f_mls malate synthase R00472 2.3.3.9 Rv1837c glcB similar to MSA in E.coli [185] Monomer 1
R24f_mcs 2-methylcitrate synthase R00931 2.3.3.5 Rv1131 prpC in KEGG as 2.3.3.1 dimer in E.coli 2
R25f_mcd methylcitrate dehydratase R04424 4.2.1.79 Rv1130 prpD * unknown, monomer in
E.coli
1
R26f_mcl isocitrate lyase (methyl) R00409 4.1.3.30 Rv0467 icl function carried out by icl1 tetramer 4
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ID Name KEGGID EC
Number
RvNumber Gene
name
Comments Ref. Structure Monomers/
active site
R28f_pck phosphoenolpyruvate
carboxykinase
R00431 4.1.1.32 Rv0211 pckA * unknown, monomer in
Msmeg
1
R43_fbp fructose 1,6-biphosphatase II R04780 3.1.3.11 Rv1099c glpX unknown 1
R44f_zwf glucose-6-phosphate
dehydrogenase
R00835 1.1.1.49 Rv1447c zwf2 * unknown, dimer or
tetramer in many other
species
2
1.1.1.49 Rv1121 zwf1 2
R45f_dev 6-phosphogluconolactonase R02035 3.1.1.31 Rv1445c pgl * unknown, monomer in
some other species
1
R47f_gnd2 phosphogluconate
dehydrogenase
R01528 1.1.1.44 Rv1122 gnd2 * unknown, dimer in many
other species
2
1.1.1.44 Rv1844c gnd1 not expressed in our samples 2
R48f_rpe ribulose-phosphate 3-epimerase R01529 5.1.3.1 Rv1408 rpe unknown 1
R49f_rpi ribose-5-phosphate isomerase R01056 5.3.1.6 Rv2465c rpiB [162] dimer 2
R50f_tkt1 transketolase R01641 2.2.1.1 Rv1449c tkt [60] dimer 2
R51f_tal transaldolase R08575 2.2.1.2 Rv1448c tal unknown 1
R52f_tkt2 transketolase R01067 2.2.1.1 Rv1449c tkt [60] dimer 2
R17r_sdh succinate dehydrogenase R00408 1.3.5.1 Rv0247c Rv0247c iron-sulfur subunit sdh1A [41] heterotertramer with one
active site
1
Rv0248c sdhA iron-sulfur subunit sdh1B 1
Rv0249c Rv0249c membrane anchor, sdh1CD 2
1.3.5.1 Rv3316 sdhC membrane anchor, sdh2C [41] heterotertramer with one
active site
1
Rv3317 sdhD membrane anchor, sdh2D 1
Rv3318 sdhA flavoprotein subunit, sdh2A 1
Rv3319 sdhB iron-sulfur subunit, sdh2B 1
R54f_pcc propionyl-CoA carboxylase R01859 6.4.1.3 Rv3285 accA3 Alpha-subunit, accA3 [62] 1
Rv3280 accD5 Beta-subunit, accD5 two rings of trimers 1
Rv3281 accE5 Eps-subunit AccE5 AccE5 increases activiy of
AccA3/D5 (∼3:1:1 ratio)
3
R55f_mcm methylmalonyl-CoA mutase R00833 5.4.99.2 Rv1492 mutA mutA [173] heterodimer of mutA/B 1
Rv1493 mutB mutB 1
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ID Name KEGGID EC
Number
RvNumber Gene
name
Comments Ref. Structure Monomers/
active site
R58_macn aconitate hydratase R04425 4.2.1.99 Rv1475c acn in KEGG only as 4.2.1.3 [10] monomer 1
R20f_kdh 2-oxoglutarate dehydrogenase
complex
R08549 1.2.4.2, Rv1248c kgd E1, kgd with other functions, 1.2.4.2 ac-
tivity not annotated in Mtb
[203] kgd is dimer 2
1.8.1.4, Rv0462 lpdC E3, also in pdh complex, was also
Rv0794c AND Rv3303c
1
2.3.1.61 Rv2215 dlaT E2 1
R56_gpm2 phosphoglycerate mutase R01518 5.4.2.11 Rv0489 gpmA was also Rv2228c AND Rv2419c AND
Rv3214 AND Rv3837c (only expressed
in Glu), and EC 5.4.2.12
2
Rv3214 gpm2 gpm2/entD cofactor dependant (2,3 PG) [205] dimer 2
R57_rmcoa methylmalonyl-CoA epimerase R02765 5.1.99.1 Rv1322A Rv1322A Annotation unclear, not in KEGG, only
expressed in early samples
[173] unknown, dimer in other
species
2
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A.21 Reactions of CCMtb
Table A.21: Summary of the reactions of the central carbon metabolism as implemented in the models. Gibbs energies
of reaction are given, along with their estimated standard deviation. Metabolite names are as in Appendix A.18.
ID ∆rG0 [kJ/mol] Substrates Products
R19f_pcx -6.4 ± 1.5 ATP + CO2 + PYR ↔ ADP + PI + OA
R28f_pck -13.4 ± 3.4 CO2 + GDP + PEP ↔ OA + GTP
R14f_idh1 6.1 ± 3.2 NADP + ICIT ↔ NADPH + CO2 + AKG
R20f_kgd -15.5 ± 3.4 AKG ↔ CO2 + SUCCSAL
R18f_mdh 26.9 ± 0.3 NAD + MAL ↔ NADH + OA
R11f_cis -38.4 ± 0.4 H2O + ACCOA + OA ↔ COA + CIT
R15f_scs 1.3 ± 1.3 ADP + PI + SUCCOA ↔ ATP + COA + SUCC
R53_frd -14.5 ± 7.1 0.300000 MQH2 + FUM → SUCC + 0.300000 MQ
R17r_sdh 14.5 ± 7.1 SUCC + 0.300000 MQ → 0.300000 MQH2 + FUM
R21f_gab -39.4 ± 2.4 H2O + NADP + SUCCSAL → NADPH + SUCC
R17f_fum -3.4 ± 0.3 H2O + FUM ↔ MAL
R12f_aco_1 8.3 ± 1.1 CIT ↔ H2O + CISACONITATE
R13f_aco_2 -0.7 ± 1.1 H2O + CISACONITATE ↔ ICIT
R20f_mez 13.0 ± 3.2 NAD + MAL ↔ NADH + CO2 + PYR
R43_fbp -9.7 ± 0.7 H2O + FDP → PI + F6P
R09_pyk -24.8 ± 0.4 ADP + PEP ↔ ATP + PYR
R10_pyd -35.5 ± 3.3 NAD + COA + PYR ↔ NADH + CO2 + ACCOA
R03_pfk -18.5 ± 0.7 ATP + F6P → ADP + FDP
R01f_hex -19.5 ± 0.4 ATP + GLC ↔ ADP + G6P
R08f_eno -4.1 ± 0.3 2PG ↔ H2O + PEP
R02f_pgi 2.5 ± 0.4 G6P ↔ F6P
R05f_tpi 5.5 ± 0.6 DHAP ↔ G3P
R06f_gpd 2.6 ± 0.4 NAD + PI + G3P ↔ NADH + 13PDG
R04f_fba 21.2 ± 0.5 FDP ↔ DHAP + G3P
R07f_pgk -18.7 ± 0.4 ADP + 13PDG ↔ ATP + 3PG
R23f_mls -36.2 ± 2.1 H2O + ACCOA + GLX ↔ COA + MAL
R22af_icl1 9.2 ± 1.4 ICIT ↔ SUCC + GLX
R55f_mcm -7.6 ± 2.1 RMMALONYLCOA ↔ SUCCOA
R54f_pcc -5.1 ± 10.4 ATP + CO2 + PROPIONYLCOA ↔ ADP + PI + SMMALONYLCOA
R26f_mcl 9.8 ± 3.0 METHYLISOCITRATE ↔ PYR + SUCC
R24f_mcs -42.9 ± 3.4 H2O + OA + PROPIONYLCOA ↔ COA + 2METHYLCITRATE
R25f_mcd -0.9 ± 5.6 2METHYLCITRATE ↔ H2O + METHYLACONITATE
R44f_zwf -6.3 ± 1.3 NADP + G6P ↔ NADPH + D6PGL
R49f_rpi -2.0 ± 0.8 RL5P ↔ R5P
R52f_tkt2 -10.1 ± 1.9 X5P + E4P ↔ F6P + G3P
R47f_gnd2 10.9 ± 3.2 NADP + D6PGC ↔ NADPH + CO2 + RL5P
R48f_rpe -3.4 ± 1.2 RL5P ↔ X5P
R50f_tkt1 -3.9 ± 1.9 R5P + X5P ↔ G3P + S7P
R45f_dev -24.6 ± 1.7 H2O + D6PGL ↔ D6PGC
R51f_tal -0.7 ± 1.4 G3P + S7P ↔ F6P + E4P
R56_gpm2 4.1 ± 0.7 3PG ↔ 2PG
R57_rmcoa 0 ±5.8 SMMALONYLCOA ↔ RMMALONYLCOA
R58_macn 0.9 ± 5.6 H2O + METHYLACONITATE ↔ METHYLISOCITRATE
R20f_kdh -28.3 ± 7.7 NAD + COA + AKG ↔ NADH + CO2 + SUCCOA
RBIO_GC1 - 1204.5 ATP + 1227.2 NADH + 266.6
NADPH + 882.6 PYR + 33.5 ACCOA
+ 74.1 AKG + 77.8 GLC + 124.6 OA +
1126.4 GTP + 42.6 PEP + 42.3 F6P +
22.2 SUCCOA + 57.1 G6P + 31.4 PROPI-
ONYLCOA + 25.6 DHAP + 85.1 R5P +
137.0 G3P + 75.0 3PG + 3.7 RL5P + 13.4
E4P + 0.06 SMMALONYLCOA
→ 1165.0 H2O + 1227.2 NAD + 266.6
NADP + 1204.5 ADP + 2669.3 PI +
87.2 COA + 809.0 CO2 + 1126.4 GDP
+ 22.2 SUCC + 55.1 FUM
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ID ∆rG0 [kJ/mol] Substrates Products
RBIO_GC2 - 1204.5 ATP + 1227.2 NADH + 266.6
NADPH + 882.6 PYR + 33.5 ACCOA
+ 74.1 AKG + 77.8 GLC + 124.6 OA +
1126.4 GTP + 42.6 PEP + 42.3 F6P +
22.2 SUCCOA + 57.1 G6P + 31.4 PROPI-
ONYLCOA + 25.7 DHAP + 85.1 R5P +
137.0 G3P + 75.0 3PG + 3.7 RL5P + 13.4
E4P + 0.06 SMMALONYLCOA
→ 1165.0 H2O + 1227.2 NAD + 266.6
NADP + 1204.5 ADP + 2669.3 PI +
87.2 COA + 809.0 CO2 + 1126.4 GDP
+ 22.2 SUCC + 55.1 FUM
RBIO_PRO - 4229.7 ATP + 981.6 NADH + 739.4 PYR
+ 74.1 AKG + 800.6 GDP + 124.6 OA +
42.6 PEP + 120.1 F6P + 23.4 SUCCOA
+ 57.1 G6P + 135.4 PROPIONYLCOA +
25.7 DHAP + 85.1 R5P + 137.0 G3P +
75.0 3PG + 3.7 RL5P + 13.4 E4P + 13.9
SMMALONYLCOA
→ 3062.6 H2O + 981.6 NAD + 4229.7
ADP + 3845.3 PI + 172.6 COA + 679.7
CO2 + 23.4 SUCC + 800.6 GTP + 55.1
FUM
RBIO_GLU - 2078.6 H2O + 4230.9 ATP + 824.7 NAD +
1588.0 NADPH + 739.4 PYR + 74.1 AKG
+ 800.6 GDP + 124.6 OA + 42.6 PEP +
120.0 F6P + 22.2 SUCCOA + 57.1 G6P +
135.4 PROPIONYLCOA + 25.7 DHAP +
85.1 R5P + 137.0 G3P + 75.0 3PG + 3.7
RL5P + 13.4 E4P + 13.9 SMMALONYL-
COA
→ 824.7 NADH + 1588.0 NADP + 4230.7
ADP + 3846.5 PI + 171.4 COA + 679.4
CO2 + 22.2 SUCC + 800.6 GTP + 55.1
FUM
RUP_GC0 - → GLC
RUP_GLU - → AKG
RUP_PRO - COA → PROPIONYLCOA
RUP_ACE - → ACCOA
RUP_GLY - → G3P
RUP_PYR - → PYR
RUP_SUC - → SUCC
RSEC_SUC - SUCC →
RSEC_ACO - ACCOA → COA
RSEC_ICT - ICIT →
RSEC_P - PI ↔
RSEC_CO2 - CO2 ↔
RSEC_H2O - H2O ↔
Rresp_nadh -45.2 ± 5.9 NADH + 2.3 MQ ↔ NAD + 2.3 MQH2
Rresp_atps -306.2 ± 13.4 H2O + ADP + PI + MQH2 ↔ ATP + MQ
Rresp_trd -0.4 ± 0.7 NAD + NADPH ↔ NADH + NADP
Rresp_ndk 2.5 ± 2.6 ADP + GTP ↔ ATP + GDP
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A.22 Used kinetic laws
Table A.22: Kinetic laws and for which reactions they were used in the dynamic models.
# Rate law Formula Used in
1 Convenience
kinetics
v = E · k
cat
+ ·∏i(Si/kMs,i) − kcat− ·∏ j(Pj/kMp, j)
∏i(1+Si/kMs,i)+∏ j(1+Pj/k
M
p, j)−1
enzymatic reactions (CCMtb)
2 Thermodynamic
Michaelis-Menten
v = E · kcat+ ·
(
∏i(Si/kMs,i)
∏i(Si/kMs,i)+∏ j(Pj/k
M
p, j)+1
)
· (1− e∆rG′/RT ) enzymatic reactions (tCCMtb, Pdtx)
3 Thermodynamic
Michaelis-Menten
without enzyme
v = vmax+ ·
(
∏i(Si/kMs,i)
∏i(Si/kMs,i)+∏ j(Pj/k
M
p, j)+1
)
· (1− e∆rG′/RT ) respiration and cofactor-converting
reactions (CCMtb, tCCMtb)
4 Michaelis Menten v = kcat · SkM+S Secretion reactions (all), individual
biomass reactions (tCCMtb, Pdtx)
5 Fixed flux v = k uptake reactions (all), biomass reaction
(CCMtb)
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A.23 Collection of known regulatory points in Mtb
Table A.23: Summary of known (potential) regulatory points in mycobacteria. Phosphorylation data for M. tuberculosis is taken from Prisic et al. [148] with the following
experimental conditions: L - log phase growth on glucose, S - stationary phase on glucose, N - nitric oxide stress, C - peroxide stress, H - hypoxia, A - acetate as carbon source.
Phosphorylation data for M. bovis is taken from Zheng et al. [215] with the follwing experimental conditions: M. bovis var BCG NCTC 5692 was grown in 5 L of Sauton’s liquid
medium for three weeks at 37 ◦C under stationary conditions. Phosphorylations on specific amino acid residues are listed (S,T,Y for serine, thyrosine and threonine, respectively)
* As activators and inhibitors only compounds which are not educts of the reaction are listed, all entries were extracted from the Brenda database except for ** [203] and *** [51].
Reaction ID Gene Mtb Uniprot ID Gene names Gene BCG Phospho Mtb Phospho BCG Activator* Inhibitor *
R04f_fba Rv0363c P9WQA3 fba BCG0401c L S18
R05f_tpi Rv1438 P9WG43 tpiA BCG1499 S13; T17
R09_pyk Rv1617 P9WKE5 pyk BCG1655 G6P
R11f_cis Rv0896 P9WPD5 gltA2 BCG0948 L,A,S
R14f_idh1 Rv3339c P9WKL1 icd BCG3409c S6 GLX, OA
Rv0066c O53611 icd2 BCG0097c L
R17f_fum Rv1098c P9WN93 fumC BCG1158c S14; Y18
R18f_mdh Rv1240 P9WK13 mdh BCG1300 L
R19f_pcx Rv2967c I6YEU0 pca BCG2988c T14 ACO
R20f_kgd Rv1248c P9WIS5 kgd BCG1308c L ACO**
R20f_kdh Rv1248c P9WIS5 kgd BCG1308c L
R20f_mez Rv2332 P9WK25 mez BCG2354 A
R22af_icl1 Rv0467 P9WKK7 icl BCG0507 MAL
R23f_mls Rv1837c P9WK17 glcB BCG1872c 3PG,D6PGL, PEP
R28f_pck Rv0211 P9WIH3 pckG BCG0248 A AKG
R43_fbp Rv1099c P9WN21 glpX BCG1159c MCIT***
R45f_dev Rv1445c P9WQP5 pgl BCG1506c S9
R50f_tkt1 Rv1449c P9WG25 tkt BCG1510c S2; T12
R52f_tkt2 Rv1449c P9WG25 tkt BCG1510c S2; T12
R55f_mcm Rv1492 P9WJK7 mutA BCG1555 S10
R56_gpm2 Rv3214 Q6MWZ7 gpm2 BCG3241 N-Term(Acetyl); T10; Y18
170 Appendix
A.24 Common regulatory edges in other bacterial species
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(R)-Methylmalonyl-CoA
L-serine
L-valine
L-cystine
D-Ribulose 5-phosphate
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Figure A.24: Enzyme inhibitions and activations of the central carbon metabolic enzymes in mycobacterial species.
Enzymes are shown on the x-axis, relevant metabolites on the y-axis. red dots indicate inhibitions, blue dots
activations, the size of the dots scales with the number of found regulations. Stacked histograms of the total number
of regulations is plotted on the margins. Data were obtained from the Brenda database.
Appendix 171
A.25 Parameter histograms of single steady state fits
ac
e_
im
_v
ac
o_
1_
km
p
ac
o_
1_
km
s
ac
o_
1_
vf
ac
o_
1_
vr
ac
o_
2_
km
p
ac
o_
2_
km
s
ac
o_
2_
vf
ac
o_
2_
vr
at
ps
FA
D
_v
at
ps
N
AD
_v
ci
s_
km
p
ci
s_
vf
ci
s_
vr
de
v_
km
p
de
v_
km
s
de
v_
vf
de
v_
vr
en
o_
km
p
en
o_
km
s
en
o_
vf
en
o_
vr
fb
a_
km
p1
fb
a_
km
p2
fb
a_
vf
fb
a_
vr
fb
p_
v
frd
_k
m
1
frd
_k
m
2
frd
_v
fu
m
_k
m
p
fu
m
_v
f
fu
m
_v
r
ga
b_
km
p1
ga
b_
km
p2
ga
b_
km
s1
ga
b_
km
s2
ga
b_
vf
ga
b_
vr
gl
c_
im
_v
gl
u_
im
_v
gl
y_
im
_v
gn
d1
_k
m
p1
gn
d1
_k
m
p2
gn
d1
_k
m
s1
gn
d1
_k
m
s2
gn
d1
_v
f
gn
d1
_v
r
gn
d2
_k
m
p1
gn
d2
_k
m
p2
gn
d2
_k
m
s1
gn
d2
_k
m
s2
gn
d2
_v
f
gn
d2
_v
r
gp
d_
km
1
gp
d_
km
2
gp
d_
km
3
gp
d_
km
4
gp
d_
vf
gp
d_
vr
he
x_
km
p1
he
x_
km
p2
he
x_
vf
he
x_
vr
ic
l1
_k
m
p1
ic
l1
_k
m
p2
ic
l1
_v
f
ic
l1
_v
r
ic
l2
_k
m
p1
ic
l2
_k
m
p2
ic
l2
_v
f
ic
l2
_v
r
id
h1
_k
m
p1
id
h1
_k
m
p2
id
h1
_v
f
id
h1
_v
r
id
h2
_k
m
p1
id
h2
_k
m
p2
id
h2
_v
f
id
h2
_v
r
kd
h_
km
p1
kd
h_
km
p2
kd
h_
km
s1
kd
h_
km
s2
kd
h_
vf
kd
h_
vr
kg
d_
km
p1
kg
d_
vf
kg
d_
vr
m
cd
_k
m
1
m
cd
_k
m
2
m
cd
_v
f
m
cd
_v
r
m
cl
_k
m
p1
m
cl
_k
m
p2
m
cl
_v
f
m
cl
_v
r
m
cm
_k
m
p
m
cm
_k
m
s
m
cm
_v
f
m
cm
_v
r
m
cs
_k
m
1
m
cs
_k
m
2
m
cs
_k
m
p
m
cs
_v
f
m
cs
_v
r
m
dh
_v
f
m
dh
_v
r
m
ez
_k
m
p1
m
ez
_k
m
p2
m
ez
_k
m
s1
m
ez
_k
m
s2
m
ez
_v
f
m
ez
_v
r
m
ls
_k
m
p
m
ls
_v
f
m
ls
_v
r
m
u_
gl
c
m
u_
gl
u
m
u_
pr
op
pc
c_
km
p1
pc
c_
km
p2
pc
c_
km
s1
pc
c_
km
s2
pc
c_
vf
pc
c_
vr
pc
k_
vf
pc
k_
vr
pc
x_
km
3
pc
x_
km
4
pc
x_
vf
pc
x_
vr
pf
k_
km
1
pf
k_
km
2
pf
k_
v
pg
i_
km
s
pg
i_
vf
pg
i_
vr
pg
k_
km
1
pg
k_
km
2
pg
k_
km
3
pg
k_
km
4
pg
k_
vf
pg
k_
vr
pr
op
_i
m
_v
py
d_
km
1
py
d_
km
2
py
d_
v
py
k_
km
2
py
k_
v
py
r_
im
_v
rp
e_
km
p
rp
e_
km
s
rp
e_
vf
rp
e_
vr
rp
i_
km
s
rp
i_
vf
rp
i_
vr
sc
s_
km
p1
sc
s_
km
p2
sc
s_
km
s1
sc
s_
km
s2
sc
s_
vf
sc
s_
vr
sd
h_
km
2
sd
h_
v
su
c_
im
_v
ta
l_
km
p1
ta
l_
km
p2
ta
l_
km
s1
ta
l_
km
s2
ta
l_
vf
ta
l_
vr
tk
t1
_k
m
p1
tk
t1
_k
m
p2
tk
t1
_k
m
s1
tk
t1
_k
m
s2
tk
t1
_v
f
tk
t1
_v
r
tk
t2
_k
m
p1
tk
t2
_k
m
p2
tk
t2
_k
m
s1
tk
t2
_k
m
s2
tk
t2
_v
f
tk
t2
_v
r
tp
i_
km
p
tp
i_
vf
tp
i_
vr
trd
_v
f
trd
_v
r
zw
f_
km
p1
zw
f_
km
p2
zw
f_
km
s2
zw
f_
vf
zw
f_
vr
G
LC
_g
lu
G
6P
_g
lu
F6
P_
gl
u
F1
6P
_g
lu
G
3P
_g
lu
D
AP
_g
lu
BP
G
_g
lu
XP
G
_g
lu
PE
P_
gl
u
PY
R
_g
lu
C
IT
_g
lu
C
AT
_g
lu
IC
T_
gl
u
AK
G
_g
lu
SC
A_
gl
u
SU
C
_g
lu
FU
M
_g
lu
M
AL
_g
lu
O
XA
_g
lu
SS
A_
gl
u
M
IC
_g
lu
M
C
T_
gl
u
G
YO
_g
lu
AT
P_
gl
u
AD
P_
gl
u
N
AD
H
_g
lu
N
AD
_g
lu
AC
O
_g
lu
PC
O
_g
lu
N
AD
P_
gl
u
N
AD
PH
_g
lu
s6
PG
L_
gl
u
s6
PG
_g
lu
R
I5
P_
gl
u
X5
P_
gl
u
R
5P
_g
lu
S7
P_
gl
u
E4
P_
gl
u
M
M
C
O
_g
lu
FA
D
_g
lu
FA
D
H
2_
gl
u
relative frequency
pa
ra
m
et
er
 v
al
ue
 b
et
we
en
 b
ou
nd
s
Figure A.25: Kernel density plots of the optimum parameters sets of ∼500 individual steady state fits for the three
different nutrients. Each subplot extends from the lower to the upper bound set for the optimization. Non-overlapping
distributions can hint to the need for regulation.
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A.26 Maximum-minimum driving force optimization problem
The MDF calculations were carried out as described in [134] solving the optimization problem
max
x,MDF
MDF
subject to − (G0+R ·T ·NT · lnx)≥MDF
xlb ≤ x≤ xub
ylb ≤O ·x≤ yub
∆rG0lb ≤ ∆rG0 ≤ ∆rG0ub
with MDF as a tight lower bound equal to the Maximum-Minimum driving force in kJ/mol
as defined by Noor et al. This value can is the negative of the specific Gibbs energy ∆rG′
of the reaction(s) in the pathway with the most shallow thermodynamic gradient (i.e. the
lowest driving force). R and T denote the ideal gas constant in kJ/mol/K and the absolute
temperature in K, respectively. The general boundaries on the model metabolite’s concentrations
xlb,xub ∈ Rm contain the feasible logarithmic concentration ranges based on physiologically
sensual values [57], in accordance with the ranges of the measured concentrations, between xmin
= 1µM and xmax = 5·104µM. For measured metabolites the concentration vector x multiplied
by the observables matrix O was confined to lie with in ±2σ of the measured values y ∈ Ry
(collected in ylb,yub ∈Ry). Note this additional constraint would be non linear in the logarithmic
concentration space and we hence have to solve a nonlinear problem as opposed to the original
linear MDF problem in [134].
A.27 Protein cost optimization problem
The optimization of the protein cost is based on the method in [57]
max
E,x
r
∑
j=1
λ j/Vtot
where λ j/Vtot = 1/(Mw j · kcat+, j · (saturation term) j · (thermodynamic term) j)
subject to xlb ≤ x≤ xub
ylb ≤O ·x≤ yub
∆rG0lb ≤ ∆rG0 ≤ ∆rG0ub
The saturation and kinetic terms are defined in the kinetic equation 7.1. Mw denotes the
molecular weight of each enzyme complex in Da. Each λ j corresponds to an entry in E,
describing the enzyme amount for reaction j in mol. Vtot is set to 1 mol/s to normalize the
protein to a unit of flux, such that the calculated enzyme abundance as depicted in Figure 7.3
has the unit mol/(mol/s).
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A.28 Flux maximization with limited enzyme allowance problem
For the maximization of the pathway flux given a limited amount of total enzyme Etot in Da we
solved the following optimization problem for values of f between 0 and 1:
max
E,x
P2
∑
i=P1
vi,1
subject to xlb ≤ x≤ xub
ylb ≤ x ·O≤ yub
∑
i∈P1
Ei ·Mwi = f ·Etot
∑
i∈P2
Ei ·Mwi = (1− f ) ·Etot
N∗ ·v= 0
Pi are vectors containing the indices of the reactions that belong to each of the pathways, Mw
is the vector of molecular weights of the enzyme complexes in Da, as above. The reduced
stoichiometry matrix N∗ contains only the rows corresponding to the internal metabolites of
both pathways (marked in color in Fig. 7.1 B)
Note that the steady state constraint, the observables constraint as well as the objective function
are nonlinear, with the flux vector v being calculated following the kinetic formulation in
Equation 7.1.
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Figure A.28: Convergence profiles of the protein fraction optimization. Colors correspond to f , the percentage of
total protein in the MCIT pathway. Please note that for the 0.8 fraction of the glucose, the best fit (marked by an
asterisk) was neglected, as it was most likely error prone (deviates from the remaining fits in the global optimum).
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A.29 Overview of reactions in Pdtx
Table A.29: Summary of the Pdtx model reactions. Species names are as in Table A.18, ∆rG0 and their standard deviations are from eQuilibrator [58], the rate law indices link to
Table A.22, sd denotes the standard deviation
ID Reaction name Reaction KEGG EC number ∆rG0
[kJ/mol]
∆rG0 sd
[kJ/mol]
rate law
pcc propionyl-CoA carboxylase
ATP + CO2 + PROPIONYLCOA ↔
ADP + PI + SMMALONYLCOA
R01859 6.4.1.3 -5.0 5.3 2
rmcoa methylmalonyl-CoA epimerase
SMMALONYLCOA ↔
RMMALONYLCOA
R02765 5.1.99.1 0.0 5.8 2
mcm methylmalonyl-CoA mutase
RMMALONYLCOA ↔
SUCCOA
R00833 5.4.99.2 -7.6 2.1 2
scs succinyl-CoA synthase
ADP + PI + SUCCOA ↔
ATP + COA + SUCC
R00405 6.2.1.5 1.3 1.4 2
mcs 2-methylcitrate synthase
H2O + OA + PROPIONYLCOA ↔
COA + 2METHYLCITRATE
R00931 2.3.3.5 -42.9 3.4 2
mcd methylcitrate dehydratase
2METHYLCITRATE ↔
H2O + METHYLACONITATE
R04424 4.2.1.79 -0.9 5.6 2
macn aconitate hydratase
H2O + METHYLACONITATE ↔
METHYLISOCITRATE
R04425 4.2.1.99 0.9 5.6 2
mcl isocitrate lyase (methyl)
METHYLISOCITRATE ↔
PYR + SUCC
R00409 4.1.3.30 9.8 3.0 2
RUP_PRO propionate uptake → PROPIONYLCOA - - - - 5
RBIO_SMMALONYLCOA Biomass drain for
S-Methlymalonyl-CoA
SMMALONYLCOA →
BIO_SMMALONYLCOA
- - - - 4
RBIO_PROPIONYLCOA Biomass drain for
Propionyl-CoA
PROPIONYLCOA →
BIO_PROPIONYLCOA
- - - - 4
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A.30 Overview of enzyme complexes in Pdtx
Table A.30: Enzyme complexes of the Pdtx model, their composition and their subunit concentrations in the two used experimental conditions in fmol/mLOD600=1.
Abbreviations: Mw - Molecular weight, AA - number of amino acids
ID RvNumber subunits/
active
site
Mw [Da] AA [#] Uniprot ID gene
names
Comments / references GC2 std PRO std
pcc Rv3285 1 63783 600 P96890 accA3 Alpha-subunit, [62] 1772.4 86.8 1718.5 195.6
Rv3280 1 59354 548 P9WQH7 accD5 Beta-subunit 573.1 41.8 635.9 7.6
Rv3281 3 19014 177 P96886 accE5 Eps-subunit 328.6 28.7 381.1 10.1
rmcoa Rv1322A 2 16626 152 L7N6B1 Rv1322A Annotation unclear, not in KEGG, [173] 56.9 5.1 66.0 18.0
mcm Rv1492 1 64744 615 P9WJK7 mutA [173] 171.4 17.0 164.2 41.1
Rv1493 1 80604 750 P9WJK5 mutB 181.1 16.7 167.4 29.7
scs Rv0952 1 31229 303 P9WGC7 sucD Brenda 2138.2 277.5 1846.5 14.4
Rv0951 1 40926 387 P9WGC5 sucC 2228.1 215.2 1863.0 50.4
mcs Rv1131 2 42969 393 I6Y9Q3 prpC in KEGG as 2.3.3.1 10.3 1.6 553.8 60.1
mcd Rv1130 1 57783 526 O06582 prpD Brenda 307.7 128.4 868.9 23.7
macn Rv1475c 1 102449 943 O53166 acn in KEGG only as 4.2.1.3, [10] 2279.2 190.2 1907.2 56.8
mcl Rv0467 4 47087 428 P9WKK7 icl function carried out by icl1, [67] 343.8 42.3 1216.3 59.4
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A.31 Fluxes of Pdtx
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Figure A.31: Fluxes of the Pdtx model corresponding to the simulations shown in Figure 7.5 in µM/s.
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A.32 Profile likelihoods of Pdtx model parameters
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Figure A.32: Summary of the profile likelihoods of all model parameters of the Pdtx model. Each black dot represents
one fit with the value of the current parameter fixes to the corresponding value on the x-axis. The y-axis depicts the
negative log-likelihood and the red dotted line indicates the 95 % threshold as explained in the Methods. The gray
asterisk denoted the found optimum parameter value, the blue histogram includes all values of the the parameter
in all profile-likelihood fits (all black dots in the figure). The x-axis is on a logarithmic scale, except for the
∆rG0 parameters.
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A.33 Parameter values and confidences of Pdtx
Table A.33: Summary of the profile likelihood estimation. For each parametr, the optimum value from the fitting and the lower and upper bounds from the optimization are given.
The column islog contains a 1 if the parameter is fitted in log space and a 0 for linear parameters. In the identifiability column, str.nID denotes structural non- identifiability,
pra.nID denotes practical non-identifiability and id identifiable parameters. lPl and uPL are resulting lower and upper limits for the confidence intervals. q2.5 and q97.5 are the
2.5 % and 97.5 % quantiles of the blue distributions shown in Figure A.32.
# Parameter fitted value lb ub islog Identifiability lPL uPL q2.5 q97.5
1 Km_bio_PROPIONYLCOA 1.39 0 6.7 1 str.nID −∞ +∞ 1.38 1.39
2 Km_bio_SMMALONYLCOA 1.62 0 6.7 1 pra.nID 1.266 +∞ 1.61 1.62
3 Km_macn_METHYLACONITATE 3.33 0 6.7 1 str.nID −∞ +∞ 2.61 3.33
4 Km_macn_METHYLISOCITRATE 2.10 0 6.7 1 str.nID −∞ +∞ 0.15 2.10
5 Km_mcd_METHYLACONITATE 6.34 0 6.7 1 str.nID −∞ +∞ 6.34 6.34
6 Km_mcd_s2METHYLCITRATE 2.45 0 6.7 1 str.nID −∞ +∞ 4.08E-05 2.45
7 Km_mcl_METHYLISOCITRATE 2.63 0 6.7 1 str.nID −∞ +∞ 0.30 2.67
8 Km_mcl_PYR 2.92 0 6.7 1 str.nID −∞ +∞ 2.09 3.92
9 Km_mcl_SUCC 2.74 0 6.7 1 str.nID −∞ +∞ 1.91 3.76
10 Km_mcm_RMMALONYLCOA 1.04 0 6.7 1 str.nID −∞ +∞ 0.56 1.04
11 Km_mcm_SUCCOA 4.22 0 6.7 1 str.nID −∞ +∞ 4.22 4.46
12 Km_mcs_COA 6.30 0 6.7 1 str.nID −∞ +∞ 6.30 6.30
13 Km_mcs_OA 3.30 0 6.7 1 str.nID −∞ +∞ 3.28 3.84
14 Km_mcs_PROPIONYLCOA 3.09 0 6.7 1 str.nID −∞ +∞ 3.07 3.65
15 Km_mcs_s2METHYLCITRATE 6.68 0 6.7 1 str.nID −∞ +∞ 6.68 6.68
16 Km_pcc_ADP 3.27 0 6.7 1 str.nID −∞ +∞ 3.27 3.64
17 Km_pcc_ATP 1.39 0 6.7 1 str.nID −∞ +∞ 0.010 1.39
18 Km_pcc_HCO3 1.19 0 6.7 1 str.nID −∞ +∞ 0.008 1.18
19 Km_pcc_PROPIONYLCOA 1.10 0 6.7 1 str.nID −∞ +∞ 0.008 1.10
20 Km_pcc_Phosphate 3.18 0 6.7 1 str.nID −∞ +∞ 3.17 3.54
21 Km_pcc_SMMALONYLCOA 2.25 0 6.7 1 str.nID −∞ +∞ 2.25 2.73
22 Km_rmcoa_RMMALONYLCOA 3.93 0 6.7 1 pra.nID −∞ +∞ 3.93 5.48
23 Km_rmcoa_SMMALONYLCOA 1.08E-05 0 6.7 1 pra.nID −∞ +∞ 2.39E-14 1.08E-05
24 Km_scs_ADP 1.35 0 6.7 1 str.nID −∞ +∞ 1.35 1.35
25 Km_scs_ATP 5.77 0 6.7 1 str.nID −∞ +∞ 5.76 5.76
26 Km_scs_COA 5.37 0 6.7 1 str.nID −∞ +∞ 5.37 5.37
27 Km_scs_Phosphate 1.27 0 6.7 1 str.nID −∞ +∞ 1.27 1.27
28 Km_scs_SUCC 5.36 0 6.7 1 str.nID −∞ +∞ 5.36 5.36
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# Parameter fitted value lb ub islog Identifiability lPL uPL q2.5 q97.5
29 Km_scs_SUCCOA 0.93 0 6.7 1 str.nID −∞ +∞ 0.93 0.93
30 dG0_macn 0.25 -4.7 6.5 0 str.nID −∞ +∞ -4.58 0.25
31 dG0_mcd 2.77 -6.5 4.7 0 str.nID −∞ +∞ -0.68 4.70
32 dG0_mcl 11.85 6.8 13 0 str.nID −∞ +∞ 11.47 12.61
33 dG0_mcm -5.48 -9.7 -5.5 0 pra.nID -5.89 +∞ -5.48 -5.48
34 dG0_mcs -40.87 -46 -40 0 str.nID −∞ +∞ -40.87 -40.70
35 dG0_pcc -1.38 -15 5.3 0 str.nID −∞ +∞ -1.87 -0.84
36 dG0_rmcoa 5.80 -5.8 5.8 0 pra.nID 5.34 +∞ 5.80 5.80
37 dG0_scs 0.95 -0.0086 2.7 0 str.nID −∞ +∞ 0.64 1.37
38 init_ADP_GC2 3.20 0 4.7 1 id 3.18 3.22 3.20 3.20
39 init_ADP_PRO 2.88 0 4.7 1 id 2.86 2.91 2.88 2.88
40 init_ATP_GC2 3.71 0 4.7 1 id 3.68 3.74 3.71 3.71
41 init_ATP_PRO 3.19 0 4.7 1 id 3.15 3.23 3.19 3.19
42 init_BIO_PROPIONYLCOA 0.00 0 1 1 fixed
43 init_BIO_SMMALONYLCOA 0.00 0 1 1 fixed
44 init_COA_GC2 2.05 0 4.7 1 id 1.96 2.15 2.05 2.05
45 init_COA_PRO 2.52 0 4.7 1 id 2.39 2.65 2.52 2.52
46 init_H2O_GC2 6.00 6 6 1 fixed
47 init_H2O_PRO 6.00 6 6 1 fixed
48 init_HCO3_GC2 2.97 0 4.7 1 str.nID −∞ +∞ 2.88 3.11
49 init_HCO3_PRO 2.53 0 4.7 1 str.nID −∞ +∞ 2.44 2.65
50 init_METHYLACONITATE_GC2 0.56 0 4.7 1 fixed
51 init_METHYLACONITATE_PRO 2.07 0 4.7 1 fixed
52 init_METHYLISOCITRATE_GC2 0.46 0 4.7 1 fixed
53 init_METHYLISOCITRATE_PRO 1.93 0 4.7 1 fixed
54 init_OA_GC2 0.96 0 1.7 1 str.nID −∞ +∞ 0.92 1.05
55 init_OA_PRO 0.72 0 1.7 1 str.nID −∞ +∞ 0.56 0.73
56 init_PROPIONYLCOA_GC2 1.36 0 4.7 1 fixed
57 init_PROPIONYLCOA_PRO 2.16 0 4.7 1 fixed
58 init_PYR_GC2 2.01 0 4.7 1 str.nID −∞ +∞ 1.91 2.46
59 init_PYR_PRO 3.70 0 4.7 1 str.nID −∞ +∞ 3.60 4.13
60 init_Phosphate_GC2 3.41 0 4.7 1 pra.nID −∞ +∞ 3.36 3.49
61 init_Phosphate_PRO 3.05 0 4.7 1 pra.nID −∞ +∞ 2.99 3.14
62 init_RMMALONYLCOA_GC2 0.67 0 4.7 1 fixed
63 init_RMMALONYLCOA_PRO 1.01 0 4.7 1 fixed
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64 init_SMMALONYLCOA_GC2 1.67 0 4.7 1 fixed
65 init_SMMALONYLCOA_PRO 2.14 0 4.7 1 fixed
66 init_SUCCOA_GC2 1.63 0 4.7 1 fixed
67 init_SUCCOA_PRO 1.97 0 4.7 1 fixed
68 init_SUCC_GC2 2.31 0 4.7 1 id 2.27 2.36 2.31 2.31
69 init_SUCC_PRO 2.03 0 4.7 1 id 1.97 2.10 2.03 2.03
70 init_s2METHYLCITRATE_GC2 0.97 0 4.7 1 fixed
71 init_s2METHYLCITRATE_PRO 2.44 0 4.7 1 fixed
72 k_cat_macn 3.39 -12 10 1 str.nID −∞ +∞ 3.39 4.89
73 k_cat_mcd 3.71 -12 10 1 str.nID −∞ +∞ 2.15 3.85
74 k_cat_mcl 3.43 -12 10 1 str.nID −∞ +∞ 2.31 4.42
75 k_cat_mcm 7.42 -12 10 1 pra.nID 2.53 +∞ 7.42 9.95
76 k_cat_mcs 4.38 -12 10 1 str.nID −∞ +∞ 4.34 5.54
77 k_cat_pcc 3.04 -12 10 1 id 2.77 4.08 3.02 3.06
78 k_cat_rmcoa 3.00 -12 10 1 pra.nID 2.86 +∞ 2.99 3.03
79 k_cat_scs 8.46 -12 10 1 pra.nID 2.18 +∞ 8.45 8.51
80 mu_PROPIONYLCOA_GC2 -0.05 -2.9 0.8 1 str.nID −∞ +∞ -0.07 -0.05
81 mu_PROPIONYLCOA_PRO -0.22 -2.9 0.8 1 str.nID −∞ +∞ -0.23 -0.21
82 mu_SMMALONYLCOA_GC2 -2.86 -2.9 0.8 1 pra.nID −∞ -0.75 -2.86 -2.84
83 mu_SMMALONYLCOA_PRO -0.96 -2.9 0.8 1 pra.nID -1.33 +∞ -0.96 -0.95
84 r_up_PRO 1.30 1.3 2.7 1 pra.nID −∞ 1.48 1.30 1.30
85 sd_ADP_obs -1.35 -5 -0.6 1 id -1.45 -1.24 -1.35 -1.35
86 sd_ATP_obs -1.11 -5 -0.6 1 id -1.20 -1.00 -1.11 -1.11
87 sd_BIO_PROPIONYLCOA -0.82 -0.82 -0.4 1 pra.nID −∞ -0.81 -0.82 -0.82
88 sd_BIO_SMMALONYLCOA -0.82 -0.82 -0.4 1 pra.nID −∞ -0.81 -0.82 -0.82
89 sd_CoA_obs -0.60 -5 -0.6 1 pra.nID -0.67 +∞ -0.60 -0.60
90 sd_PropCoA_obs -0.93 -5 -0.6 1 id -1.02 -0.82 -0.93 -0.92
91 sd_Suc_mMalCoA_obs -1.05 -5 -0.6 1 id -1.15 -0.93 -1.05 -1.05
92 sd_mMalonate_Suc_obs -0.90 -5 -0.6 1 id -0.99 -0.79 -0.90 -0.90
93 sd_mMalonylCoA_obs -0.97 -5 -0.6 1 id -1.07 -0.85 -0.97 -0.96
94 sd_methylcitrate_methylisocitrate_obs -1.35 -5 -0.6 1 id -1.45 -1.25 -1.36 -1.35
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A.34 Response coefficients of Pdtx
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Figure A.34: Response coefficients of the Pdtx model, corresponding to the simulations in Figure 7.5.
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A.35 Example simulation of the tCCMtb model
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Figure A.35: Simulations and data of two individual model simulations (lines and shaded error estimates) for
propionate (blue) and glutamate (gray) control data (dots).


The Road goes ever on and on,
Down from the door where it began.
Now far ahead the Road has gone,
And I must follow, if I can.
Bilbo Baggins
